SB 622: Optometry.
- Session Year: 2015-2016
- House: Senate
- Latest Version Date: 2016-06-22
The Optometry Practice Act provides for the licensure and regulation of the practice of optometry by the State Board of Optometry, and defines the practice of optometry to include, among other things, the prevention and diagnosis of disorders and dysfunctions of the visual system, and the treatment and management of certain disorders and dysfunctions of the visual system, as well as the provision of rehabilitative optometric services, and doing certain things, including, but not limited to, the examination of the human eyes, the determination of the powers or range of human vision, and the prescribing of contact and spectacle lenses. Existing law authorizes an optometrist certified to use therapeutic pharmaceutical agents to diagnose and treat specified conditions, use specified pharmaceutical agents, and order specified diagnostic tests. The act requires optometrists treating or diagnosing eye disease, as specified, to be held to the same standard of care to which physicians and surgeons and osteopathic physician and surgeons are held. The act requires an optometrist, in certain circumstances, to refer a patient to an ophthalmologist or a physician and surgeon, including when a patient has been diagnosed with a central corneal ulcer and the central corneal ulcer has not improved within 48 hours of the diagnosis. The act makes a violation of any of its provisions a crime. All moneys collected pursuant to the act, except where otherwise provided, are deposited in the Optometry Fund and continuously appropriated to the board to carry out the act.
This bill would revise and recast those provisions. The bill would delete certain requirements that an optometrist refer a patient to an ophthalmologist or a physician and surgeon, including when a patient has been diagnosed with a central corneal ulcer and the central corneal ulcer has not improved within 48 hours of the diagnosis. The bill would additionally define the practice of optometry as the provision of habilitative optometric services, and would authorize the board to allow optometrists to use nonsurgical technology to treat any authorized condition under the act. The bill would additionally authorize an optometrist certified to use therapeutic pharmaceutical agents to collect blood by skin puncture or venipuncture, to perform skin tests, as specified, to diagnose ocular allergies, and to use mechanical lipid extraction of meibomian glands and nonsurgical techniques. The bill would require the board to grant an optometrist certified to treat glaucoma a certificate for the use of specified immunizations if certain conditions are met, including, among others, that the optometrist is certified in basic life support. The bill would additionally authorize an optometrist certified to use therapeutic pharmaceutical agents to, among other things, be certified to use anterior segment lasers, as specified, and to be certified to perform specified minor procedures, as specified, if certain requirements are met.
The bill would require the board to charge a fee of not more than $150 to cover the reasonable regulatory cost of certifying an optometrist to use anterior segment lasers, a fee of not more than $150 to cover the reasonable regulatory cost of certifying an optometrist to use minor procedures, and a fee of not more than $100 to cover the reasonable regulatory cost of certifying an optometrist to use immunizations. Because this bill would increase those moneys deposited in a continuously appropriated fund, it would make an appropriation.
Existing law establishes the Office of Statewide Health Planning and Development, which is vested with all the duties, powers, responsibilities, and jurisdiction of the State Department of Public Health relating to health planning and research development.
This bill would declare the intent of the Legislature that the Office of Statewide Health Planning and Development designate a pilot project to test, demonstrate, and evaluate expanded roles for optometrists in the performance of management and treatment of diabetes mellitus, hypertension, and hypercholesterolemia.
Because a violation of the act is a crime, this bill would expand the scope of an existing crime and would, therefore, result in a state-mandated local program.
The California Constitution requires the state to reimburse local agencies and school districts for certain costs mandated by the state. Statutory provisions establish procedures for making that reimbursement.
This bill would provide that no reimbursement is required by this act for a specified reason.
The Optometry Practice Act provides for the licensure and regulation of the practice of optometry by the State Board of Optometry, and defines the practice of optometry to include, among other things, the prevention and diagnosis of disorders and dysfunctions of the visual system, and the treatment and management of certain disorders and dysfunctions of the visual system, as well as the provision of rehabilitative optometric services, and doing certain things, including, but not limited to, the examination of the human eyes, the determination of the powers or range of human vision, and the prescribing of contact and spectacle lenses. Existing law authorizes an optometrist certified to use therapeutic pharmaceutical agents to diagnose and treat specified conditions, use specified pharmaceutical agents, and order specified diagnostic tests. The act requires optometrists treating or diagnosing eye disease, as specified, to be held to the same standard of care to which physicians and surgeons and osteopathic physician and surgeons are held. The act requires an optometrist, in certain circumstances, to refer a patient to an opthamologist ophthalmologist or a physician and surgeon, including when a patient has been diagnosed with a central corneal ulcer and the central corneal ulcer has not improved within 48 hours of the diagnosis. The act makes a violation of any of its provisions a crime. All moneys collected pursuant to the act, except where otherwise provided, are deposited in the Optometry Fund and continuously appropriated to the board to carry out the act.
This bill would revise and recast those provisions. The bill would delete certain requirements that an optometrist refer a patient to an opthamologist ophthalmologist or a physician and surgeon, including when a patient has been diagnosed with a central corneal ulcer and the central corneal ulcer has not improved within 48 hours of the diagnosis. The bill would additionally define the practice of optometry as the provision of habilitative optometric services, and would authorize the board to allow optometrists to use nonsurgical technology to treat any authorized condition under the act. The bill would additionally authorize an optometrist certified to use therapeutic pharmaceutical agents to collect a blood specimen by finger prick method, skin puncture or venipuncture, to perform skin tests, as specified, to diagnose ocular allergies, and to use mechanical lipid extraction of meibomian glands and nonsurgical techniques. The bill would require the board to grant an optometrist certified to treat glaucoma a certificate for the use of specified immunizations if certain conditions are met, including, among others, that the optometrist is certified in basic life support. The bill would additionally authorize an optometrist certified to use therapeutic pharmaceutical agents to, among other things, be certified to use anterior segment lasers, as specified, and to be certified to perform specified minor procedures, as specified, if certain requirements are met.
The bill would require the board to charge a fee of not more than $150 to cover the reasonable regulatory cost of certifying an optometrist to use anterior segment lasers, a fee of not more than $150 to cover the reasonable regulatory cost of certifying an optometrist to use minor procedures, and a fee of not more than $100 to cover the reasonable regulatory cost of certifying an optometrist to use immunizations. Because this bill would increase those moneys deposited in a continuously appropriated fund, it would make an appropriation.
Existing law establishes the Office of Statewide Health Planning and Development, which is vested with all the duties, powers, responsibilities, and jurisdiction of the State Department of Public Health relating to health planning and research development.
This bill would declare the intent of the Legislature that the Office of Statewide Health Planning and Development designate a pilot project to test, demonstrate, and evaluate expanded roles for optometrists in the performance of management and treatment of diabetes mellitus, hypertension, and hypercholesterolemia.
Because a violation of the act is a crime, this bill would expand the scope of an existing crime and would, therefore, result in a state-mandated local program.
The California Constitution requires the state to reimburse local agencies and school districts for certain costs mandated by the state. Statutory provisions establish procedures for making that reimbursement.
This bill would provide that no reimbursement is required by this act for a specified reason.
The Optometry Practice Act provides for the licensure and regulation of the practice of optometry by the State Board of Optometry, and defines the practice of optometry to include, among other things, the prevention and diagnosis of disorders and dysfunctions of the visual system, and the treatment and management of certain disorders and dysfunctions of the visual system, as well as the provision of rehabilitative optometric services, and doing certain things, including, but not limited to, the examination of the human eyes, the determination of the powers or range of human vision, and the prescribing of contact and spectacle lenses. Existing law authorizes an optometrist certified to use therapeutic pharmaceutical agents to diagnose and treat specified conditions, use specified pharmaceutical agents, and order specified diagnostic tests. The act requires optometrists treating or diagnosing eye disease, as specified, to be held to the same standard of care to which physicians and surgeons and osteopathic physician and surgeons are held. The act requires an optometrist, in certain circumstances, to refer a patient to an opthamologist or a physician and surgeon, including when a patient has been diagnosed with a central corneal ulcer and the central corneal ulcer has not improved within 48 hours of the diagnosis. The act makes a violation of any of its provisions a crime. All moneys collected pursuant to the act, except where otherwise provided, are deposited in the Optometry Fund and continuously appropriated to the board to carry out the act.
This bill would revise and recast those provisions. The bill would delete certain requirements that an optometrist refer a patient to an opthamologist or a physician and surgeon, including when a patient has been diagnosed with a central corneal ulcer and the central corneal ulcer has not improved within 48 hours of the diagnosis. The bill would additionally define the practice of optometry as the provision of habilitative optometric services, and would authorize the board to allow optometrists to use nonsurgical technology to treat any authorized condition under the act. The bill would additionally authorize an optometrist certified to use diagnostic therapeutic pharmaceutical agents, as specified, including, but not limited to, oral and topical diagnostic pharmaceutical agents that are not controlled substances. agents to collect a blood specimen by finger prick method, to perform skin tests, as specified, to diagnose ocular allergies, and to use mechanical lipid extraction of meibomian glands and nonsurgical techniques. The bill would authorize an optometrist to independently initiate and administer vaccines, as specified, for a person 3 years of age and older, if the optometrist meets certain requirements, including, but not limited to, require the board to grant an optometrist certified to treat glaucoma a certificate for the use of specified immunizations if certain conditions are met, including, among others, that he or she the optometrist is certified in basic life support for health care professionals. support. The bill would additionally authorize an optometrist certified to use therapeutic pharmaceutical agents to, among other things, be certified to use anterior segment lasers, as specified, and to be certified to perform specified minor procedures, as specified, if certain requirements are met.
The bill would require the board to charge a fee of not more than $150 to cover the reasonable regulatory cost of certifying an optometrist to use anterior segment lasers. lasers, a fee of not more than $150 to cover the reasonable regulatory cost of certifying an optometrist to use minor procedures, and a fee of not more than $100 to cover the reasonable regulatory cost of certifying an optometrist to use immunizations. Because this bill would increase those moneys deposited in a continuously appropriated fund, it would make an appropriation.
Existing law establishes the Office of Statewide Health Planning and Development, which is vested with all the duties, powers, responsibilities, and jurisdiction of the State Department of Public Health relating to health planning and research development.
This bill would declare the intent of the Legislature that the Office of Statewide Health Planning designate a pilot project to test, demonstrate, and evaluate expanded roles for optometrists in the performance of management and treatment of diabetes mellitus, hypertension, and hypercholesterolemia.
Because a violation of the act is a crime, this bill would expand the scope of an existing crime and would, therefore, result in a state-mandated local program.
The California Constitution requires the state to reimburse local agencies and school districts for certain costs mandated by the state. Statutory provisions establish procedures for making that reimbursement.
This bill would provide that no reimbursement is required by this act for a specified reason.
The Optometry Practice Act provides for the licensure and regulation of the practice of optometry by the State Board of Optometry, and defines the practice of optometry to include, among other things, the prevention and diagnosis of disorders and dysfunctions of the visual system, and the treatment and management of certain disorders and dysfunctions of the visual system, as well as the provision of rehabilitative optometric services, and doing certain things, including, but not limited to, the examination of the human eyes, the determination of the powers or range of human vision, and the prescribing of contact and spectacle lenses. Existing law authorizes an optometrist certified to use therapeutic pharmaceutical agents to diagnose and treat specified conditions, use specified pharmaceutical agents, and order specified diagnostic tests. The act requires optometrists treating or diagnosing eye disease, as specified, to be held to the same standard of care to which physicians and surgeons and osteopathic physician and surgeons are held. The act makes a violation of any of its provisions a crime. All moneys collected pursuant to the act, except where otherwise provided, are deposited in the Optometry Fund and continuously appropriated to the board to carry out the act.
This bill would revise and recast those provisions. The bill would additionally define the practice of optometry as the provision of habilitative optometric services, and would authorize the board to allow optometrists to use nonsurgical technology to treat any authorized condition under the act. The bill would authorize an optometrist to use diagnostic pharmaceutical agents, as specified, including, but not limited to, oral and topical diagnostic pharmaceutical agents that are not controlled substances. The bill would authorize an optometrist to independently initiate and administer vaccines, as specified, for a person 3 years of age and older, if the optometrist meets certain requirements, including, but not limited to, that he or she is certified in basic life support for health care professionals. The bill would additionally authorize an optometrist certified to use therapeutic pharmaceutical agents to, among other things, be certified to use anterior segment lasers, as specified, and to be certified to perform specified minor procedures, as specified, if certain requirements are met.
The bill would require the board to charge a fee of not more than $150 to cover the reasonable regulatory cost of certifying an optometrist to use anterior segment lasers. Because this bill would increase those moneys deposited in a continuously appropriated fund, it would make an appropriation.
Because a violation of the act is a crime, this bill would expand the scope of an existing crime and would, therefore, result in a state-mandated local program.
The California Constitution requires the state to reimburse local agencies and school districts for certain costs mandated by the state. Statutory provisions establish procedures for making that reimbursement.
This bill would provide that no reimbursement is required by this act for a specified reason.
The Vocational Nursing Practice Act provides for the licensure and regulation of the practice of vocational nursing by the Board of Vocational Nursing and Psychiatric Technicians within the Department of Consumer Affairs. The act requires the board to consist of 11 members, including one member that is a licensed vocational nurse or registered nurse who has had no less than 5 years experience as a teacher or administrator in an accredited school of vocational nursing.
This bill would require that the vocational nurse or registered nurses experience be in an accredited school of vocational nursing approved by the board.
The Vocational Nursing Practice Act provides for the licensure and regulation of the practice of vocational nursing by the Board of Vocational Nursing and Psychiatric Technicians within the Department of Consumer Affairs. The act requires the board to consist of 11 members, including one member that is a licensed vocational nurse or registered nurse who has had no less than 5 years experience as a teacher or administrator in an accredited school of vocational nursing.
This bill would require that the vocational nurse or registered nurses experience be in an accredited school of vocational nursing approved by the board.
(a)The practice of optometry includes the prevention and diagnosis of disorders and dysfunctions of the visual system, and the treatment and management of certain disorders and dysfunctions of the visual system, as well as the provision of habilitative or rehabilitative optometric services, and is the doing of any or all of the following:
(1)The examination of the human eye or eyes, or its or their appendages, and the analysis of the human vision system, either subjectively or objectively.
(2)The determination of the powers or range of human vision and the accommodative and refractive states of the human eye or eyes, including the scope of its or their functions and general condition.
(3)The prescribing or directing the use of, or using, any optical device in connection with ocular exercises, visual training, vision training, or orthoptics.
(4)The prescribing of contact and spectacle lenses for, or the fitting or adaptation of contact and spectacle lenses to, the human eye, including lenses that may be classified as drugs or devices by any law of the United States or of this state.
(5)The use of topical pharmaceutical agents for the purpose of the examination of the human eye or eyes for any disease or pathological condition.
(b)The State Board of Optometry shall, by regulation, establish educational and examination requirements for licensure to ensure the competence of optometrists to practice pursuant to this chapter, except as specified in Section 3041.3 related to the use of anterior segment lasers and in Section 3041.4 related to minor procedures. Satisfactory completion of the required educational and examination requirements shall be a condition for the issuance of an original optometrist license or required certifications pursuant to this chapter.
(c)The board may promulgate regulations authorizing optometrists to use noninvasive, nonsurgical technology to treat a condition authorized by this chapter. The board shall require a licensee to take a minimum of four hours of education courses on the new technology and perform an appropriate number of complete clinical procedures on live human patients to qualify to use each new technology authorized by the board pursuant to this subdivision.
SEC. 2.Section 3041.1 of the Business and Professions Code is repealed.SEC. 3.Section 3041.1 is added to the Business and Professions Code, to read:3041.1.(a)(1)An optometrist who is certified to use therapeutic pharmaceutical agents pursuant to this section may also diagnose and treat the human eye or eyes, or any of its or their appendages, for all of the following conditions:
(A)Through medical treatment, infections of the anterior segment and adnexa.
(B)Ocular allergies of the anterior segment and adnexa.
(C)Ocular inflammation, nonsurgical in cause except when comanaged with the treating physician and surgeon, limited to inflammation resulting from traumatic iritis, peripheral corneal inflammatory keratitis, episcleritis, and unilateral nonrecurrent nongranulomatous idiopathic iritis in patients over 18 years of age.
(D)Traumatic or recurrent conjunctival or corneal abrasions and erosions.
(E)Corneal and conjunctival surface disease and dry eyes disease.
(F)Ocular pain that is nonsurgical in cause, except when comanaged with the treating physician and surgeon.
(G) Hypotrichosis and blepharitis.
(2)For purposes of this section, treat means the use of therapeutic pharmaceutical agents, as described in subdivision (b), and the procedures described in subdivision (c).
(3)For purposes of this chapter, adnexa means ocular adnexa.
(b)In diagnosing and treating the conditions listed in subdivision (a), an optometrist certified to use therapeutic pharmaceutical agents pursuant to this section may use all of the following therapeutic pharmaceutical agents:
(1)Topical pharmaceutical agents for the purpose of the examination of the human eye or eyes for any disease or pathological condition, including, but not limited to, topical miotics.
(2)Topical lubricants.
(3)Antiallergy agents. In using topical steroid medication for the treatment of ocular allergies, an optometrist shall consult with an ophthalmologist if the patients condition worsens 21 days after diagnosis.
(4)Topical and oral anti-inflammatories.
(5)Topical antibiotic agents.
(6)Topical hyperosmotics.
(7)Topical and oral antiglaucoma agents pursuant to the certification process defined in Section 3041.2.
(8)Nonprescription medications used for the rational treatment of an ocular disorder.
(9)Oral antihistamines.
(10)Prescription oral nonsteroidal anti-inflammatory agents.
(11)Oral antibiotics for medical treatment of ocular disease.
(12)Topical and oral antiviral medication for the medical treatment of herpes simplex viral keratitis, herpes simplex viral conjunctivitis, periocular herpes simplex viral dermatitis, varicella zoster viral keratitis, varicella zoster viral conjunctivitis, and periocular varicella zoster viral dermatitis.
(13)Oral analgesics that are not controlled substances.
(14)Codeine with compounds and hydrocodone with compounds as listed in the California Uniform Controlled Substances Act (Division 10 (commencing with Section 11000) of the Health and Safety Code) and the United States Uniform Controlled Substances Act (21 U.S.C. Sec. 801 et seq.). The use of these agents shall be limited to five days, with a referral to an ophthalmologist if the pain persists.
(c)An optometrist who is certified to use therapeutic pharmaceutical agents pursuant to this section may also perform all of the following:
(1)Corneal scraping with cultures.
(2)Debridement of corneal epithelia.
(3)Mechanical epilation.
(4)Collection of blood by skin puncture or venipuncture for testing patients suspected of having diabetes.
(5)Suture removal, with prior consultation with the treating health care provider.
(6)Treatment or removal of sebaceous cysts by expression.
(7)Administration of oral fluorescein to patients suspected as having diabetic retinopathy.
(8)Use of an auto-injector to counter anaphylaxis.
(9)Ordering of smears, cultures, sensitivities, complete blood count, mycobacterial culture, acid fast stain, urinalysis, tear fluid analysis, and X-rays necessary for the diagnosis of conditions or diseases of the eye or adnexa. An optometrist may order other types of images subject to prior consultation with an ophthalmologist or appropriate physician and surgeon.
(10)A clinical laboratory test or examination classified as waived under the Clinical Laboratory Improvement Amendments of 1988 (CLIA)(42 U.S.C. Sec. 263a; Public Law 100-578) and that is and designated as waived in paragraph (9) necessary for the diagnosis of conditions and diseases of the eye or adnexa, to detect systemic disease with ocular effects, or if otherwise specifically authorized by this chapter.
(11)Skin test to diagnose ocular allergies. Skin tests shall be limited to the superficial layer of the skin.
(12)Punctal occlusion by plugs, excluding laser, diathermy, cryotherapy, or other means constituting surgery as defined in this chapter.
(13)The prescription of therapeutic contact lenses, diagnostic contact lenses, or biological or technological corneal devices that diagnose or treat a condition authorized under this chapter.
(14)Removal of foreign bodies from the cornea, eyelid, and conjunctiva with any appropriate instrument other than a scalpel. Corneal foreign bodies shall be nonperforating, be no deeper than the midstroma, and require no surgical repair upon removal.
(15)For patients over 12 years of age, lacrimal irrigation and dilation, excluding probing of the nasal lacrimal tract. The board shall certify any optometrist who graduated from an accredited school of optometry before May 1, 2000, to perform this procedure after submitting proof of satisfactory completion and confirmation of 10 procedures under the supervision of an ophthalmologist or optometrist who is certified in lacrimal irrigation and dilation. Any optometrist who graduated from an accredited school of optometry on or after May 1, 2000, shall be exempt from the certification requirement contained in this paragraph.
(16)Use of mechanical lipid extraction of meibomian glands and nonsurgical techniques.
(d)In order to be certified to use therapeutic pharmaceutical agents and authorized to diagnose and treat the conditions listed in this section, an optometrist shall apply for a certificate from the board and meet all requirements imposed by the board.
(e)The board shall grant a certificate to use therapeutic pharmaceutical agents to any applicant who graduated from a California accredited school of optometry prior to January 1, 1996, is licensed as an optometrist in California, and meets all of the following requirements:
(1)Satisfactorily completes a didactic course of no less than 80 classroom hours in the diagnosis, pharmacological, and other treatment and management of ocular disease provided by either an accredited school of optometry in California or a recognized residency review committee in ophthalmology in California.
(2)Completes a preceptorship of no less than 65 hours, during a period of not less than two months nor more than one year, in either an ophthalmologists office or an optometric clinic. The training received during the preceptorship shall be on the diagnosis, treatment, and management of ocular, systemic disease. The preceptor shall certify completion of the preceptorship. Authorization for the ophthalmologist to serve as a preceptor shall be provided by an accredited school of optometry in California, or by a recognized residency review committee in ophthalmology, and the preceptor shall be licensed as an ophthalmologist in California, board certified in ophthalmology, and in good standing with the Medical Board of California. The individual serving as the preceptor shall schedule no more than three optometrist applicants for each of the required 65 hours of the preceptorship program. This paragraph shall not be construed to limit the total number of optometrist applicants for whom an individual may serve as a preceptor, and is intended only to ensure the quality of the preceptorship by requiring that the ophthalmologist preceptor schedule the training so that each applicant optometrist completes each of the 65 hours of the preceptorship while scheduled with no more than two other optometrist applicants.
(3)Successfully completes a minimum of 20 hours of self-directed education.
(4)Passes the National Board of Examiners in Optometrys Treatment and Management of Ocular Disease examination or, in the event this examination is no longer offered, its equivalent, as determined by the State Board of Optometry.
(5)Passes the examination issued upon completion of the 80-hour didactic course required under paragraph (1) and provided by the accredited school of optometry or residency program in ophthalmology.
(6)When any or all of the requirements contained in paragraph (1), (4), or (5) have been satisfied on or after July 1, 1992, and before January 1, 1996, an optometrist shall not be required to fulfill the satisfied requirements in order to obtain certification to use therapeutic pharmaceutical agents. In order for this paragraph to apply to the requirement contained in paragraph (5), the didactic examination that the applicant successfully completed shall meet equivalency standards, as determined by the board.
(7)Any optometrist who graduated from an accredited school of optometry on or after January 1, 1992, and before January 1, 1996, shall not be required to fulfill the requirements contained in paragraphs (1), (4), and (5).
(f)The board shall grant a certificate to use therapeutic pharmaceutical agents to any applicant who graduated from a California accredited school of optometry on or after January 1, 1996, who is licensed as an optometrist in California, and who meets all of the following requirements:
(1)Passes the National Board of Examiners in Optometrys national board examination, or its equivalent, as determined by the State Board of Optometry.
(2)Of the total clinical training required by a school of optometrys curriculum, successfully completed at least 65 of those hours on the diagnosis, treatment, and management of ocular, systemic disease.
(3)Is certified by an accredited school of optometry as competent in the diagnosis, treatment, and management of ocular, systemic disease to the extent authorized by this section.
(4)Is certified by an accredited school of optometry as having completed at least 10 hours of experience with a board-certified ophthalmologist.
(g)The board shall grant a certificate to use therapeutic pharmaceutical agents to any applicant who is an optometrist who obtained his or her license outside of California if he or she meets all of the requirements for an optometrist licensed in California to be certified to use therapeutic pharmaceutical agents.
(1)In order to obtain a certificate to use therapeutic pharmaceutical agents, any optometrist who obtained his or her license outside of California and graduated from an accredited school of optometry prior to January 1, 1996, shall be required to fulfill the requirements set forth in subdivision (e). In order for the applicant to be eligible for the certificate to use therapeutic pharmaceutical agents, the education he or she received at the accredited out-of-state school of optometry shall be equivalent to the education provided by any accredited school of optometry in California for persons who graduated before January 1, 1996. For those out-of-state applicants who request that any of the requirements contained in subdivision (e) be waived based on fulfillment of the requirement in another state, if the board determines that the completed requirement was equivalent to that required in California, the requirement shall be waived.
(2)In order to obtain a certificate to use therapeutic pharmaceutical agents, any optometrist who obtained his or her license outside of California and who graduated from an accredited school of optometry on or after January 1, 1996, shall be required to fulfill the requirements set forth in subdivision (f). In order for the applicant to be eligible for the certificate to use therapeutic pharmaceutical agents, the education he or she received by the accredited out-of-state school of optometry shall be equivalent to the education provided by any accredited school of optometry for persons who graduated on or after January 1, 1996. For those out-of-state applicants who request that any of the requirements contained in subdivision (f) be waived based on fulfillment of the requirement in another state, if the board determines that the completed requirement was equivalent to that required in California, the requirement shall be waived.
(3)The State Board of Optometry shall decide all issues relating to the equivalency of an optometrists education or training under this subdivision.
(h)Other than for prescription ophthalmic devices described in subdivision (b) of Section 2541, any dispensing of a therapeutic pharmaceutical agent by an optometrist shall be without charge.
(i)Except as authorized by this chapter, the practice of optometry does not include performing surgery. Surgery means any procedure in which human tissue is cut, altered, or otherwise infiltrated by mechanical or laser means. Surgery does not include those procedures specified in subdivision (c). This section does not limit an optometrists authority to utilize diagnostic laser and ultrasound technology within his or her scope of practice.
(j)In an emergency, an optometrist shall stabilize, if possible, and immediately refer any patient who has an acute attack of angle closure to an ophthalmologist.
SEC. 4.Section 3041.2 of the Business and Professions Code is repealed.SEC. 5.Section 3041.2 is added to the Business and Professions Code, to read:3041.2.(a)For purposes of this chapter, glaucoma means any of the following:
(1)All primary open-angle glaucoma.
(2)Exfoliation and pigmentary glaucoma.
(3)Increase in intraocular pressure caused by steroid medication prescribed by the optometrist.
(4)Increase in intraocular pressure caused by steroid medication not prescribed by the optometrist, after consultation and treatment approval by the prescribing physician.
(b)An optometrist certified pursuant to Section 3041.1 shall be certified for the treatment of glaucoma, as described in subdivision (a), in patients over 18 years of age after the optometrist meets the following applicable requirements:
(1)For licensees who graduated from an accredited school of optometry on or after May 1, 2008, submission of proof of graduation from that institution.
(2)For licensees who were certified to treat glaucoma under this section prior to January 1, 2009, submission of proof of completion of that certification program.
(3)For licensees who completed a didactic course of not less than 24 hours in the diagnosis, pharmacological, and other treatment and management of glaucoma, submission of proof of satisfactory completion of the case management requirements for certification established by the board.
(4)For licensees who graduated from an accredited school of optometry on or before May 1, 2008, and are not described in paragraph (2) or (3), submission of proof of satisfactory completion of the requirements for certification established by the board.
SEC. 6.Section 3041.3 of the Business and Professions Code is repealed.SEC. 7.Section 3041.3 is added to the Business and Professions Code, to read:3041.3.(a)For the purposes of this chapter, anterior segment laser means any of the following:
(1)Therapeutic lasers appropriate for treatment of glaucoma.
(2)Notwithstanding subdivision (a) of Section 3041.2, peripheral iridotomy for the prophylactic treatment of angle closure glaucoma.
(3)Therapeutic lasers used for posterior capsulotomy secondary to cataract surgery.
(b)An optometrist certified to treat glaucoma pursuant to Section 3041.2 shall be additionally certified for the use of anterior segment lasers after submitting proof of satisfactory completion of a course that is approved by the board, provided by an accredited school of optometry, and developed in consultation with an ophthalmologist who has experience educating optometric students. The board shall issue a certificate pursuant to this section only to an optometrist that has graduated from an approved school of optometry.
(1)The board-approved course shall be at least 25 hours in length, and include a test for competency of the following:
(A)Laser physics, hazards, and safety.
(B)Biophysics of laser.
(C)Laser application in clinical optometry.
(D)Laser tissue interactions.
(E)Laser indications, contraindications, and potential complications.
(F)Gonioscopy.
(G)Laser therapy for open-angle glaucoma.
(H)Laser therapy for angle closure glaucoma.
(I)Posterior capsulotomy.
(J)Common complications of the lids, lashes, and lacrimal system.
(K)Medicolegal aspects of anterior segment procedures.
(L)Peripheral iridotomy.
(M)Laser trabeculoplasty.
(2)The school of optometry shall require each applicant for certification to perform a sufficient number of complete anterior segment laser procedures to verify that the applicant has demonstrated competency to practice independently. At a minimum, each applicant shall complete 24 anterior segment laser procedures on live humans as follows:
(A)Eight YAG capsulotomy procedures.
(B)Eight laser trabeculoplasty procedures.
(C)Eight peripheral iridotomy procedures.
(c)The board, by regulation, shall set the fee for issuance and renewal of a certificate authorizing the use of anterior segment lasers at an amount no higher than the reasonable cost of regulating anterior segment laser certified optometrists pursuant to this section. The fee shall not exceed one hundred fifty dollars ($150).
(d)An optometrist certified to use anterior segment lasers pursuant to this section shall complete four hours of continuing education on anterior segment lasers as part of the required 50 hours of continuing education required to be completed every two years on the diagnosis, treatment, and management of glaucoma.
SEC. 8.Section 3041.4 is added to the Business and Professions Code, to read:3041.4.(a)For the purposes of this chapter, minor procedure means either of the following:
(1)Removal, destruction, or drainage of lesions of the eyelid and adnexa clinically evaluated by the optometrist to be noncancerous, not involving the eyelid margin, lacrimal supply or drainage systems, no deeper than the orbicularis muscle, and smaller than five millimeters in diameter.
(2)Closure of a wound resulting from a procedure described in paragraph (1).
(3)Administration of injections for the diagnoses or treatment of conditions of the eye and adnexa authorized by this chapter, excluding intraorbital injections and injections administered for cosmetic effect.
(4)Minor procedures does not include blepharoplasty or other cosmetic surgery procedures that reshape normal structures of the body in order to improve appearance and self-esteem.
(b)An optometrist certified to treat glaucoma pursuant to Section 3041.2 shall be additionally certified to perform minor procedures after submitting proof of satisfactory completion of a course that is approved by the board, provided by an accredited school of optometry, and developed in consultation with an ophthalmologist who has experience teaching optometric students. The board shall issue a certificate pursuant to this section only to an optometrist that has graduated from an approved school of optometry.
(1)The board-approved course shall be at least 25 hours in length and include a test for competency of the following:
(A)Minor surgical procedures.
(B)Overview of surgical instruments, asepsis, and the state and federal Occupational Safety and Health Administrations.
(C)Surgical anatomy of the eyelids.
(D)Emergency surgical procedures.
(E)Chalazion management.
(F)Epiluminescence microscopy.
(G)Suture techniques.
(H)Local anesthesia techniques and complications.
(I)Anaphylaxsis and other office emergencies.
(J)Radiofrequency surgery.
(K)Postoperative wound care.
(L)Injection techniques.
(2)The school of optometry shall require each applicant for certification to perform a sufficient number of minor procedures to verify that the applicant has demonstrated competency to practice independently. At a minimum, each applicant shall perform 32 complete minor procedures on live humans.
(c)The board, by regulation, shall set the fee for issuance and renewal of a certificate authorizing the use of minor procedures at an amount no greater than the reasonable cost of regulating minor procedure certified optometrists pursuant to this section. The fee shall not exceed one hundred fifty dollars ($150).
(d)An optometrist certified to perform minor procedures pursuant to Section 3041.1 shall complete five hours of continuing education on the diagnosis, treatment, and management of lesions of the eyelid and adnexa as part of the 50 hours of continuing education required every two years in Section 3059.
SEC. 9.Section 3041.5 is added to the Business and Professions Code, to read:3041.5.(a)The board shall grant to an optometrist a certificate for the use of immunizations described in subdivision (b), if the optometrist is certified pursuant to Section 3041.2 and after the optometrist meets all of the following requirements:
(1)Completes an immunization training program endorsed by the federal Centers for Disease Control and Prevention (CDC) that, at a minimum, includes hands-on injection technique, clinical evaluation of indications and contraindications of vaccines, and the recognition and treatment of emergency reactions to vaccines, and maintains that training.
(2)Is certified in basic life support.
(3)Complies with all state and federal recordkeeping and reporting requirements, including providing documentation to the patients primary care provider and entering information in the appropriate immunization registry designated by the immunization branch of the State Department of Public Health.
(b)For the purposes of this section, immunization means the administration of immunizations for influenza, herpes zoster virus, and pneumococcus in compliance with individual Advisory Committee on Immunization Practices (ACIP) vaccine recommendations published by the CDC for persons 18 years of age or older.
(c)The board, by regulation, shall set the fee for issuance and renewal of a certificate for the use of immunizations at the reasonable cost of regulating immunization certified optometrists pursuant to this section. The fee shall not exceed one hundred dollars ($100).
SEC. 10.Section 3041.6 is added to the Business and Professions Code, to read:3041.6.An optometrist licensed under this chapter is subject to the provisions of Section 2290.5 for purposes of practicing telehealth.
SEC. 11.Section 3041.7 is added to the Business and Professions Code, to read:3041.7.Optometrists diagnosing or treating eye disease shall be held to the same standard of care to which physicians and surgeons and osteopathic physicians and surgeons are held. An optometrist shall consult with and, if necessary, refer to a physician and surgeon or other appropriate health care provider when a situation or condition occurs that is beyond the optometrists scope of practice.
SEC. 12.Section 3041.8 is added to the Business and Professions Code, to read:3041.8.It is the intent of the Legislature that the Office of Statewide Health Planning and Development, under the Health Workforce Pilot Projects Program, designate a pilot project to test, demonstrate, and evaluate expanded roles for optometrists in the performance of management and treatment of diabetes mellitus, hypertension, and hypercholesterolemia.
SEC. 13.Section 3110 of the Business and Professions Code is amended to read:3110.The board may take action against any licensee who is charged with unprofessional conduct, and may deny an application for a license if the applicant has committed unprofessional conduct. In addition to other provisions of this article, unprofessional conduct includes, but is not limited to, the following:
(a)Violating or attempting to violate, directly or indirectly assisting in or abetting the violation of, or conspiring to violate any provision of this chapter or any of the rules and regulations adopted by the board pursuant to this chapter.
(b)Gross negligence.
(c)Repeated negligent acts. To be repeated, there must be two or more negligent acts or omissions.
(d)Incompetence.
(e)The commission of fraud, misrepresentation, or any act involving dishonesty or corruption, that is substantially related to the qualifications, functions, or duties of an optometrist.
(f)Any action or conduct that would have warranted the denial of a license.
(g)The use of advertising relating to optometry that violates Section 651 or 17500.
(h)Denial of licensure, revocation, suspension, restriction, or any other disciplinary action against a health care professional license by another state or territory of the United States, by any other governmental agency, or by another California health care professional licensing board. A certified copy of the decision or judgment shall be conclusive evidence of that action.
(i)Procuring his or her license by fraud, misrepresentation, or mistake.
(j)Making or giving any false statement or information in connection with the application for issuance of a license.
(k)Conviction of a felony or of any offense substantially related to the qualifications, functions, and duties of an optometrist, in which event the record of the conviction shall be conclusive evidence thereof.
(l)Administering to himself or herself any controlled substance or using any of the dangerous drugs specified in Section 4022, or using alcoholic beverages to the extent, or in a manner, as to be dangerous or injurious to the person applying for a license or holding a license under this chapter, or to any other person, or to the public, or, to the extent that the use impairs the ability of the person applying for or holding a license to conduct with safety to the public the practice authorized by the license, or the conviction of a misdemeanor or felony involving the use, consumption, or self-administration of any of the substances referred to in this subdivision, or any combination thereof.
(m)(1)Committing or soliciting an act punishable as a sexually related crime, if that act or solicitation is substantially related to the qualifications, functions, or duties of an optometrist.
(2)Committing any act of sexual abuse, misconduct, or relations with a patient. The commission of and conviction for any act of sexual abuse, sexual misconduct, or attempted sexual misconduct, whether or not with a patient, shall be considered a crime substantially related to the qualifications, functions, or duties of a licensee. This paragraph shall not apply to sexual contact between any person licensed under this chapter and his or her spouse or person in an equivalent domestic relationship when that licensee provides optometry treatment to his or her spouse or person in an equivalent domestic relationship.
(3)Conviction of a crime that requires the person to register as a sex offender pursuant to Chapter 5.5 (commencing with Section 290) of Title 9 of Part 1 of the Penal Code. A conviction within the meaning of this paragraph means a plea or verdict of guilty or a conviction following a plea of nolo contendere. A conviction described in this paragraph shall be considered a crime substantially related to the qualifications, functions, or duties of a licensee.
(n)Repeated acts of excessive prescribing, furnishing, or administering of controlled substances or dangerous drugs specified in Section 4022, or repeated acts of excessive treatment.
(o)Repeated acts of excessive use of diagnostic or therapeutic procedures, or repeated acts of excessive use of diagnostic or treatment facilities.
(p)The prescribing, furnishing, or administering of controlled substances or drugs specified in Section 4022, or treatment without a good faith prior examination of the patient and optometric reason.
(q)The failure to maintain adequate and accurate records relating to the provision of services to his or her patients.
(r)Performing, or holding oneself out as being able to perform, or offering to perform, any professional services beyond the scope of the license authorized by this chapter.
(s)The practice of optometry without a valid, unrevoked, unexpired license.
(t)The employing, directly or indirectly, of any suspended or unlicensed optometrist to perform any work for which an optometry license is required.
(u) Permitting another person to use the licensees optometry license for any purpose.
(v)Altering with fraudulent intent a license issued by the board, or using a fraudulently altered license, permit certification or any registration issued by the board.
(w)Except for good cause, the knowing failure to protect patients by failing to follow infection control guidelines of the board, thereby risking transmission of bloodborne infectious diseases from optometrist to patient, from patient to patient, or from patient to optometrist. In administering this subdivision, the board shall consider the standards, regulations, and guidelines of the State Department of Public Health developed pursuant to Section 1250.11 of the Health and Safety Code and the standards, guidelines, and regulations pursuant to the California Occupational Safety and Health Act of 1973 (Part 1 (commencing with Section 6300) of Division 5 of the Labor Code) for preventing the transmission of HIV, hepatitis B, and other bloodborne pathogens in health care settings. As necessary, the board may consult with the Medical Board of California, the California Board of Podiatric Medicine, the Board of Registered Nursing, and the Board of Vocational Nursing and Psychiatric Technicians of the State of California, to encourage appropriate consistency in the implementation of this subdivision.
(x)Failure or refusal to comply with a request for the clinical records of a patient, that is accompanied by that patients written authorization for release of records to the board, within 15 days of receiving the request and authorization, unless the licensee is unable to provide the documents within this time period for good cause.
(y) Failure to refer a patient to an appropriate physician if an examination of the eyes indicates a substantial likelihood of any pathology that requires the attention of that physician.
SEC. 14.No reimbursement is required by this act pursuant to Section 6 of Article XIIIB of the California Constitution because the only costs that may be incurred by a local agency or school district will be incurred because this act creates a new crime or infraction, eliminates a crime or infraction, or changes the penalty for a crime or infraction, within the meaning of Section 17556 of the Government Code, or changes the definition of a crime within the meaning of Section 6 of Article XIIIB of the California Constitution.
(a)The practice of optometry includes the prevention and diagnosis of disorders and dysfunctions of the visual system, and the treatment and management of certain disorders and dysfunctions of the visual system, as well as the provision of habilitative or rehabilitative optometric services, and is the doing of any or all of the following:
(1)The examination of the human eye or eyes, or its or their appendages, and the analysis of the human vision system, either subjectively or objectively.
(2)The determination of the powers or range of human vision and the accommodative and refractive states of the human eye or eyes, including the scope of its or their functions and general condition.
(3)The prescribing or directing the use of, or using, any optical device in connection with ocular exercises, visual training, vision training, or orthoptics.
(4)The prescribing of contact and spectacle lenses for, or the fitting or adaptation of contact and spectacle lenses to, the human eye, including lenses that may be classified as drugs or devices by any law of the United States or of this state.
(5)The use of topical pharmaceutical agents for the purpose of the examination of the human eye or eyes for any disease or pathological condition.
(b)The State Board of Optometry shall, by regulation, establish educational and examination requirements for licensure to ensure the competence of optometrists to practice pursuant to this chapter, except as specified in Section 3041.3 related to the use of anterior segment lasers and in Section 3041.4 related to minor procedures. Satisfactory completion of the required educational and examination requirements shall be a condition for the issuance of an original optometrist license or required certifications pursuant to this chapter.
(c)The board may promulgate regulations authorizing optometrists to use noninvasive, nonsurgical technology to treat a condition authorized by this chapter. The board shall require a licensee to take a minimum of four hours of education courses on the new technology and perform an appropriate number of complete clinical procedures on live human patients to qualify to use each new technology authorized by the board pursuant to this subdivision.
SEC. 2.Section 3041.1 of the Business and Professions Code is repealed.SEC. 3.Section 3041.1 is added to the Business and Professions Code, to read:3041.1.(a)(1)An optometrist who is certified to use therapeutic pharmaceutical agents pursuant to this section may also diagnose and treat the human eye or eyes, or any of its or their appendages, for all of the following conditions:
(A)Through medical treatment, infections of the anterior segment and adnexa.
(B)Ocular allergies of the anterior segment and adnexa.
(C)Ocular inflammation, nonsurgical in cause except when comanaged with the treating physician and surgeon, limited to inflammation resulting from traumatic iritis, peripheral corneal inflammatory keratitis, episcleritis, and unilateral nonrecurrent nongranulomatous idiopathic iritis in patients over 18 years of age.
(D)Traumatic or recurrent conjunctival or corneal abrasions and erosions.
(E)Corneal and conjunctival surface disease and dry eyes disease.
(F)Ocular pain that is nonsurgical in cause, except when comanaged with the treating physician and surgeon.
(G) Hypotrichosis and blepharitis.
(2)For purposes of this section, treat means the use of therapeutic pharmaceutical agents, as described in subdivision (b), and the procedures described in subdivision (c).
(3)For purposes of this chapter, adnexa means ocular adnexa.
(b)In diagnosing and treating the conditions listed in subdivision (a), an optometrist certified to use therapeutic pharmaceutical agents pursuant to this section may use all of the following therapeutic pharmaceutical agents:
(1)Topical pharmaceutical agents for the purpose of the examination of the human eye or eyes for any disease or pathological condition, including, but not limited to, topical miotics.
(2)Topical lubricants.
(3)Antiallergy agents. In using topical steroid medication for the treatment of ocular allergies, an optometrist shall consult with an ophthalmologist if the patients condition worsens 21 days after diagnosis.
(4)Topical and oral anti-inflammatories.
(5)Topical antibiotic agents.
(6)Topical hyperosmotics.
(7)Topical and oral antiglaucoma agents pursuant to the certification process defined in Section 3041.2.
(8)Nonprescription medications used for the rational treatment of an ocular disorder.
(9)Oral antihistamines.
(10)Prescription oral nonsteroidal anti-inflammatory agents.
(11)Oral antibiotics for medical treatment of ocular disease.
(12)Topical and oral antiviral medication for the medical treatment of herpes simplex viral keratitis, herpes simplex viral conjunctivitis, periocular herpes simplex viral dermatitis, varicella zoster viral keratitis, varicella zoster viral conjunctivitis, and periocular varicella zoster viral dermatitis.
(13)Oral analgesics that are not controlled substances.
(14)Codeine with compounds and hydrocodone with compounds as listed in the California Uniform Controlled Substances Act (Division 10 (commencing with Section 11000) of the Health and Safety Code) and the United States Uniform Controlled Substances Act (21 U.S.C. Sec. 801 et seq.). The use of these agents shall be limited to five days, with a referral to an ophthalmologist if the pain persists.
(c)An optometrist who is certified to use therapeutic pharmaceutical agents pursuant to this section may also perform all of the following:
(1)Corneal scraping with cultures.
(2)Debridement of corneal epithelia.
(3)Mechanical epilation.
(4)Collection of a blood specimen by finger prick method skin puncture or venipuncture for testing patients suspected of having diabetes.
(5)Suture removal, with prior consultation with the treating health care provider.
(6)Treatment or removal of sebaceous cysts by expression.
(7)Administration of oral fluorescein to patients suspected as having diabetic retinopathy.
(8)Use of an auto-injector to counter anaphylaxis.
(9)Ordering of smears, cultures, sensitivities, complete blood count, mycobacterial culture, acid fast stain, urinalysis, tear fluid analysis, and X-rays necessary for the diagnosis of conditions or diseases of the eye or adnexa. An optometrist may order other types of images subject to prior consultation with the an ophthalmologist or appropriate physician and surgeon.
(10)A clinical laboratory test or examination classified as waived under the Clinical Laboratory Improvement Amendments of 1988 (CLIA)(42 U.S.C. Sec. 263a; Public Law 100-578) or any regulations adopted pursuant to CLIA, and that are is necessary for the diagnosis of conditions and diseases of the eye or adnexa, to detect systemic disease with ocular effects, or if otherwise specifically authorized by this chapter.
(11)Skin test to diagnose ocular allergies. Skin tests shall be limited to the superficial lawyer layer of the skin.
(12)Punctal occlusion by plugs, excluding laser, diathermy, cryotherapy, or other means constituting surgery as defined in this chapter.
(13)The prescription of therapeutic contact lenses, diagnostic contact lenses, or biological or technological corneal devices that diagnose or treat a condition authorized under this chapter.
(14)Removal of foreign bodies from the cornea, eyelid, and conjunctiva with any appropriate instrument other than a scalpel. Corneal foreign bodies shall be nonperforating, be no deeper than the midstroma, and require no surgical repair upon removal.
(15)For patients over 12 years of age, lacrimal irrigation and dilation, excluding probing of the nasal lacrimal tract. The board shall certify any optometrist who graduated from an accredited school of optometry before May 1, 2000, to perform this procedure after submitting proof of satisfactory completion and confirmation of 10 procedures under the supervision of an ophthalmologist or optometrist who is certified in lacrimal irrigation and dilation. Any optometrist who graduated from an accredited school of optometry on or after May 1, 2000, shall be exempt from the certification requirement contained in this paragraph.
(16)Use of mechanical lipid extraction of meibomian glands and nonsurgical techniques.
(d)In order to be certified to use therapeutic pharmaceutical agents and authorized to diagnose and treat the conditions listed in this section, an optometrist shall apply for a certificate from the board and meet all requirements imposed by the board.
(e)The board shall grant a certificate to use therapeutic pharmaceutical agents to any applicant who graduated from a California accredited school of optometry prior to January 1, 1996, is licensed as an optometrist in California, and meets all of the following requirements:
(1)Satisfactorily completes a didactic course of no less than 80 classroom hours in the diagnosis, pharmacological, and other treatment and management of ocular disease provided by either an accredited school of optometry in California or a recognized residency review committee in ophthalmology in California.
(2)Completes a preceptorship of no less than 65 hours, during a period of not less than two months nor more than one year, in either an ophthalmologists office or an optometric clinic. The training received during the preceptorship shall be on the diagnosis, treatment, and management of ocular, systemic disease. The preceptor shall certify completion of the preceptorship. Authorization for the ophthalmologist to serve as a preceptor shall be provided by an accredited school of optometry in California, or by a recognized residency review committee in ophthalmology, and the preceptor shall be licensed as an ophthalmologist in California, board certified in ophthalmology, and in good standing with the Medical Board of California. The individual serving as the preceptor shall schedule no more than three optometrist applicants for each of the required 65 hours of the preceptorship program. This paragraph shall not be construed to limit the total number of optometrist applicants for whom an individual may serve as a preceptor, and is intended only to ensure the quality of the preceptorship by requiring that the ophthalmologist preceptor schedule the training so that each applicant optometrist completes each of the 65 hours of the preceptorship while scheduled with no more than two other optometrist applicants.
(3)Successfully completes a minimum of 20 hours of self-directed education.
(4)Passes the National Board of Examiners in Optometrys Treatment and Management of Ocular Disease examination or, in the event this examination is no longer offered, its equivalent, as determined by the State Board of Optometry.
(5)Passes the examination issued upon completion of the 80-hour didactic course required under paragraph (1) and provided by the accredited school of optometry or residency program in ophthalmology.
(6)When any or all of the requirements contained in paragraph (1), (4), or (5) have been satisfied on or after July 1, 1992, and before January 1, 1996, an optometrist shall not be required to fulfill the satisfied requirements in order to obtain certification to use therapeutic pharmaceutical agents. In order for this paragraph to apply to the requirement contained in paragraph (5), the didactic examination that the applicant successfully completed shall meet equivalency standards, as determined by the board.
(7)Any optometrist who graduated from an accredited school of optometry on or after January 1, 1992, and before January 1, 1996, shall not be required to fulfill the requirements contained in paragraphs (1), (4), and (5).
(f)The board shall grant a certificate to use therapeutic pharmaceutical agents to any applicant who graduated from a California accredited school of optometry on or after January 1, 1996, who is licensed as an optometrist in California, and who meets all of the following requirements:
(1)Passes the National Board of Examiners in Optometrys national board examination, or its equivalent, as determined by the State Board of Optometry.
(2)Of the total clinical training required by a school of optometrys curriculum, successfully completed at least 65 of those hours on the diagnosis, treatment, and management of ocular, systemic disease.
(3)Is certified by an accredited school of optometry as competent in the diagnosis, treatment, and management of ocular, systemic disease to the extent authorized by this section.
(4)Is certified by an accredited school of optometry as having completed at least 10 hours of experience with a board-certified ophthalmologist.
(g)The board shall grant a certificate to use therapeutic pharmaceutical agents to any applicant who is an optometrist who obtained his or her license outside of California if he or she meets all of the requirements for an optometrist licensed in California to be certified to use therapeutic pharmaceutical agents.
(1)In order to obtain a certificate to use therapeutic pharmaceutical agents, any optometrist who obtained his or her license outside of California and graduated from an accredited school of optometry prior to January 1, 1996, shall be required to fulfill the requirements set forth in subdivision (e). In order for the applicant to be eligible for the certificate to use therapeutic pharmaceutical agents, the education he or she received at the accredited out-of-state school of optometry shall be equivalent to the education provided by any accredited school of optometry in California for persons who graduated before January 1, 1996. For those out-of-state applicants who request that any of the requirements contained in subdivision (e) be waived based on fulfillment of the requirement in another state, if the board determines that the completed requirement was equivalent to that required in California, the requirement shall be waived.
(2)In order to obtain a certificate to use therapeutic pharmaceutical agents, any optometrist who obtained his or her license outside of California and who graduated from an accredited school of optometry on or after January 1, 1996, shall be required to fulfill the requirements set forth in subdivision (f). In order for the applicant to be eligible for the certificate to use therapeutic pharmaceutical agents, the education he or she received by the accredited out-of-state school of optometry shall be equivalent to the education provided by any accredited school of optometry for persons who graduated on or after January 1, 1996. For those out-of-state applicants who request that any of the requirements contained in subdivision (f) be waived based on fulfillment of the requirement in another state, if the board determines that the completed requirement was equivalent to that required in California, the requirement shall be waived.
(3)The State Board of Optometry shall decide all issues relating to the equivalency of an optometrists education or training under this subdivision.
(h)Other than for prescription ophthalmic devices described in subdivision (b) of Section 2541, any dispensing of a therapeutic pharmaceutical agent by an optometrist shall be without charge.
(i)Except as authorized by this chapter, the practice of optometry does not include performing surgery. Surgery means any procedure in which human tissue is cut, altered, or otherwise infiltrated by mechanical or laser means. Surgery does not include those procedures specified in subdivision (c). This section does not limit an optometrists authority to utilize diagnostic laser and ultrasound technology within his or her scope of practice.
(j)In an emergency, an optometrist shall stabilize, if possible, and immediately refer any patient who has an acute attack of angle closure to an ophthalmologist.
SEC. 4.Section 3041.2 of the Business and Professions Code is repealed.SEC. 5.Section 3041.2 is added to the Business and Professions Code, to read:3041.2.(a)For purposes of this chapter, glaucoma means any of the following:
(1)All primary open-angle glaucoma.
(2)Exfoliation and pigmentary glaucoma.
(3)Increase in intraocular pressure caused by steroid medication prescribed by the optometrist.
(4)Increase in intraocular pressure caused by steroid medication not prescribed by the optometrist, after consultation and treatment approval by the prescribing physician.
(b)An optometrist certified pursuant to Section 3041.1 shall be certified for the treatment of glaucoma, as described in subdivision (a), in patients over 18 years of age after the optometrist meets the following applicable requirements:
(1)For licensees who graduated from an accredited school of optometry on or after May 1, 2008, submission of proof of graduation from that institution.
(2)For licensees who were certified to treat glaucoma under this section prior to January 1, 2009, submission of proof of completion of that certification program.
(3)For licensees who completed a didactic course of not less than 24 hours in the diagnosis, pharmacological, and other treatment and management of glaucoma, submission of proof of satisfactory completion of the case management requirements for certification established by the board.
(4)For licensees who graduated from an accredited school of optometry on or before May 1, 2008, and are not described in paragraph (2) or (3), submission of proof of satisfactory completion of the requirements for certification established by the board.
SEC. 6.Section 3041.3 of the Business and Professions Code is repealed.SEC. 6.Section 3041.3 of the Business and Professions Code is repealed.3041.3.(a)In order to be certified to use therapeutic pharmaceutical agents and authorized to diagnose and treat the conditions listed in subdivisions (b) and (e) of Section 3041, an optometrist shall apply for a certificate from the board and meet all requirements imposed by the board.
(b)The board shall grant a therapeutic pharmaceutical agents (TPA) certification to any applicant who graduated from a California accredited school of optometry prior to January 1, 1996, is licensed as an optometrist in California, and meets all of the following requirements:
(1)Completes a preceptorship of no less than 65 hours, during a period of not less than two months nor more than one year, with either a TPA-certified optometrist in good standing or a physician and surgeon board-certified in ophthalmology in good standing. The training received during the preceptorship shall be on the diagnosis, treatment, and management of ocular and systemic disease. The preceptor shall certify completion of the preceptorship using a form approved by the board. The individual serving as the preceptor shall schedule no more than three optometrist applicants for each of the required 65 hours of the preceptorship program. This paragraph shall not be construed to limit the total number of optometrist applicants for whom an individual may serve as a preceptor, and is intended only to ensure the quality of the preceptorship by requiring that the preceptor schedule the training so that each applicant optometrist completes each of the 65 hours of the preceptorship while scheduled with no more than two other optometrist applicants.
(2)Successfully completes a minimum of 100 hours of directed and accredited education in ocular and systemic diseases within two years prior to meeting the requirements of paragraph (1).
(3)Passes the National Board of Examiners in Optometrys Treatment and Management of Ocular Disease examination or, in the event this examination is no longer offered, its equivalent, as determined by the State Board of Optometry.
(c)The board shall grant a therapeutic pharmaceutical agents certification to any applicant who graduated from a California accredited school of optometry on or after January 1, 1996, who is licensed as an optometrist in California, and who passes all sections of the National Board of Examiners in Optometrys national board examination or its equivalent, as determined by the State Board of Optometry.
(d)The board shall grant a therapeutic pharmaceutical agents certification to any applicant who is an optometrist who obtained his or her license outside of California if he or she meets all of the requirements for an optometrist licensed in California to be granted a therapeutic pharmaceutical agents certification.
(1)In order to obtain a therapeutic pharmaceutical agents certification, any optometrist who obtained his or her license outside of California and graduated from an accredited school of optometry prior to January 1, 1996, shall be required to fulfill the requirements set forth in subdivision (b). In order for the applicant to be eligible for therapeutic pharmaceutical agents certification, the education he or she received at the accredited out-of-state school of optometry shall be equivalent to the education provided by any accredited school of optometry in California for persons who graduate before January 1, 1996. For those out-of-state applicants who request that any of the requirements contained in subdivision (b) be waived based on fulfillment of the requirement in another state, if the board determines that the completed requirement was equivalent to that required in California, the requirement shall be waived.
(2)In order to obtain a therapeutic pharmaceutical agents certification, any optometrist who obtained his or her license outside of California and who graduated from an accredited school of optometry on or after January 1, 1996, shall be required to fulfill the requirements set forth in subdivision (c). In order for the applicant to be eligible for therapeutic pharmaceutical agents certification, the education he or she received by the accredited out-of-state school of optometry shall be equivalent to the education provided by any accredited school of optometry for persons who graduate on or after January 1, 1996. For those out-of-state applicants who request that any of the requirements contained in subdivision (c) be waived based on fulfillment of the requirement in another state, if the board determines that the completed requirement was equivalent to that required in California, the requirement shall be waived.
(3)The State Board of Optometry shall decide all issues relating to the equivalency of an optometrists education or training under this subdivision.
SEC. 7.Section 3041.3 is added to the Business and Professions Code, to read:3041.3.(a)For the purposes of this chapter, anterior segment laser means any of the following:
(1)Therapeutic lasers appropriate for treatment of glaucoma.
(2)Notwithstanding subdivision (a) of Section 3041.2, peripheral iridotomy for the prophylactic treatment of angle closure glaucoma.
(3)Therapeutic lasers used for posterior capsulotomy secondary to cataract surgery.
(b)An optometrist certified to treat glaucoma pursuant to Section 3041.2 shall be additionally certified for the use of anterior segment lasers after submitting proof of satisfactory completion of a course that is approved by the board, provided by an accredited school of optometry, and developed in consultation with an ophthalmologist who has experience educating optometric students. The board shall issue a certificate pursuant to this section only to an optometrist that has graduated from an approved school of optometry.
(1)The board-approved course shall be at least 25 hours in length, and include a test for competency of the following:
(A)Laser physics, hazards, and safety.
(B)Biophysics of laser.
(C)Laser application in clinical optometry.
(D)Laser tissue interactions.
(E)Laser indications, contraindications, and potential complications.
(F)Gonioscopy.
(G)Laser therapy for open-angle glaucoma.
(H)Laser therapy for angle closure glaucoma.
(I)Posterior capsulotomy.
(J)Common complications of the lids, lashes, and lacrimal system.
(K)Medicolegal aspects of anterior segment procedures.
(L)Peripheral iridotomy.
(M)Laser trabeculoplasty.
(2)The school of optometry shall require each applicant for certification to perform a sufficient number of complete anterior segment laser procedures to verify that the applicant has demonstrated competency to practice independently. At a minimum, each applicant shall complete 24 anterior segment laser procedures on live humans as follows:
(A)Eight YAG capsulotomy procedures.
(B)Eight laser trabeculoplasty procedures.
(C)Eight peripheral iridotomy procedures.
(c)The board, by regulation, shall set the fee for issuance and renewal of a certificate authorizing the use of anterior segment lasers at an amount no higher than the reasonable cost of regulating anterior segment laser certified optometrists pursuant to this section. The fee shall not exceed one hundred fifty dollars ($150).
(d)An optometrist certified to use anterior segment lasers pursuant to this section shall complete four hours of continuing education on anterior segment lasers as part of the required 50 hours of continuing education required to be completed every two years on the diagnosis, treatment, and management of glaucoma.
SEC. 8.Section 3041.4 is added to the Business and Professions Code, to read:3041.4.(a)For the purposes of this chapter, minor procedure means either of the following:
(1)Removal, destruction, or drainage of lesions of the eyelid and adnexa clinically evaluated by the optometrist to be noncancerous, not involving the eyelid margin, lacrimal supply or drainage systems, no deeper than the orbicularis muscle, and smaller than five millimeters in diameter.
(2)Closure of a wound resulting from a procedure described in paragraph (1).
(3)Administration of injections for the diagnoses or treatment of conditions of the eye and adnexa authorized by this chapter, excluding intraorbital injections and injections administered for cosmetic effect.
(4)Minor procedures does not include blepharoplasty or other cosmetic surgery procedures that reshape normal structures of the body in order to improve appearance and self-esteem.
(b)An optometrist certified to treat glaucoma pursuant to Section 3041.2 shall be additionally certified to perform minor procedures after submitting proof of satisfactory completion of a course that is approved by the board, provided by an accredited school of optometry, and developed in consultation with an ophthalmologist who has experience teaching optometric students. The board shall issue a certificate pursuant to this section only to an optometrist that has graduated from an approved school of optometry.
(1)The board-approved course shall be at least 25 hours in length and include a test for competency of the following:
(A)Minor surgical procedures.
(B)Overview of surgical instruments, asepsis, and the state and federal Occupational Safety and Health Administrations.
(C)Surgical anatomy of the eyelids.
(D)Emergency surgical procedures.
(E)Chalazion management.
(F)Epiluminescence microscopy.
(G)Suture techniques.
(H)Local anesthesia techniques and complications.
(I)Anaphylaxsis and other office emergencies.
(J)Radiofrequency surgery.
(K)Postoperative wound care.
(L)Injection techniques.
(2)The school of optometry shall require each applicant for certification to perform a sufficient number of minor procedures to verify that the applicant has demonstrated competency to practice independently. At a minimum, each applicant shall perform 32 complete minor procedures on live humans.
(c)The board, by regulation, shall set the fee for issuance and renewal of a certificate authorizing the use of minor procedures at an amount no greater than the reasonable cost of regulating minor procedure certified optometrists pursuant to this section. The fee shall not exceed one hundred fifty dollars ($150).
(d)An optometrist certified to perform minor procedures pursuant to Section 3041.1 shall complete five hours of continuing education on the diagnosis, treatment, and management of lesions of the eyelid and adnexa as part of the 50 hours of continuing education required every two years in Section 3059.
SEC. 9.Section 3041.5 is added to the Business and Professions Code, to read:3041.5.(a)The board shall grant to an optometrist a certificate for the use of immunizations described in subdivision (b), if the optometrist is certified pursuant to Section 3041.2 and after the optometrist meets all of the following requirements:
(1)Completes an immunization training program endorsed by the federal Centers for Disease Control and Prevention (CDC) that, at a minimum, includes hands-on injection technique, clinical evaluation of indications and contraindications of vaccines, and the recognition and treatment of emergency reactions to vaccines, and maintains that training.
(2)Is certified in basic life support.
(3)Complies with all state and federal recordkeeping and reporting requirements, including providing documentation to the patients primary care provider and entering information in the appropriate immunization registry designated by the immunization branch of the State Department of Public Health.
(b)For the purposes of this section, immunization means the administration of immunizations for influenza, herpes zoster virus, and pneumococcus in compliance with individual Advisory Committee on Immunization Practices (ACIP) vaccine recommendations published by the CDC for persons 18 years of age or older.
(c)The board, by regulation, shall set the fee for issuance and renewal of a certificate for the use of immunizations at the reasonable cost of regulating immunization certified optometrists pursuant to this section. The fee shall not exceed one hundred dollars ($100).
SEC. 10.Section 3041.6 is added to the Business and Professions Code, to read:3041.6.An optometrist licensed under this chapter is subject to the provisions of Section 2290.5 for purposes of practicing telehealth.
SEC. 11.Section 3041.7 is added to the Business and Professions Code, to read:3041.7.Optometrists diagnosing or treating eye disease shall be held to the same standard of care to which physicians and surgeons and osteopathic physicians and surgeons are held. An optometrist shall consult with and, if necessary, refer to a physician and surgeon or other appropriate health care provider when a situation or condition occurs that is beyond the optometrists scope of practice.
SEC. 12.Section 3041.8 is added to the Business and Professions Code, to read:3041.8.It is the intent of the Legislature that the Office of Statewide Health Planning and Development, under the Health Workforce Pilot Projects Program, designate a pilot project to test, demonstrate, and evaluate expanded roles for optometrists in the performance of management and treatment of diabetes mellitus, hypertension, and hypercholesterolemia.
SEC. 13.Section 3110 of the Business and Professions Code is amended to read:3110.The board may take action against any licensee who is charged with unprofessional conduct, and may deny an application for a license if the applicant has committed unprofessional conduct. In addition to other provisions of this article, unprofessional conduct includes, but is not limited to, the following:
(a)Violating or attempting to violate, directly or indirectly assisting in or abetting the violation of, or conspiring to violate any provision of this chapter or any of the rules and regulations adopted by the board pursuant to this chapter.
(b)Gross negligence.
(c)Repeated negligent acts. To be repeated, there must be two or more negligent acts or omissions.
(d)Incompetence.
(e)The commission of fraud, misrepresentation, or any act involving dishonesty or corruption, that is substantially related to the qualifications, functions, or duties of an optometrist.
(f)Any action or conduct that would have warranted the denial of a license.
(g)The use of advertising relating to optometry that violates Section 651 or 17500.
(h)Denial of licensure, revocation, suspension, restriction, or any other disciplinary action against a health care professional license by another state or territory of the United States, by any other governmental agency, or by another California health care professional licensing board. A certified copy of the decision or judgment shall be conclusive evidence of that action.
(i)Procuring his or her license by fraud, misrepresentation, or mistake.
(j)Making or giving any false statement or information in connection with the application for issuance of a license.
(k)Conviction of a felony or of any offense substantially related to the qualifications, functions, and duties of an optometrist, in which event the record of the conviction shall be conclusive evidence thereof.
(l)Administering to himself or herself any controlled substance or using any of the dangerous drugs specified in Section 4022, or using alcoholic beverages to the extent, or in a manner, as to be dangerous or injurious to the person applying for a license or holding a license under this chapter, or to any other person, or to the public, or, to the extent that the use impairs the ability of the person applying for or holding a license to conduct with safety to the public the practice authorized by the license, or the conviction of a misdemeanor or felony involving the use, consumption, or self-administration of any of the substances referred to in this subdivision, or any combination thereof.
(m)(1)Committing or soliciting an act punishable as a sexually related crime, if that act or solicitation is substantially related to the qualifications, functions, or duties of an optometrist.
(2)Committing any act of sexual abuse, misconduct, or relations with a patient. The commission of and conviction for any act of sexual abuse, sexual misconduct, or attempted sexual misconduct, whether or not with a patient, shall be considered a crime substantially related to the qualifications, functions, or duties of a licensee. This paragraph shall not apply to sexual contact between any person licensed under this chapter and his or her spouse or person in an equivalent domestic relationship when that licensee provides optometry treatment to his or her spouse or person in an equivalent domestic relationship.
(3)Conviction of a crime that requires the person to register as a sex offender pursuant to Chapter 5.5 (commencing with Section 290) of Title 9 of Part 1 of the Penal Code. A conviction within the meaning of this paragraph means a plea or verdict of guilty or a conviction following a plea of nolo contendere. A conviction described in this paragraph shall be considered a crime substantially related to the qualifications, functions, or duties of a licensee.
(n)Repeated acts of excessive prescribing, furnishing, or administering of controlled substances or dangerous drugs specified in Section 4022, or repeated acts of excessive treatment.
(o)Repeated acts of excessive use of diagnostic or therapeutic procedures, or repeated acts of excessive use of diagnostic or treatment facilities.
(p)The prescribing, furnishing, or administering of controlled substances or drugs specified in Section 4022, or treatment without a good faith prior examination of the patient and optometric reason.
(q)The failure to maintain adequate and accurate records relating to the provision of services to his or her patients.
(r)Performing, or holding oneself out as being able to perform, or offering to perform, any professional services beyond the scope of the license authorized by this chapter.
(s)The practice of optometry without a valid, unrevoked, unexpired license.
(t)The employing, directly or indirectly, of any suspended or unlicensed optometrist to perform any work for which an optometry license is required.
(u) Permitting another person to use the licensees optometry license for any purpose.
(v)Altering with fraudulent intent a license issued by the board, or using a fraudulently altered license, permit certification or any registration issued by the board.
(w)Except for good cause, the knowing failure to protect patients by failing to follow infection control guidelines of the board, thereby risking transmission of bloodborne infectious diseases from optometrist to patient, from patient to patient, or from patient to optometrist. In administering this subdivision, the board shall consider the standards, regulations, and guidelines of the State Department of Public Health developed pursuant to Section 1250.11 of the Health and Safety Code and the standards, guidelines, and regulations pursuant to the California Occupational Safety and Health Act of 1973 (Part 1 (commencing with Section 6300) of Division 5 of the Labor Code) for preventing the transmission of HIV, hepatitis B, and other bloodborne pathogens in health care settings. As necessary, the board may consult with the Medical Board of California, the California Board of Podiatric Medicine, the Board of Registered Nursing, and the Board of Vocational Nursing and Psychiatric Technicians, Technicians of the State of California, to encourage appropriate consistency in the implementation of this subdivision.
(x)Failure or refusal to comply with a request for the clinical records of a patient, that is accompanied by that patients written authorization for release of records to the board, within 15 days of receiving the request and authorization, unless the licensee is unable to provide the documents within this time period for good cause.
(y) Failure to refer a patient to an appropriate physician if an examination of the eyes indicates a substantial likelihood of any pathology that requires the attention of that physician.
SEC. 14.No reimbursement is required by this act pursuant to Section 6 of Article XIIIB of the California Constitution because the only costs that may be incurred by a local agency or school district will be incurred because this act creates a new crime or infraction, eliminates a crime or infraction, or changes the penalty for a crime or infraction, within the meaning of Section 17556 of the Government Code, or changes the definition of a crime within the meaning of Section 6 of Article XIIIB of the California Constitution.
(a)The practice of optometry includes the prevention and diagnosis of disorders and dysfunctions of the visual system, and the treatment and management of certain disorders and dysfunctions of the visual system, as well as the provision of habilitative or rehabilitative optometric services, and is the doing of any or all of the following:
(1)The examination of the human eye or eyes, or its or their appendages, and the analysis of the human vision system, either subjectively or objectively.
(2)The determination of the powers or range of human vision and the accommodative and refractive states of the human eye or eyes, including the scope of its or their functions and general condition.
(3)The prescribing or directing the use of, or using, any optical device in connection with ocular exercises, visual training, vision training, or orthoptics.
(4)The prescribing of contact and spectacle lenses for, or the fitting or adaptation of contact and spectacle lenses to, the human eye, including lenses that may be classified as drugs or devices by any law of the United States or of this state.
(5)The use of topical pharmaceutical agents for the purpose of the examination of the human eye or eyes for any disease or pathological condition.
(b)The State Board of Optometry shall, by regulation, establish educational and examination requirements for licensure to ensure the competence of optometrists to practice pursuant to this chapter. chapter, except as specified in Section 3041.3 related to the use of anterior segment lasers and in Section 3041.4 related to minor procedures. Satisfactory completion of the required educational and examination requirements shall be a condition for the issuance of an original optometrist license or required certifications pursuant to this chapter.
(c)The board may authorize promulgate regulations authorizing optometrists to use noninvasive, nonsurgical technology to treat a condition authorized by this chapter. The board shall require a licensee to take a minimum of four hours of education courses on the new technology and perform an appropriate number of complete clinical procedures on live human patients to qualify to use each new technology authorized by the board pursuant to this subdivision.
SEC. 2.Section 3041.1 of the Business and Professions Code is repealed.SEC. 3.Section 3041.1 is added to the Business and Professions Code, to read:3041.1.(a)(1)An optometrist who is certified to use therapeutic pharmaceutical agents pursuant to this section may also diagnose and treat the human eye or eyes, or any of its or their appendages, for all of the following conditions:
(A)Through medical treatment, infections of the anterior segment and adnexa.
(B)Ocular allergies of the anterior segment and adnexa.
(C)Ocular inflammation that is nonsurgical in cause, except when comanaged with the treating physician and surgeon.
(C)Ocular inflammation, nonsurgical in cause except when comanaged with the treating physician and surgeon, limited to inflammation resulting from traumatic iritis, peripheral corneal inflammatory keratitis, episcleritis, and unilateral nonrecurrent nongranulomatous idiopathic iritis in patients over 18 years of age.
(D)Traumatic or recurrent conjunctival or corneal abrasions and erosions.
(E)Corneal and conjunctival surface disease and dry eyes disease.
(F)Ocular pain that is nonsurgical in cause, except when comanaged with the treating physician and surgeon.
(G)Eyelid disorders, including, but not limited to, hypotrichosis and blepharitis. Hypotrichosis and blepharitis.
(2)For purposes of this section, treat means the use of therapeutic pharmaceutical agents, as described in subdivision (b), and the procedures described in subdivision (c).
(3)For purposes of this chapter, adnexa means ocular adnexa.
(b)In diagnosing and treating the conditions listed in subdivision (a), an optometrist certified to use therapeutic pharmaceutical agents pursuant to this section may use all of the following diagnostic and therapeutic pharmaceutical agents:
(1)Oral and topical diagnostic and therapeutic pharmaceutical agents that are not controlled substances. The use of pharmaceutical agents shall be limited to the use for which the drug has been approved for marketing by the federal Food and Drug Administration (FDA).
(2)Notwithstanding paragraph (1), an optometrist certified to use therapeutic pharmaceutical agents may use a drug in a way for which the drug has not been approved for marketing by the FDA if all of the following requirements are met:
(A)The drug is approved by the FDA.
(B)The drug has been recognized for treatment of the condition by either of the following:
(i)The American Hospital Formulary Services Drug Information.
(ii)Two articles from major peer reviewed medical journals that present data supporting the proposed off-label use or uses as generally safe and effective, unless there is clear and convincing contradictory evidence presented in a major peer reviewed medical journal.
(3)Notwithstanding paragraph (1), codeine with compounds and hydrocodone with compounds as listed in the California Uniform Controlled Substances Act (Division 10 (commencing with Section 11000) of the Health and Safety Code) and the federal Controlled Substances Act (21 U.S.C. Sec. 801, et seq.) may be used. The use of these controlled substances shall be limited to five days.
(1)Topical pharmaceutical agents for the purpose of the examination of the human eye or eyes for any disease or pathological condition, including, but not limited to, topical miotics.
(2)Topical lubricants.
(3)Antiallergy agents. In using topical steroid medication for the treatment of ocular allergies, an optometrist shall consult with an ophthalmologist if the patients condition worsens 21 days after diagnosis.
(4)Topical and oral anti-inflammatories.
(5)Topical antibiotic agents.
(6)Topical hyperosmotics.
(7)Topical and oral antiglaucoma agents pursuant to the certification process defined in Section 3041.2.
(8)Nonprescription medications used for the rational treatment of an ocular disorder.
(9)Oral antihistamines.
(10)Prescription oral nonsteroidal anti-inflammatory agents.
(11)Oral antibiotics for medical treatment of ocular disease.
(12)Topical and oral antiviral medication for the medical treatment of herpes simplex viral keratitis, herpes simplex viral conjunctivitis, periocular herpes simplex viral dermatitis, varicella zoster viral keratitis, varicella zoster viral conjunctivitis, and periocular varicella zoster viral dermatitis.
(13)Oral analgesics that are not controlled substances.
(14)Codeine with compounds and hydrocodone with compounds as listed in the California Uniform Controlled Substances Act (Division 10 (commencing with Section 11000) of the Health and Safety Code) and the United States Uniform Controlled Substances Act (21 U.S.C. Sec. 801 et seq.). The use of these agents shall be limited to five days, with a referral to an ophthalmologist if the pain persists.
(c)An optometrist who is certified to use therapeutic pharmaceutical agents pursuant to this section may also perform all of the following:
(1)Corneal scraping with cultures.
(2)Debridement of corneal epithelia.
(3)Mechanical epilation.
(4)Collection of a blood specimen by finger prick method or venipuncture for testing patients suspected of having diabetes.
(5)Suture removal, with prior consultation with the treating health care provider.
(6)Treatment or removal of sebaceous cysts by expression.
(7)Administration of oral fluorescein to patients suspected as having diabetic retinopathy.
(8)Use of an auto-injector to counter anaphylaxis.
(9)Ordering of clinical laboratory and imaging tests related to the practice of optometry.
(10)A clinical laboratory test or examination classified as waived under CLIA and related to the practice of optometry.
(9)Ordering of smears, cultures, sensitivities, complete blood count, mycobacterial culture, acid fast stain, urinalysis, tear fluid analysis, and X-rays necessary for the diagnosis of conditions or diseases of the eye or adnexa. An optometrist may order other types of images subject to prior consultation with the appropriate physician and surgeon.
(10)A clinical laboratory test or examination classified as waived under the Clinical Laboratory Improvement Amendments of 1988 (CLIA)(42 U.S.C. Sec. 263a; Public Law 100-578) or any regulations adopted pursuant to CLIA, and that are necessary for the diagnosis of conditions and diseases of the eye or adnexa, or if otherwise specifically authorized by this chapter.
(11)Skin test to diagnose ocular allergies. Skin tests shall be limited to the superficial lawyer of the skin.
(12)Punctal occlusion by plugs, excluding laser, diathermy, cryotherapy, or other means constituting surgery as defined in this chapter.
(13)The prescription of therapeutic contact lenses, diagnostic contact lenses, or biological or technological corneal devices. devices that diagnose or treat a condition authorized under this chapter.
(14)Removal of foreign bodies from the cornea, eyelid, and conjunctiva with any appropriate instrument other than a scalpel or needle. scalpel. Corneal foreign bodies shall be nonperforating, be no deeper than the midstroma, and require no surgical repair upon removal.
(15)For patients over 12 years of age, lacrimal irrigation and dilation, excluding probing of the nasal lacrimal tract. The board shall certify any optometrist who graduated from an accredited school of optometry before May 1, 2000, to perform this procedure after submitting proof of satisfactory completion and confirmation of 10 procedures under the supervision of an ophthalmologist or optometrist who is certified in lacrimal irrigation and dilation. Any optometrist who graduated from an accredited school of optometry on or after May 1, 2000, shall be exempt from the certification requirement contained in this paragraph.
(16)Use of mechanical lipid extraction of meibomian glands and nonsurgical techniques.
(17)Notwithstanding subdivision (b), administration of injections for the diagnoses or treatment of conditions of the eye and adnexa, excluding intraorbital injections and injections administered for cosmetic effect, provided that the optometrist has satisfactorily received four hours of continuing education on performing all injections authorized by this paragraph.
(d)In order to be certified to use therapeutic pharmaceutical agents and authorized to diagnose and treat the conditions listed in this section, an optometrist shall apply for a certificate from the board and meet all requirements imposed by the board.
(e)The board shall grant a certificate to use therapeutic pharmaceutical agents to any applicant who graduated from a California accredited school of optometry prior to January 1, 1996, is licensed as an optometrist in California, and meets all of the following requirements:
(1)Satisfactorily completes a didactic course of no less than 80 classroom hours in the diagnosis, pharmacological, and other treatment and management of ocular disease provided by either an accredited school of optometry in California or a recognized residency review committee in ophthalmology in California.
(2)Completes a preceptorship of no less than 65 hours, during a period of not less than two months nor more than one year, in either an ophthalmologists office or an optometric clinic. The training received during the preceptorship shall be on the diagnosis, treatment, and management of ocular, systemic disease. The preceptor shall certify completion of the preceptorship. Authorization for the ophthalmologist to serve as a preceptor shall be provided by an accredited school of optometry in California, or by a recognized residency review committee in ophthalmology, and the preceptor shall be licensed as an ophthalmologist in California, board certified in ophthalmology, and in good standing with the Medical Board of California. The individual serving as the preceptor shall schedule no more than three optometrist applicants for each of the required 65 hours of the preceptorship program. This paragraph shall not be construed to limit the total number of optometrist applicants for whom an individual may serve as a preceptor, and is intended only to ensure the quality of the preceptorship by requiring that the ophthalmologist preceptor schedule the training so that each applicant optometrist completes each of the 65 hours of the preceptorship while scheduled with no more than two other optometrist applicants.
(3)Successfully completes a minimum of 20 hours of self-directed education.
(4)Passes the National Board of Examiners in Optometrys Treatment and Management of Ocular Disease examination or, in the event this examination is no longer offered, its equivalent, as determined by the State Board of Optometry.
(5)Passes the examination issued upon completion of the 80-hour didactic course required under paragraph (1) and provided by the accredited school of optometry or residency program in ophthalmology.
(6)When any or all of the requirements contained in paragraph (1), (4), or (5) have been satisfied on or after July 1, 1992, and before January 1, 1996, an optometrist shall not be required to fulfill the satisfied requirements in order to obtain certification to use therapeutic pharmaceutical agents. In order for this paragraph to apply to the requirement contained in paragraph (5), the didactic examination that the applicant successfully completed shall meet equivalency standards, as determined by the board.
(7)Any optometrist who graduated from an accredited school of optometry on or after January 1, 1992, and before January 1, 1996, shall not be required to fulfill the requirements contained in paragraphs (1), (4), and (5).
(f)The board shall grant a certificate to use therapeutic pharmaceutical agents to any applicant who graduated from a California accredited school of optometry on or after January 1, 1996, who is licensed as an optometrist in California, and who meets all of the following requirements:
(1)Passes the National Board of Examiners in Optometrys national board examination, or its equivalent, as determined by the State Board of Optometry.
(2)Of the total clinical training required by a school of optometrys curriculum, successfully completed at least 65 of those hours on the diagnosis, treatment, and management of ocular, systemic disease.
(3)Is certified by an accredited school of optometry as competent in the diagnosis, treatment, and management of ocular, systemic disease to the extent authorized by this section.
(4)Is certified by an accredited school of optometry as having completed at least 10 hours of experience with a board-certified ophthalmologist.
(g)The board shall grant a certificate to use therapeutic pharmaceutical agents to any applicant who is an optometrist who obtained his or her license outside of California if he or she meets all of the requirements for an optometrist licensed in California to be certified to use therapeutic pharmaceutical agents.
(1)In order to obtain a certificate to use therapeutic pharmaceutical agents, any optometrist who obtained his or her license outside of California and graduated from an accredited school of optometry prior to January 1, 1996, shall be required to fulfill the requirements set forth in subdivision (e). In order for the applicant to be eligible for the certificate to use therapeutic pharmaceutical agents, the education he or she received at the accredited out-of-state school of optometry shall be equivalent to the education provided by any accredited school of optometry in California for persons who graduated before January 1, 1996. For those out-of-state applicants who request that any of the requirements contained in subdivision (e) be waived based on fulfillment of the requirement in another state, if the board determines that the completed requirement was equivalent to that required in California, the requirement shall be waived.
(2)In order to obtain a certificate to use therapeutic pharmaceutical agents, any optometrist who obtained his or her license outside of California and who graduated from an accredited school of optometry on or after January 1, 1996, shall be required to fulfill the requirements set forth in subdivision (f). In order for the applicant to be eligible for the certificate to use therapeutic pharmaceutical agents, the education he or she received by the accredited out-of-state school of optometry shall be equivalent to the education provided by any accredited school of optometry for persons who graduated on or after January 1, 1996. For those out-of-state applicants who request that any of the requirements contained in subdivision (f) be waived based on fulfillment of the requirement in another state, if the board determines that the completed requirement was equivalent to that required in California, the requirement shall be waived.
(3)The State Board of Optometry shall decide all issues relating to the equivalency of an optometrists education or training under this subdivision.
(h)Other than for prescription ophthalmic devices described in subdivision (b) of Section 2541, any dispensing of a therapeutic pharmaceutical agent by an optometrist shall be without charge.
(i)Except as authorized by this chapter, the practice of optometry does not include performing surgery. Surgery means any procedure in which human tissue is cut, altered, or otherwise infiltrated by mechanical or laser means. Surgery does not include those procedures specified in subdivision (c). This section does not limit an optometrists authority to utilize diagnostic laser and ultrasound technology within his or her scope of practice.
(j)In an emergency, an optometrist shall stabilize, if possible, and immediately refer any patient who has an acute attack of angle closure to an ophthalmologist.
SEC. 4.Section 3041.2 of the Business and Professions Code is repealed.SEC. 5.Section 3041.2 is added to the Business and Professions Code, to read:3041.2.(a)For purposes of this chapter, glaucoma means any of the following:
(1)All primary open-angle glaucoma.
(2)Exfoliation and pigmentary glaucoma.
(3)Increase in intraocular pressure caused by steroid medication. medication prescribed by the optometrist.
(4)Increase in intraocular pressure caused by steroid medication not prescribed by the optometrist, after consultation and treatment approval by the prescribing physician.
(b)An optometrist certified pursuant to Section 3041.1 shall be certified for the treatment of glaucoma, as described in subdivision (a), in patients over 18 years of age after the optometrist meets the following applicable requirements:
(1)For licensees who graduated from an accredited school of optometry on or after May 1, 2008, submission of proof of graduation from that institution.
(2)For licensees who were certified to treat glaucoma under this section prior to January 1, 2009, submission of proof of completion of that certification program.
(3)For licensees who completed a didactic course of not less than 24 hours in the diagnosis, pharmacological, and other treatment and management of glaucoma, submission of proof of satisfactory completion of the case management requirements for certification established by the board.
(4)For licensees who graduated from an accredited school of optometry on or before May 1, 2008, and are not described in paragraph (2) or (3), submission of proof of satisfactory completion of the requirements for certification established by the board.
SEC. 6.Section 3041.3 of the Business and Professions Code is repealed.SEC. 7.Section 3041.3 is added to the Business and Professions Code, to read:3041.3.(a)For the purposes of this chapter, anterior segment laser means any of the following:
(1)Therapeutic lasers appropriate for treatment of glaucoma.
(2)Notwithstanding subdivision (a) of Section 3041.2, peripheral iridotomy for the prophylactic treatment of angle closure glaucoma.
(3)Therapeutic lasers used for posterior capsulotomy secondary to cataract surgery.
(b)An optometrist certified to treat glaucoma pursuant to Section 3041.2 shall be additionally certified for the use of anterior segment lasers after submitting proof of satisfactory completion of a course that is approved by the board, provided by an accredited school of optometry, and developed in consultation with an ophthalmologist who has experience educating optometric students. The board shall issue a certificate pursuant to this section only to an optometrist that has graduated from an approved school of optometry.
(1)The board-approved course shall be a minimum of 16 at least 25 hours in length, and include a test for competency of the following:
(A)Laser physics, hazards, and safety.
(B)Biophysics of laser.
(C)Laser application in clinical optometry.
(D)Laser tissue interactions.
(E)Laser indications, contraindications, and potential complications.
(F)Gonioscopy.
(G)Laser therapy for open-angle glaucoma.
(H)Laser therapy for angle closure glaucoma.
(I)Posterior capsulotomy.
(J)Common complications of the lids, lashes, and lacrimal system.
(K)Medicolegal aspects of anterior segment procedures.
(L)Peripheral iridotomy.
(M)Laser trabeculoplasty.
(2)The school of optometry shall require each applicant for certification to perform a sufficient number of complete anterior segment laser procedures to verify that the applicant has demonstrated competency to practice independently. At a minimum, each applicant shall complete 14 24 anterior segment laser procedures on live humans. humans as follows:
(A)Eight YAG capsulotomy procedures.
(B)Eight laser trabeculoplasty procedures.
(C)Eight peripheral iridotomy procedures.
(c)The board, by regulation, shall set the fee for issuance and renewal of a certificate authorizing the use of anterior segment lasers at an amount no higher than the reasonable cost of regulating anterior segment laser certified optometrists pursuant to this section. The fee shall not exceed one hundred fifty dollars ($150).
(d)An optometrist certified to use anterior segment lasers pursuant to this section shall complete four hours of continuing education on anterior segment lasers as part of the required 50 hours of continuing education required to be completed every two years on the diagnosis, treatment, and management of glaucoma.
SEC. 8.Section 3041.4 is added to the Business and Professions Code, to read:3041.4.(a)For the purposes of this chapter, minor procedure means either of the following:
(1)Removal, destruction, or drainage of lesions of the eyelid and adnexa clinically evaluated by the optometrist to be noncancerous, not involving the eyelid margin, lacrimal supply or drainage systems, no deeper than the orbicularis muscle, and smaller than five millimeters in diameter.
(2)Closure of a wound resulting from a procedure described in paragraph (1).
(3)Administration of injections for the diagnoses or treatment of conditions of the eye and adnexa authorized by this chapter, excluding intraorbital injections and injections administered for cosmetic effect.
(4)Minor procedures does not include blepharoplasty or other cosmetic surgery procedures that reshape normal structures of the body in order to improve appearance and self-esteem.
(b)An optometrist certified to treat glaucoma pursuant to Section 3041.2 shall be additionally certified to perform minor procedures after submitting proof of satisfactory completion of a course that is approved by the board, provided by an accredited school of optometry, and developed in consultation with an ophthalmologist who has experience teaching optometric students. The board shall issue a certificate pursuant to this section only to an optometrist that has graduated from an approved school of optometry.
(1)The board-approved course shall be a minimum of 32 hours at least 25 hours in length and include a test for competency of the following:
(A)Minor surgical procedures.
(B)Overview of surgical instruments, asepsis, and the state and federal Occupational Safety and Health Administrations.
(C)Surgical anatomy of the eyelids.
(D)Emergency surgical procedures.
(E)Chalazion management.
(F)Epiluminescence microscopy.
(G)Suture techniques.
(H)Local anesthesia techniques and complications.
(I)Anaphylaxsis and other office emergencies.
(J)Radiofrequency surgery.
(K)Postoperative wound care.
(L)Injection techniques.
(2)The school of optometry shall require each applicant for certification to perform a sufficient number of minor procedures to verify that the applicant has demonstrated competency to practice independently. At a minimum, each applicant shall perform 32 complete five minor procedures on live humans.
(c)The board, by regulation, shall set the fee for issuance and renewal of a certificate authorizing the use of minor procedures at an amount no greater than the reasonable cost of regulating minor procedure certified optometrists pursuant to this section. The fee shall not exceed one hundred fifty dollars ($150).
(d)An optometrist certified to perform minor procedures pursuant to Section 3041.1 shall complete five hours of continuing education on the diagnosis, treatment, and management of lesions of the eyelid and adnexa as part of the 50 hours of continuing education required every two years in Section 3059.
SEC. 9.Section 3041.5 is added to the Business and Professions Code, to read:3041.5.(a)An optometrist may independently initiate and administer vaccines listed on the routine immunization schedules recommended by the federal Advisory Committee on Immunization Practices (ACIP), in compliance with individual ACIP vaccine recommendations, and published by the federal Centers for Disease Control and Prevention (CDC) for persons three years of age and older.
(b)In order to initiate and administer an immunization described in subdivision (a), an optometrist shall do all of the following:
(1)Complete an immunization training program endorsed by the CDC or the Accreditation Council for Pharmacy Education that, at a minimum, includes hands-on injection technique, clinical evaluation of indications and contraindications of vaccines, and the recognition and treatment of emergency reactions to vaccines, and shall maintain that training.
(2)Be certified in basic life support for health care professionals.
(3)Comply with all state and federal recordkeeping and reporting requirements, including providing documentation to the patients primary care provider and entering information in the appropriate immunization registry designated by the immunization branch of the State Department of Public Health.
SEC. 9.Section 3041.5 is added to the Business and Professions Code, to read:3041.5.(a)The board shall grant to an optometrist a certificate for the use of immunizations described in subdivision (b), if the optometrist is certified pursuant to Section 3041.2 and after the optometrist meets all of the following requirements:
(1)Completes an immunization training program endorsed by the federal Centers for Disease Control (CDC) that, at a minimum, includes hands-on injection technique, clinical evaluation of indications and contraindications of vaccines, and the recognition and treatment of emergency reactions to vaccines, and maintains that training.
(2)Is certified in basic life support.
(3)Complies with all state and federal recordkeeping and reporting requirements, including providing documentation to the patients primary care provider and entering information in the appropriate immunization registry designated by the immunization branch of the State Department of Public Health.
(b)For the purposes of this section, immunization means the administration of immunizations for influenza, herpes zoster virus, and pneumococcus in compliance with individual Advisory Committee on Immunization Practices (ACIP) vaccine recommendations published by the CDC for persons 18 years of age or older.
(c)The board, by regulation, shall set the fee for issuance and renewal of a certificate for the use of immunizations at the reasonable cost of regulating immunization certified optometrists pursuant to this section. The fee shall not exceed one hundred dollars ($100).
SEC. 10.Section 3041.6 is added to the Business and Professions Code, to read:3041.6.An optometrist licensed under this chapter is subject to the provisions of Section 2290.5 for purposes of practicing telehealth.
SEC. 11.Section 3041.7 is added to the Business and Professions Code, to read:3041.7.Optometrists diagnosing or treating eye disease shall be held to the same standard of care to which physicians and surgeons and osteopathic physicians and surgeons are held. An optometrist shall consult with and, if necessary, refer to a physician and surgeon or other appropriate health care provider when a situation or condition occurs that is beyond the optometrists scope of practice.
SEC. 12.Section 3041.8 is added to the Business and Professions Code, to read:3041.8.It is the intent of the Legislature that the Office of Statewide Health Planning and Development, under the Health Workforce Pilot Projects Program, designate a pilot project to test, demonstrate, and evaluate expanded roles for optometrists in the performance of management and treatment of diabetes mellitus, hypertension, and hypercholesterolemia.
SEC. 13.Section 3110 of the Business and Professions Code is amended to read:3110.The board may take action against any licensee who is charged with unprofessional conduct, and may deny an application for a license if the applicant has committed unprofessional conduct. In addition to other provisions of this article, unprofessional conduct includes, but is not limited to, the following:
(a)Violating or attempting to violate, directly or indirectly assisting in or abetting the violation of, or conspiring to violate any provision of this chapter or any of the rules and regulations adopted by the board pursuant to this chapter.
(b)Gross negligence.
(c)Repeated negligent acts. To be repeated, there must be two or more negligent acts or omissions.
(d)Incompetence.
(e)The commission of fraud, misrepresentation, or any act involving dishonesty or corruption, that is substantially related to the qualifications, functions, or duties of an optometrist.
(f)Any action or conduct that would have warranted the denial of a license.
(g)The use of advertising relating to optometry that violates Section 651 or 17500.
(h)Denial of licensure, revocation, suspension, restriction, or any other disciplinary action against a health care professional license by another state or territory of the United States, by any other governmental agency, or by another California health care professional licensing board. A certified copy of the decision or judgment shall be conclusive evidence of that action.
(i)Procuring his or her license by fraud, misrepresentation, or mistake.
(j)Making or giving any false statement or information in connection with the application for issuance of a license.
(k)Conviction of a felony or of any offense substantially related to the qualifications, functions, and duties of an optometrist, in which event the record of the conviction shall be conclusive evidence thereof.
(l)Administering to himself or herself any controlled substance or using any of the dangerous drugs specified in Section 4022, or using alcoholic beverages to the extent, or in a manner, as to be dangerous or injurious to the person applying for a license or holding a license under this chapter, or to any other person, or to the public, or, to the extent that the use impairs the ability of the person applying for or holding a license to conduct with safety to the public the practice authorized by the license, or the conviction of a misdemeanor or felony involving the use, consumption, or self-administration of any of the substances referred to in this subdivision, or any combination thereof.
(m)(1)Committing or soliciting an act punishable as a sexually related crime, if that act or solicitation is substantially related to the qualifications, functions, or duties of an optometrist.
(2)Committing any act of sexual abuse, misconduct, or relations with a patient. The commission of and conviction for any act of sexual abuse, sexual misconduct, or attempted sexual misconduct, whether or not with a patient, shall be considered a crime substantially related to the qualifications, functions, or duties of a licensee. This paragraph shall not apply to sexual contact between any person licensed under this chapter and his or her spouse or person in an equivalent domestic relationship when that licensee provides optometry treatment to his or her spouse or person in an equivalent domestic relationship.
(3)Conviction of a crime that requires the person to register as a sex offender pursuant to Chapter 5.5 (commencing with Section 290) of Title 9 of Part 1 of the Penal Code. A conviction within the meaning of this paragraph means a plea or verdict of guilty or a conviction following a plea of nolo contendere. A conviction described in this paragraph shall be considered a crime substantially related to the qualifications, functions, or duties of a licensee.
(n)Repeated acts of excessive prescribing, furnishing, or administering of controlled substances or dangerous drugs specified in Section 4022, or repeated acts of excessive treatment.
(o)Repeated acts of excessive use of diagnostic or therapeutic procedures, or repeated acts of excessive use of diagnostic or treatment facilities.
(p)The prescribing, furnishing, or administering of controlled substances or drugs specified in Section 4022, or treatment without a good faith prior examination of the patient and optometric reason.
(q)The failure to maintain adequate and accurate records relating to the provision of services to his or her patients.
(r)Performing, or holding oneself out as being able to perform, or offering to perform, any professional services beyond the scope of the license authorized by this chapter.
(s)The practice of optometry without a valid, unrevoked, unexpired license.
(t)The employing, directly or indirectly, of any suspended or unlicensed optometrist to perform any work for which an optometry license is required.
(u) Permitting another person to use the licensees optometry license for any purpose.
(v)Altering with fraudulent intent a license issued by the board, or using a fraudulently altered license, permit certification or any registration issued by the board.
(w)Except for good cause, the knowing failure to protect patients by failing to follow infection control guidelines of the board, thereby risking transmission of bloodborne infectious diseases from optometrist to patient, from patient to patient, or from patient to optometrist. In administering this subdivision, the board shall consider the standards, regulations, and guidelines of the State Department of Public Health developed pursuant to Section 1250.11 of the Health and Safety Code and the standards, guidelines, and regulations pursuant to the California Occupational Safety and Health Act of 1973 (Part 1 (commencing with Section 6300) of Division 5 of the Labor Code) for preventing the transmission of HIV, hepatitis B, and other bloodborne pathogens in health care settings. As necessary, the board may consult with the Medical Board of California, the Board of Podiatric Medicine, the Board of Registered Nursing, and the Board of Vocational Nursing and Psychiatric Technicians, to encourage appropriate consistency in the implementation of this subdivision.
(x)Failure or refusal to comply with a request for the clinical records of a patient, that is accompanied by that patients written authorization for release of records to the board, within 15 days of receiving the request and authorization, unless the licensee is unable to provide the documents within this time period for good cause.
(y) Failure to refer a patient to an appropriate physician in either of the following circumstances:
(1)Where physician if an examination of the eyes indicates a substantial likelihood of any pathology that requires the attention of that physician.
(2)As required by subdivision (c) of Section 3041.
SEC. 13.SEC. 14.No reimbursement is required by this act pursuant to Section 6 of Article XIIIB of the California Constitution because the only costs that may be incurred by a local agency or school district will be incurred because this act creates a new crime or infraction, eliminates a crime or infraction, or changes the penalty for a crime or infraction, within the meaning of Section 17556 of the Government Code, or changes the definition of a crime within the meaning of Section 6 of Article XIIIB of the California Constitution.
(a)The practice of optometry includes the prevention and diagnosis of disorders and dysfunctions of the visual system, and the treatment and management of certain disorders and dysfunctions of the visual system, as well as the provision of habilitative or rehabilitative optometric services, and is the doing of any or all of the following:
(1)The examination of the human eye or eyes, or its or their appendages, and the analysis of the human vision system, either subjectively or objectively.
(2)The determination of the powers or range of human vision and the accommodative and refractive states of the human eye or eyes, including the scope of its or their functions and general condition.
(3)The prescribing or directing the use of, or using, any optical device in connection with ocular exercises, visual training, vision training, or orthoptics.
(4)The prescribing of contact and spectacle lenses for, or the fitting or adaptation of contact and spectacle lenses to, the human eye, including lenses that may be classified as drugs or devices by any law of the United States or of this state.
(5)The use of topical pharmaceutical agents for the purpose of the examination of the human eye or eyes for any disease or pathological condition.
(b)(1)An optometrist who is certified to use therapeutic pharmaceutical agents, pursuant to Section 3041.3, may also diagnose and treat the human eye or eyes, or any of its or their appendages, for all of the following conditions:
(A)Through medical treatment, infections of the anterior segment and adnexa, excluding the lacrimal gland, the lacrimal drainage system, and the sclera in patients under 12 years of age.
(B)Ocular allergies of the anterior segment and adnexa.
(C)Ocular inflammation, nonsurgical in cause except when comanaged with the treating physician and surgeon, limited to inflammation resulting from traumatic iritis, peripheral corneal inflammatory keratitis, episcleritis, and unilateral nonrecurrent nongranulomatous idiopathic iritis in patients over 18 years of age. Unilateral nongranulomatous idiopathic iritis recurring within one year of the initial occurrence shall be referred to an ophthalmologist. An optometrist shall consult with an ophthalmologist or appropriate physician and surgeon if a patient has a recurrent case of episcleritis within one year of the initial occurrence. An optometrist shall consult with an ophthalmologist or appropriate physician and surgeon if a patient has a recurrent case of peripheral corneal inflammatory keratitis within one year of the initial occurrence.
(D)Traumatic or recurrent conjunctival or corneal abrasions and erosions.
(E)Corneal surface disease and dry eyes.
(F)Ocular pain, nonsurgical in cause except when comanaged with the treating physician and surgeon, associated with conditions optometrists are authorized to treat.
(G)Pursuant to subdivision (f), glaucoma in patients over 18 years of age, as described in subdivision (j).
(2)For purposes of this section, treat means the use of therapeutic pharmaceutical agents, as described in subdivision (c), and the procedures described in subdivision (e).
(c)In diagnosing and treating the conditions listed in subdivision (b), an optometrist certified to use therapeutic pharmaceutical agents pursuant to Section 3041.3 may use all of the following therapeutic pharmaceutical agents:
(1)Pharmaceutical agents as described in paragraph (5) of subdivision (a), as well as topical miotics.
(2)Topical lubricants.
(3)Antiallergy agents. In using topical steroid medication for the treatment of ocular allergies, an optometrist shall consult with an ophthalmologist if the patients condition worsens 21 days after diagnosis.
(4)Topical and oral anti-inflammatories. In using steroid medication for:
(A)Unilateral nonrecurrent nongranulomatous idiopathic iritis or episcleritis, an optometrist shall consult with an ophthalmologist or appropriate physician and surgeon if the patients condition worsens 72 hours after the diagnosis, or if the patients condition has not resolved three weeks after diagnosis. If the patient is still receiving medication for these conditions six weeks after diagnosis, the optometrist shall refer the patient to an ophthalmologist or appropriate physician and surgeon.
(B)Peripheral corneal inflammatory keratitis, excluding Moorens and Terriens diseases, an optometrist shall consult with an ophthalmologist or appropriate physician and surgeon if the patients condition worsens 72 hours after diagnosis.
(C)Traumatic iritis, an optometrist shall consult with an ophthalmologist or appropriate physician and surgeon if the patients condition worsens 72 hours after diagnosis and shall refer the patient to an ophthalmologist or appropriate physician and surgeon if the patients condition has not resolved one week after diagnosis.
(5)Topical antibiotic agents.
(6)Topical hyperosmotics.
(7)Topical and oral antiglaucoma agents pursuant to the certification process defined in subdivision (f).
(A)The optometrist shall refer the patient to an ophthalmologist if requested by the patient or if angle closure glaucoma develops.
(B)If the glaucoma patient also has diabetes, the optometrist shall consult with the physician treating the patients diabetes in developing the glaucoma treatment plan and shall inform the physician in writing of any changes in the patients glaucoma medication.
(8)Nonprescription medications used for the rational treatment of an ocular disorder.
(9)Oral antihistamines.
(10)Prescription oral nonsteroidal anti-inflammatory agents.
(11)Oral antibiotics for medical treatment of ocular disease.
(A)If the patient has been diagnosed with a central corneal ulcer and the central corneal ulcer has not improved 48 hours after diagnosis, the optometrist shall refer the patient to an ophthalmologist.
(B)If the patient has been diagnosed with preseptal cellulitis or dacryocystitis and the condition has not improved 48 hours after diagnosis, the optometrist shall refer the patient to an ophthalmologist.
(12)Topical and oral antiviral medication for the medical treatment of the following: herpes simplex viral keratitis, herpes simplex viral conjunctivitis, and periocular herpes simplex viral dermatitis; and varicella zoster viral keratitis, varicella zoster viral conjunctivitis, and periocular varicella zoster viral dermatitis.
(A)If the patient has been diagnosed with herpes simplex keratitis or varicella zoster viral keratitis and the patients condition has not improved seven days after diagnosis, the optometrist shall refer the patient to an ophthalmologist. If a patients condition has not resolved three weeks after diagnosis, the optometrist shall refer the patient to an ophthalmologist.
(B)If the patient has been diagnosed with herpes simplex viral conjunctivitis, herpes simplex viral dermatitis, varicella zoster viral conjunctivitis, or varicella zoster viral dermatitis, and if the patients condition worsens seven days after diagnosis, the optometrist shall consult with an ophthalmologist. If the patients condition has not resolved three weeks after diagnosis, the optometrist shall refer the patient to an ophthalmologist.
(13)Oral analgesics that are not controlled substances.
(14)Codeine with compounds and hydrocodone with compounds as listed in the California Uniform Controlled Substances Act (Division 10 (commencing with Section 11000) of the Health and Safety Code) and the United States Uniform Controlled Substances Act (21 U.S.C. Sec. 801 et seq.). The use of these agents shall be limited to three days, with a referral to an ophthalmologist if the pain persists.
(d)In any case where this chapter requires that an optometrist consult with an ophthalmologist, the optometrist shall maintain a written record in the patients file of the information provided to the ophthalmologist, the ophthalmologists response, and any other relevant information. Upon the consulting ophthalmologists request and with the patients consent, the optometrist shall furnish a copy of the record to the ophthalmologist.
(e)An optometrist who is certified to use therapeutic pharmaceutical agents pursuant to Section 3041.3 may also perform all of the following:
(1)Corneal scraping with cultures.
(2)Debridement of corneal epithelia.
(3)Mechanical epilation.
(4)Venipuncture for testing patients suspected of having diabetes.
(5)Suture removal, with prior consultation with the treating physician and surgeon.
(6)Treatment or removal of sebaceous cysts by expression.
(7)Administration of oral fluorescein to patients suspected as having diabetic retinopathy.
(8)Use of an auto-injector to counter anaphylaxis.
(9)Ordering of smears, cultures, sensitivities, complete blood count, mycobacterial culture, acid fast stain, urinalysis, tear fluid analysis, and X-rays necessary for the diagnosis of conditions or diseases of the eye or adnexa. An optometrist may order other types of images subject to prior consultation with an ophthalmologist or appropriate physician and surgeon.
(10)A clinical laboratory test or examination classified as waived under CLIA and designated as waived in paragraph (9) necessary for the diagnosis of conditions and diseases of the eye or adnexa, or if otherwise specifically authorized by this chapter.
(11)Punctal occlusion by plugs, excluding laser, diathermy, cryotherapy, or other means constituting surgery as defined in this chapter.
(12)The prescription of therapeutic contact lenses, including lenses or devices that incorporate a medication or therapy the optometrist is certified to prescribe or provide.
(13)Removal of foreign bodies from the cornea, eyelid, and conjunctiva with any appropriate instrument other than a scalpel or needle. Corneal foreign bodies shall be nonperforating, be no deeper than the midstroma, and require no surgical repair upon removal.
(14)For patients over 12 years of age, lacrimal irrigation and dilation, excluding probing of the nasal lacrimal tract. The board shall certify any optometrist who graduated from an accredited school of optometry before May 1, 2000, to perform this procedure after submitting proof of satisfactory completion of 10 procedures under the supervision of an ophthalmologist as confirmed by the ophthalmologist. Any optometrist who graduated from an accredited school of optometry on or after May 1, 2000, shall be exempt from the certification requirement contained in this paragraph.
(f)The board shall grant a certificate to an optometrist certified pursuant to Section 3041.3 for the treatment of glaucoma, as described in subdivision (j), in patients over 18 years of age after the optometrist meets the following applicable requirements:
(1)For licensees who graduated from an accredited school of optometry on or after May 1, 2008, submission of proof of graduation from that institution.
(2)For licensees who were certified to treat glaucoma under this section prior to January 1, 2009, submission of proof of completion of that certification program.
(3)For licensees who have substantially completed the certification requirements pursuant to this section in effect between January 1, 2001, and December 31, 2008, submission of proof of completion of those requirements on or before December 31, 2009. Substantially completed means both of the following:
(A)Satisfactory completion of a didactic course of not less than 24 hours in the diagnosis, pharmacological, and other treatment and management of glaucoma.
(B)Treatment of 50 glaucoma patients with a collaborating ophthalmologist for a period of two years for each patient that will conclude on or before December 31, 2009.
(4)For licensees who completed a didactic course of not less than 24 hours in the diagnosis, pharmacological, and other treatment and management of glaucoma, submission of proof of satisfactory completion of the case management requirements for certification established by the board pursuant to Section 3041.10.
(5)For licensees who graduated from an accredited school of optometry on or before May 1, 2008, and not described in paragraph (2), (3), or (4), submission of proof of satisfactory completion of the requirements for certification established by the board pursuant to Section 3041.10.
(g)Other than for prescription ophthalmic devices described in subdivision (b) of Section 2541, any dispensing of a therapeutic pharmaceutical agent by an optometrist shall be without charge.
(h)The practice of optometry does not include performing surgery. Surgery means any procedure in which human tissue is cut, altered, or otherwise infiltrated by mechanical or laser means. Surgery does not include those procedures specified in subdivision (e). Nothing in this section shall limit an optometrists authority to utilize diagnostic laser and ultrasound technology within his or her scope of practice.
(i)An optometrist licensed under this chapter is subject to the provisions of Section 2290.5 for purposes of practicing telehealth.
(j)For purposes of this chapter, glaucoma means either of the following:
(1)All primary open-angle glaucoma.
(2)Exfoliation and pigmentary glaucoma.
(k)For purposes of this chapter, adnexa means ocular adnexa.
(l)In an emergency, an optometrist shall stabilize, if possible, and immediately refer any patient who has an acute attack of angle closure to an ophthalmologist.
(b)The State Board of Optometry shall, by regulation, establish educational and examination requirements for licensure to ensure the competence of optometrists to practice pursuant to this chapter. Satisfactory completion of the required educational and examination requirements shall be a condition for the issuance of an original optometrist license or required certifications pursuant to this chapter.
(c)The board may authorize optometrists to use nonsurgical technology to treat a condition authorized by this chapter.
SEC. 2.Section 3041.1 of the Business and Professions Code is repealed.3041.1.With respect to the practices set forth in subdivisions (b), (d), and (e) of Section 3041, optometrists diagnosing or treating eye disease shall be held to the same standard of care to which physicians and surgeons and osteopathic physicians and surgeons are held.
SEC. 3.Section 3041.1 is added to the Business and Professions Code, to read:3041.1.(a)(1)An optometrist who is certified to use therapeutic pharmaceutical agents pursuant to this section may also diagnose and treat the human eye or eyes, or any of its or their appendages, for all of the following conditions:
(A)Through medical treatment, infections of the anterior segment and adnexa.
(B)Ocular allergies of the anterior segment and adnexa.
(C)Ocular inflammation that is nonsurgical in cause, except when comanaged with the treating physician and surgeon.
(D)Traumatic or recurrent conjunctival or corneal abrasions and erosions.
(E)Corneal and conjunctival surface disease and dry eyes disease.
(F)Ocular pain that is nonsurgical in cause, except when comanaged with the treating physician and surgeon.
(G)Eyelid disorders, including, but not limited to, hypotrichosis and blepharitis.
(2)For purposes of this section, treat means the use of therapeutic pharmaceutical agents, as described in subdivision (b), and the procedures described in subdivision (c).
(3)For purposes of this chapter, adnexa means ocular adnexa.
(b)In diagnosing and treating the conditions listed in subdivision (a), an optometrist certified to use therapeutic pharmaceutical agents pursuant to this section may use all of the following diagnostic and therapeutic pharmaceutical agents:
(1)Oral and topical diagnostic and therapeutic pharmaceutical agents that are not controlled substances. The use of pharmaceutical agents shall be limited to the use for which the drug has been approved for marketing by the federal Food and Drug Administration (FDA).
(2)Notwithstanding paragraph (1), an optometrist certified to use therapeutic pharmaceutical agents may use a drug in a way for which the drug has not been approved for marketing by the FDA if all of the following requirements are met:
(A)The drug is approved by the FDA.
(B)The drug has been recognized for treatment of the condition by either of the following:
(i)The American Hospital Formulary Services Drug Information.
(ii)Two articles from major peer reviewed medical journals that present data supporting the proposed off-label use or uses as generally safe and effective, unless there is clear and convincing contradictory evidence presented in a major peer reviewed medical journal.
(3)Notwithstanding paragraph (1), codeine with compounds and hydrocodone with compounds as listed in the California Uniform Controlled Substances Act (Division 10 (commencing with Section 11000) of the Health and Safety Code) and the federal Controlled Substances Act (21 U.S.C. Sec. 801, et seq.) may be used. The use of these controlled substances shall be limited to five days.
(c)An optometrist who is certified to use therapeutic pharmaceutical agents pursuant to this section may also perform all of the following:
(1)Corneal scraping with cultures.
(2)Debridement of corneal epithelia.
(3)Mechanical epilation.
(4)Collection of a blood specimen by finger prick method or venipuncture for testing patients suspected of having diabetes.
(5)Suture removal, with prior consultation with the treating health care provider.
(6)Treatment or removal of sebaceous cysts by expression.
(7)Administration of oral fluorescein to patients suspected as having diabetic retinopathy.
(8)Use of an auto-injector to counter anaphylaxis.
(9)Ordering of clinical laboratory and imaging tests related to the practice of optometry.
(10)A clinical laboratory test or examination classified as waived under CLIA and related to the practice of optometry.
(11)Skin test to diagnose ocular allergies. Skin tests shall be limited to the superficial lawyer of the skin.
(12)Punctal occlusion by plugs, excluding laser, diathermy, cryotherapy, or other means constituting surgery as defined in this chapter.
(13)The prescription of therapeutic contact lenses, diagnostic contact lenses, or biological or technological corneal devices.
(14)Removal of foreign bodies from the cornea, eyelid, and conjunctiva with any appropriate instrument other than a scalpel or needle. Corneal foreign bodies shall be nonperforating, be no deeper than the midstroma, and require no surgical repair upon removal.
(15)For patients over 12 years of age, lacrimal irrigation and dilation, excluding probing of the nasal lacrimal tract. The board shall certify any optometrist who graduated from an accredited school of optometry before May 1, 2000, to perform this procedure after submitting proof of satisfactory completion and confirmation of 10 procedures under the supervision of an ophthalmologist or optometrist who is certified in lacrimal irrigation and dilation. Any optometrist who graduated from an accredited school of optometry on or after May 1, 2000, shall be exempt from the certification requirement contained in this paragraph.
(16)Use of mechanical lipid extraction of meibomian glands and nonsurgical techniques.
(17)Notwithstanding subdivision (b), administration of injections for the diagnoses or treatment of conditions of the eye and adnexa, excluding intraorbital injections and injections administered for cosmetic effect, provided that the optometrist has satisfactorily received four hours of continuing education on performing all injections authorized by this paragraph.
(d)In order to be certified to use therapeutic pharmaceutical agents and authorized to diagnose and treat the conditions listed in this section, an optometrist shall apply for a certificate from the board and meet all requirements imposed by the board.
(e)The board shall grant a certificate to use therapeutic pharmaceutical agents to any applicant who graduated from a California accredited school of optometry prior to January 1, 1996, is licensed as an optometrist in California, and meets all of the following requirements:
(1)Satisfactorily completes a didactic course of no less than 80 classroom hours in the diagnosis, pharmacological, and other treatment and management of ocular disease provided by either an accredited school of optometry in California or a recognized residency review committee in ophthalmology in California.
(2)Completes a preceptorship of no less than 65 hours, during a period of not less than two months nor more than one year, in either an ophthalmologists office or an optometric clinic. The training received during the preceptorship shall be on the diagnosis, treatment, and management of ocular, systemic disease. The preceptor shall certify completion of the preceptorship. Authorization for the ophthalmologist to serve as a preceptor shall be provided by an accredited school of optometry in California, or by a recognized residency review committee in ophthalmology, and the preceptor shall be licensed as an ophthalmologist in California, board-certified in ophthalmology, and in good standing with the Medical Board of California. The individual serving as the preceptor shall schedule no more than three optometrist applicants for each of the required 65 hours of the preceptorship program. This paragraph shall not be construed to limit the total number of optometrist applicants for whom an individual may serve as a preceptor, and is intended only to ensure the quality of the preceptorship by requiring that the ophthalmologist preceptor schedule the training so that each applicant optometrist completes each of the 65 hours of the preceptorship while scheduled with no more than two other optometrist applicants.
(3)Successfully completes a minimum of 20 hours of self-directed education.
(4)Passes the National Board of Examiners in Optometrys Treatment and Management of Ocular Disease examination or, in the event this examination is no longer offered, its equivalent, as determined by the State Board of Optometry.
(5)Passes the examination issued upon completion of the 80-hour didactic course required under paragraph (1) and provided by the accredited school of optometry or residency program in ophthalmology.
(6)When any or all of the requirements contained in paragraph (1), (4), or (5) have been satisfied on or after July 1, 1992, and before January 1, 1996, an optometrist shall not be required to fulfill the satisfied requirements in order to obtain certification to use therapeutic pharmaceutical agents. In order for this paragraph to apply to the requirement contained in paragraph (5), the didactic examination that the applicant successfully completed shall meet equivalency standards, as determined by the board.
(7)Any optometrist who graduated from an accredited school of optometry on or after January 1, 1992, and before January 1, 1996, shall not be required to fulfill the requirements contained in paragraphs (1), (4), and (5).
(f)The board shall grant a certificate to use therapeutic pharmaceutical agents to any applicant who graduated from a California accredited school of optometry on or after January 1, 1996, who is licensed as an optometrist in California, and who meets all of the following requirements:
(1)Passes the National Board of Examiners in Optometrys national board examination, or its equivalent, as determined by the State Board of Optometry.
(2)Of the total clinical training required by a school of optometrys curriculum, successfully completed at least 65 of those hours on the diagnosis, treatment, and management of ocular, systemic disease.
(3)Is certified by an accredited school of optometry as competent in the diagnosis, treatment, and management of ocular, systemic disease to the extent authorized by this section.
(4)Is certified by an accredited school of optometry as having completed at least 10 hours of experience with a board-certified ophthalmologist.
(g)The board shall grant a certificate to use therapeutic pharmaceutical agents to any applicant who is an optometrist who obtained his or her license outside of California if he or she meets all of the requirements for an optometrist licensed in California to be certified to use therapeutic pharmaceutical agents.
(1)In order to obtain a certificate to use therapeutic pharmaceutical agents, any optometrist who obtained his or her license outside of California and graduated from an accredited school of optometry prior to January 1, 1996, shall be required to fulfill the requirements set forth in subdivision (e). In order for the applicant to be eligible for the certificate to use therapeutic pharmaceutical agents, the education he or she received at the accredited out-of-state school of optometry shall be equivalent to the education provided by any accredited school of optometry in California for persons who graduated before January 1, 1996. For those out-of-state applicants who request that any of the requirements contained in subdivision (e) be waived based on fulfillment of the requirement in another state, if the board determines that the completed requirement was equivalent to that required in California, the requirement shall be waived.
(2)In order to obtain a certificate to use therapeutic pharmaceutical agents, any optometrist who obtained his or her license outside of California and who graduated from an accredited school of optometry on or after January 1, 1996, shall be required to fulfill the requirements set forth in subdivision (f). In order for the applicant to be eligible for the certificate to use therapeutic pharmaceutical agents, the education he or she received by the accredited out-of-state school of optometry shall be equivalent to the education provided by any accredited school of optometry for persons who graduated on or after January 1, 1996. For those out-of-state applicants who request that any of the requirements contained in subdivision (f) be waived based on fulfillment of the requirement in another state, if the board determines that the completed requirement was equivalent to that required in California, the requirement shall be waived.
(3)The State Board of Optometry shall decide all issues relating to the equivalency of an optometrists education or training under this subdivision.
(h)Other than for prescription ophthalmic devices described in subdivision (b) of Section 2541, any dispensing of a therapeutic pharmaceutical agent by an optometrist shall be without charge.
(i)Except as authorized by this chapter, the practice of optometry does not include performing surgery. Surgery means any procedure in which human tissue is cut, altered, or otherwise infiltrated by mechanical or laser means. Surgery does not include those procedures specified in subdivision (c). This section does not limit an optometrists authority to utilize diagnostic laser and ultrasound technology within his or her scope of practice.
(j)In an emergency, an optometrist shall stabilize, if possible, and immediately refer any patient who has an acute attack of angle closure to an ophthalmologist.
SEC. 4.Section 3041.2 of the Business and Professions Code is repealed.3041.2.(a)The State Board of Optometry shall, by regulation, establish educational and examination requirements for licensure to ensure the competence of optometrists to practice pursuant to subdivision (a) of Section 3041. Satisfactory completion of the educational and examination requirements shall be a condition for the issuance of an original optometrist license under this chapter, on and after January 1, 1980. Only those optometrists who have successfully completed educational and examination requirements as determined by the State Board of Optometry shall be permitted the use of pharmaceutical agents specified by subdivision (a) of Section 3041.
(b)Nothing in this section shall authorize an optometrist issued an original optometrist license under this chapter before January 1, 1996, to use or prescribe therapeutic pharmaceutical agents specified in subdivision (d) of Section 3041 without otherwise meeting the requirements of Section 3041.3.
SEC. 5.Section 3041.2 is added to the Business and Professions Code, to read:3041.2.(a)For purposes of this chapter, glaucoma means any of the following:
(1)All primary open-angle glaucoma.
(2)Exfoliation and pigmentary glaucoma.
(3)Increase in intraocular pressure caused by steroid medication.
(b)An optometrist certified pursuant to Section 3041.1 shall be certified for the treatment of glaucoma, as described in subdivision (a), in patients over 18 years of age after the optometrist meets the following applicable requirements:
(1)For licensees who graduated from an accredited school of optometry on or after May 1, 2008, submission of proof of graduation from that institution.
(2)For licensees who were certified to treat glaucoma under this section prior to January 1, 2009, submission of proof of completion of that certification program.
(3)For licensees who completed a didactic course of not less than 24 hours in the diagnosis, pharmacological, and other treatment and management of glaucoma, submission of proof of satisfactory completion of the case management requirements for certification established by the board.
(4)For licensees who graduated from an accredited school of optometry on or before May 1, 2008, and are not described in paragraph (2) or (3), submission of proof of satisfactory completion of the requirements for certification established by the board.
SEC. 6.Section 3041.3 of the Business and Professions Code is repealed.3041.3.(a)In order to be certified to use therapeutic pharmaceutical agents and authorized to diagnose and treat the conditions listed in subdivisions (b), (d), and (e) of Section 3041, an optometrist shall apply for a certificate from the board and meet all requirements imposed by the board.
(b)The board shall grant a certificate to use therapeutic pharmaceutical agents to any applicant who graduated from a California accredited school of optometry prior to January 1, 1996, is licensed as an optometrist in California, and meets all of the following requirements:
(1)Satisfactorily completes a didactic course of no less than 80 classroom hours in the diagnosis, pharmacological, and other treatment and management of ocular disease provided by either an accredited school of optometry in California or a recognized residency review committee in ophthalmology in California.
(2)Completes a preceptorship of no less than 65 hours, during a period of not less than two months nor more than one year, in either an ophthalmologists office or an optometric clinic. The training received during the preceptorship shall be on the diagnosis, treatment, and management of ocular, systemic disease. The preceptor shall certify completion of the preceptorship. Authorization for the ophthalmologist to serve as a preceptor shall be provided by an accredited school of optometry in California, or by a recognized residency review committee in ophthalmology, and the preceptor shall be licensed as an ophthalmologist in California, board-certified in ophthalmology, and in good standing with the Medical Board of California. The individual serving as the preceptor shall schedule no more than three optometrist applicants for each of the required 65 hours of the preceptorship program. This paragraph shall not be construed to limit the total number of optometrist applicants for whom an individual may serve as a preceptor, and is intended only to ensure the quality of the preceptorship by requiring that the ophthalmologist preceptor schedule the training so that each applicant optometrist completes each of the 65 hours of the preceptorship while scheduled with no more than two other optometrist applicants.
(3)Successfully completes a minimum of 20 hours of self-directed education.
(4)Passes the National Board of Examiners in Optometrys Treatment and Management of Ocular Disease examination or, in the event this examination is no longer offered, its equivalent, as determined by the State Board of Optometry.
(5)Passes the examination issued upon completion of the 80-hour didactic course required under paragraph (1) and provided by the accredited school of optometry or residency program in ophthalmology.
(6)When any or all of the requirements contained in paragraph (1), (4), or (5) have been satisfied on or after July 1, 1992, and before January 1, 1996, an optometrist shall not be required to fulfill the satisfied requirements in order to obtain certification to use therapeutic pharmaceutical agents. In order for this paragraph to apply to the requirement contained in paragraph (5), the didactic examination that the applicant successfully completed shall meet equivalency standards, as determined by the board.
(7)Any optometrist who graduated from an accredited school of optometry on or after January 1, 1992, and before January 1, 1996, shall not be required to fulfill the requirements contained in paragraphs (1), (4), and (5).
(c)The board shall grant a certificate to use therapeutic pharmaceutical agents to any applicant who graduated from a California accredited school of optometry on or after January 1, 1996, who is licensed as an optometrist in California, and who meets all of the following requirements:
(1)Passes the National Board of Examiners in Optometrys national board examination, or its equivalent, as determined by the State Board of Optometry.
(2)Of the total clinical training required by a school of optometrys curriculum, successfully completed at least 65 of those hours on the diagnosis, treatment, and management of ocular, systemic disease.
(3)Is certified by an accredited school of optometry as competent in the diagnosis, treatment, and management of ocular, systemic disease to the extent authorized by this section.
(4)Is certified by an accredited school of optometry as having completed at least 10 hours of experience with a board-certified ophthalmologist.
(d)The board shall grant a certificate to use therapeutic pharmaceutical agents to any applicant who is an optometrist who obtained his or her license outside of California if he or she meets all of the requirements for an optometrist licensed in California to be certified to use therapeutic pharmaceutical agents.
(1)In order to obtain a certificate to use therapeutic pharmaceutical agents, any optometrist who obtained his or her license outside of California and graduated from an accredited school of optometry prior to January 1, 1996, shall be required to fulfill the requirements set forth in subdivision (b). In order for the applicant to be eligible for the certificate to use therapeutic pharmaceutical agents, the education he or she received at the accredited out-of-state school of optometry shall be equivalent to the education provided by any accredited school of optometry in California for persons who graduate before January 1, 1996. For those out-of-state applicants who request that any of the requirements contained in subdivision (b) be waived based on fulfillment of the requirement in another state, if the board determines that the completed requirement was equivalent to that required in California, the requirement shall be waived.
(2)In order to obtain a certificate to use therapeutic pharmaceutical agents, any optometrist who obtained his or her license outside of California and who graduated from an accredited school of optometry on or after January 1, 1996, shall be required to fulfill the requirements set forth in subdivision (c). In order for the applicant to be eligible for the certificate to use therapeutic pharmaceutical agents, the education he or she received by the accredited out-of-state school of optometry shall be equivalent to the education provided by any accredited school of optometry for persons who graduate on or after January 1, 1996. For those out-of-state applicants who request that any of the requirements contained in subdivision (c) be waived based on fulfillment of the requirement in another state, if the board determines that the completed requirement was equivalent to that required in California, the requirement shall be waived.
(3)The State Board of Optometry shall decide all issues relating to the equivalency of an optometrists education or training under this subdivision.
SEC. 7.Section 3041.3 is added to the Business and Professions Code, to read:3041.3.(a)For the purposes of this chapter, anterior segment laser means any of the following:
(1)Therapeutic lasers appropriate for treatment of glaucoma.
(2)Notwithstanding subdivision (a) of Section 3041.2, peripheral iridotomy for the prophylactic treatment of angle closure glaucoma.
(3)Therapeutic lasers used for posterior capsulotomy secondary to cataract surgery.
(b)An optometrist certified to treat glaucoma pursuant to Section 3041.2 shall be additionally certified for the use of anterior segment lasers after submitting proof of satisfactory completion of a course that is approved by the board, provided by an accredited school of optometry, and developed in consultation with an ophthalmologist who has experience educating optometric students.
(1)The board-approved course shall be a minimum of 16 hours in length, and include a test for competency of the following:
(A)Laser physics, hazards, and safety.
(B)Biophysics of laser.
(C)Laser application in clinical optometry.
(D)Laser tissue interactions.
(E)Laser indications, contraindications, and potential complications.
(F)Gonioscopy.
(G)Laser therapy for open-angle glaucoma.
(H)Laser therapy for angle closure glaucoma.
(I)Posterior capsulotomy.
(J)Common complications of the lids, lashes, and lacrimal system.
(K)Medicolegal aspects of anterior segment procedures.
(L)Peripheral iridotomy.
(M)Laser trabeculoplasty.
(2)The school of optometry shall require each applicant for certification to perform a sufficient number of anterior segment laser procedures to verify that the applicant has demonstrated competency to practice independently. At a minimum, each applicant shall complete 14 anterior segment laser procedures on live humans.
(c)The board, by regulation, shall set the fee for issuance and renewal of a certificate authorizing the use of anterior segment lasers at an amount no higher than the reasonable cost of regulating anterior segment laser certified optometrists pursuant to this section. The fee shall not exceed one hundred fifty dollars ($150).
SEC. 8.Section 3041.4 is added to the Business and Professions Code, to read:3041.4.(a)For the purposes of this chapter, minor procedure means either of the following:
(1)Removal, destruction, or drainage of lesions of the eyelid and adnexa clinically evaluated by the optometrist to be noncancerous, not involving the eyelid margin, lacrimal supply or drainage systems, no deeper than the orbicularis muscle, and smaller than five millimeters in diameter.
(2)Closure of a wound resulting from a procedure described in paragraph (1).
(b)An optometrist certified to treat glaucoma pursuant to Section 3041.2 shall be additionally certified to perform minor procedures after submitting proof of satisfactory completion of a course that is approved by the board, provided by an accredited school of optometry, and developed in consultation with an ophthalmologist who has experience teaching optometric students.
(1)The board-approved course shall be a minimum of 32 hours in length and include a test for competency of the following:
(A)Minor surgical procedures.
(B)Overview of surgical instruments, asepsis, and the state and federal Occupational Safety and Health Administrations.
(C)Surgical anatomy of the eyelids.
(D)Emergency surgical procedures.
(E)Chalazion management.
(F)Epilumeninesence microscopy.
(G)Suture techniques.
(H)Local anesthesia techniques and complications.
(I)Anaphylaxsis and other office emergencies.
(J)Radiofrequency surgery.
(K)Postoperative wound care.
(2)The school of optometry shall require each applicant for certification to perform a sufficient number of minor procedures to verify that the applicant has demonstrated competency to practice independently. At a minimum, each applicant shall complete five minor procedures on live humans.
SEC. 9.Section 3041.5 is added to the Business and Professions Code, to read:3041.5.(a)An optometrist may independently initiate and administer vaccines listed on the routine immunization schedules recommended by the federal Advisory Committee on Immunization Practices (ACIP), in compliance with individual ACIP vaccine recommendations, and published by the federal Centers for Disease Control and Prevention (CDC) for persons three years of age and older.
(b)In order to initiate and administer an immunization described in subdivision (a), an optometrist shall do all of the following:
(1)Complete an immunization training program endorsed by the CDC or the Accreditation Council for Pharmacy Education that, at a minimum, includes hands-on injection technique, clinical evaluation of indications and contraindications of vaccines, and the recognition and treatment of emergency reactions to vaccines, and shall maintain that training.
(2)Be certified in basic life support for health care professionals.
(3)Comply with all state and federal recordkeeping and reporting requirements, including providing documentation to the patients primary care provider and entering information in the appropriate immunization registry designated by the immunization branch of the State Department of Public Health.
SEC. 10.Section 3041.6 is added to the Business and Professions Code, to read:3041.6.An optometrist licensed under this chapter is subject to the provisions of Section 2290.5 for purposes of practicing telehealth.
SEC. 11.Section 3041.7 is added to the Business and Professions Code, to read:3041.7.Optometrists diagnosing or treating eye disease shall be held to the same standard of care to which physicians and surgeons and osteopathic physicians and surgeons are held. An optometrist shall consult with and, if necessary, refer to a physician and surgeon or other appropriate health care provider when a situation or condition occurs that is beyond the optometrists scope of practice.
SEC. 12.Section 3041.8 is added to the Business and Professions Code, to read:3041.8.It is the intent of the Legislature that the Office of Statewide Health Planning and Development, under the Health Workforce Pilot Projects Program, designate a pilot project to test, demonstrate, and evaluate expanded roles for optometrists in the performance of management and treatment of diabetes mellitus, hypertension, and hypercholesterolemia.
SEC. 13.No reimbursement is required by this act pursuant to Section 6 of Article XIIIB of the California Constitution because the only costs that may be incurred by a local agency or school district will be incurred because this act creates a new crime or infraction, eliminates a crime or infraction, or changes the penalty for a crime or infraction, within the meaning of Section 17556 of the Government Code, or changes the definition of a crime within the meaning of Section 6 of Article XIIIB of the California Constitution.
SECTION 1.Section 2842 of the Business and Professions Code is amended to read:2842.(a)Each member of the board shall be a citizen of the United States and a resident of the State of California. The board shall have the following composition:
(1)Two members shall be duly licensed vocational nurses who have been licensed for a period of not less than three years prior to appointment.
(2)Two members shall be licensed psychiatric technicians, each of whom shall have had not less than five years experience in a psychiatric hospital, or in a psychiatric unit of a hospital licensed by the State Department of Health Services, or a private institution licensed by the State Department of Health Services.
(3)One member shall be a licensed vocational nurse or registered nurse who shall have had not less than five years experience as a teacher or administrator in an accredited school of vocational nursing approved by the board.
(4)Six members shall be public members who are not licentiates of the board or any other board under this division or of any board referred to in Sections 1000 and 3600.
(b)No person may serve as a member of the board for more than two consecutive terms.
(c)Per diem and expenses of members of the board who are licensed psychiatric technicians shall be paid solely from revenues received pursuant to Chapter 10 (commencing with Section 4500) of Division 2.
(a)Each member of the board shall be a citizen of the United States and a resident of the State of California. The board shall have the following composition:
(1)Two members shall be duly licensed vocational nurses who have been licensed for a period of not less than three years prior to appointment.
(2)Two members shall be licensed psychiatric technicians, each of whom shall have had not less than five years experience in a psychiatric hospital, or in a psychiatric unit of a hospital licensed by the State Department of Health Services, or a private institution licensed by the State Department of Health Services.
(3)One member shall be a licensed vocational nurse or registered nurse who shall have had not less than five years experience as a teacher or administrator in an accredited school of vocational nursing approved by the board.
(4)Six members shall be public members who are not licentiates of the board or any other board under this division or of any board referred to in Sections 1000 and 3600.
(b)No person may serve as a member of the board for more than two consecutive terms.
(c)Per diem and expenses of members of the board who are licensed psychiatric technicians shall be paid solely from revenues received pursuant to Chapter 10 (commencing with Section 4500) of Division 2.
|
Date
|
Status
|
|---|---|
| May 18, 2015 | From committee: Do pass. (Ayes 7. Noes 0.) (May 18). |
| Jun 28, 2016 | June 28 set for final hearing canceled at the request of author. |
| Jun 22, 2016 | From committee with author's amendments. Read second time and amended. Re-referred to Com. on B. & P. |
| Jun 21, 2016 | June 21 hearing postponed by committee. |
| Jun 16, 2016 | From committee with author's amendments. Read second time and amended. Re-referred to Com. on B. & P. |
| Jul 14, 2015 | July 14 set for second hearing canceled at the request of author. |
| Jul 7, 2015 | July 7 set for first hearing canceled at the request of author. |
| Jun 11, 2015 | Referred to Com. on B. & P. |
| May 22, 2015 | Read third time. Passed. (Ayes 33. Noes 4.) Ordered to the Assembly. |
| May 22, 2015 | Read third time. Passed. (Ayes 33. Noes 4. Page 1070.) Ordered to the Assembly. |
| May 22, 2015 | In Assembly. Read first time. Held at Desk. |
| May 19, 2015 | Read second time. Ordered to third reading. |
| Feb 27, 2015 | Introduced. To Com. on RLS. for assignment. To print. |
| May 18, 2015 | From committee: Do pass. (Ayes 7. Noes 0. Page 1034.) (May 18). |
| May 8, 2015 | Set for hearing May 18. |
| May 4, 2015 | Read second time and amended. Re-referred to Com. on APPR. |
| Apr 30, 2015 | From committee: Do pass as amended and re-refer to Com. on APPR. (Ayes 9. Noes 0. Page 794.) (April 27). |
| Apr 9, 2015 | From committee with author's amendments. Read second time and amended. Re-referred to Com. on B., P. & E.D. |
| Mar 26, 2015 | Set for hearing April 27. |
| Mar 25, 2015 | April 13 hearing postponed by committee. |
| Mar 18, 2015 | Set for hearing April 13. |
| Mar 12, 2015 | Referred to Coms. on B., P. & E.D. and APPR. |
| Mar 2, 2015 | Read first time. |
| Mar 2, 2015 | From printer. May be acted upon on or after April 1. |
|
Date
|
Description
|
Location
|
Votes
|
|
|---|---|---|---|---|
| May 22, 2015 | Senate 3rd Reading SB622 Hernandez | Senate Floor |
Passed |
|
| May 18, 2015 | Do pass | Senate Standing Committee on Appropriations |
Passed |
|
| Apr 27, 2015 | Do pass as amended, but first amend, and re-refer to the Committee on [Appropriations] | Senate Standing Committee on Business, Professions and Economic Development |
Passed |
This list shows positions taken on this bill by organizations on the date displayed, which is linked to the original source.
Positions by individuals are not included.
|
Organization
|
Position
|
Date
|
|---|---|---|
| American Federation of State, County and Municipal Employees | ** Against | May 22, 2015 |
| Blind Childrens Center | ** Against | May 22, 2015 |
| California Academy Of Eye Physicians & Surgeons | ** Against | May 22, 2015 |
| California Academy Of Family Physicians | ** Against | May 22, 2015 |
| California Association of Health System Pharmacists | ** Support | May 22, 2015 |
| California Medical Association, Inc. | ** Against | May 22, 2015 |
| California Optometric Association | ** Support | May 22, 2015 |
| California Society Of Plastic Surgeons | ** Against | May 22, 2015 |
| Latino Physicians Of California | ** Against | May 22, 2015 |
| Medical Board of California | ** Against | May 22, 2015 |
| u D) | ** Against | May 18, 2015 |
| Ventura County American Chinese Medical Dental Association | ** Against | May 22, 2015 |
| Vision Service Plan | * Indeterminate | May 18, 2015 |
| VSP Vision Care | ** Support | May 22, 2015 |
| Western University Of Health Sciences | ** Support | May 22, 2015 |
Date of Hearing:
ASSEMBLY COMMITTEE ON BUSINESS AND PROFESSIONS
Rudy Salas, Chair
SBPCA Bill Id:
Author:() – As Ver:
SENATE VOTE:
SUBJECT:
SUMMARY: This bill expands the scope of practice for optometrists to include the use noninvasive, nonsurgical technology to treat a condition authorized by the Optometric Act (Act), perform laser and minor procedures, and administer certain vaccines.
EXISTING LAW:
- Establishes the California Board of Optometry (Board), within the Department of Consumer Affairs (DCA), which licenses optometrists and regulates the practice of optometry. (BPC § 3010.5)
- Authorizes the Board to establish educational and examination requirements for licensure. (BPC § 3041.2)
- Defines the practice of optometry as follows:
- Prevention and diagnosis of disorders and dysfunctions of the visual system;
- Treatment and management of certain disorders and dysfunctions of the visual systems;
- Provision of rehabilitative optometric services;
- Examination of the human eyes;
- Determination of the powers or range of human vision;
- Prescribing or directing the use of any optical device in connection with ocular exercises, visual training, vision training or orthoptics;
- Prescribing of contact lenses and glasses; and,
- Use of topical pharmaceutical agents for the purpose of the examination of the human eye or eyes for any disease or pathological condition. (BPC § 3041)
- Specifies that an optometrist who is certified to use therapeutic pharmaceutical agents may also diagnose and treat the human eye or eyes or any of its appendages for the following conditions:
- Infections;
- Ocular allergies;
- Ocular inflammation, non-surgical in cause except when co-managed with the treating physician and surgeon;
- Traumatic or recurrent conjunctival or corneal abrasions and erosions;
- Corneal surface disease and dry eyes;
- Ocular pain, non-surgical in cause except when co-managed with the treating physician and surgeon; and,
- Glaucoma in patients over the age of 18. (BPC § 3041(b)(1))
- Permits optometrists to use the following therapeutic pharmaceutical agents:
- Topical miotics;
- Topical lubricants;
- Anti-allergy agents;
- Topical and oral anti-inflammatories;
- Topical antibiotic agents;
- Topical hyperosmotics;
- Topical and oral anti-glaucoma agents;
- Non-prescription medications;
- Oral antihistamines;
- Prescription oral non-steroidal anti-inflammatory agents;
- Oral antibiotics for treatment of ocular disease;
- Topical and oral antiviral medication for treatment of:
- Herpes;
- Viral Keratitis;
- Herpes Simplex Viral conjunctivitis;
- Periocular herpes simplex viral dermatitis;
- Varicella zoster viral keratitis;
- Varicella zoster viral conjunctivitis; and,
- Periocular varicella zoster viral dermatitis;
- Oral analgesics that are not controlled substances; and,
- Codeine with compounds and hydrocodone with compounds with specific restrictions regarding usage timeframe. (BPC § 3041(c))
- Specifies that an optometrist who is certified to use therapeutic pharmaceutical agents may also perform the following:
- Corneal scraping with cultures;
- Debridement of corneal epithelia;
- Mechanical epilation;
- Venipuncture for testing patients suspected of having diabetes;
- Suture removal, with prior consultation with the treating physician and surgeon;
- Treatment or removal of sebaceous cysts by expression;
- Administration of oral fluorescein to patients suspected as having diabetic retinopathy;
- Use of an auto-injector to counter anaphylaxis;
- Ordering of smears, cultures, sensitivities, complete blood count, mycobacterial culture, acid fast stain, urinalysis, tear fluid analysis and X-rays necessary for the diagnosis of conditions or diseases of the eye or adnexa;
- A clinical laboratory test or examination classified as waived under CLIA
necessary for the diagnosis of conditions and diseases of the eye or adnexa;
- Punctal occlusion by plugs, excluding laser, diathermy, cryotherapy or other means constituting surgery;
- The prescription of therapeutic contact lenses, including lenses or devices that incorporate a medication or therapy the optometrist is certified to prescribe or provide;
- Removal of foreign bodies from the cornea, eyelid and conjunctiva with any appropriate instrument other than a scalpel or needle; and,
- Lacrimal irrigation and dilation, excluding probing of the nasal lacrimal tract for patients over 12 years of age. (BPC § 3401(e))
THIS BILL:
- Requires the Board to establish educational and examination requirements for licensure to ensure the competence of optometrists to use anterior segment lasers and perform minor procedures. Specifies that satisfactory completion of the required educational and examination requirements shall be a condition for the issuance of an original optometrist license or required certifications.
- Specifies that the Board may promulgate regulations authorizing optometrists to use noninvasive, nonsurgical technology to treat conditions, as specified. Further states that the Board shall require a licensee to take a minimum of four hours of education courses on the new technology and perform an appropriate number of complete clinical procedures on live human patients to qualify to use each new technology authorized by the Board.
- Indicates that an optometrist who is certified to use therapeutic pharmaceutical agents may also diagnose and treat the human eye or eyes, or any of its or their appendages, for all of the following conditions:
- Through medical treatment, infections of the anterior segment and adnexa;
- Ocular allergies of the anterior segment and adnexa;
- Ocular inflammation, nonsurgical in cause except when comanaged with the treating physician and surgeon, limited to inflammation resulting from traumatic iritis, peripheral corneal inflammatory keratitis, episcleritis, and unilateral nonrecurrent nongranulomatous idiopathic iritis in patients over 18 years of age;
- Traumatic or recurrent conjunctival or corneal abrasions and erosions;
- Corneal and conjunctival surface disease and dry eyes disease;
- Ocular pain that is nonsurgical in cause, except when comanaged with the treating physician and surgeon; and,
- Hypotrichosis and blepharitis;
- Defines “adnexa” to mean ocular adnexa.
- Specifies that in diagnosing and treating the conditions listed above, an optometrist certified to use therapeutic pharmaceutical agents may use all of the following therapeutic pharmaceutical agents:
- Topical pharmaceutical agents for the purpose of the examination of the human eye or eyes for any disease or pathological condition, including, but not limited to, topical miotics;
- Topical lubricants;
- Antiallergy agents. In using topical steroid medication for the treatment of ocular allergies, an optometrist shall consult with an ophthalmologist if the patient’s condition worsens 21 days after diagnosis;
- Topical and oral anti-inflammatories;
- Topical antibiotic agents;
- Topical hyperosmotics;
- Topical and oral antiglaucoma agents pursuant to the certification process, as specified;
- Nonprescription medications used for the rational treatment of an ocular disorder;
- Oral antihistamines;
- Prescription oral nonsteroidal anti-inflammatory agents;
- Oral antibiotics for medical treatment of ocular disease;
- Topical and oral antiviral medication for the medical treatment of herpes simplex viral keratitis, herpes simplex viral conjunctivitis, periocular herpes simplex viral dermatitis, varicella zoster viral keratitis, varicella zoster viral conjunctivitis, and periocular varicella zoster viral dermatitis;
- Oral analgesics that are not controlled substances; and,
- Codeine with compounds and hydrocodone with compounds—the use of these agents shall be limited to five days, with a referral to an ophthalmologist if the pain persists.
- Authorizes an optometrist who is certified to use therapeutic pharmaceutical agents to perform all of the following:
- Corneal scraping with cultures;
- Debridement of corneal epithelia;
- Mechanical epilation;
- Collection of blood by skin puncture or venipuncture for testing patients suspected of having diabetes;
- Suture removal, with prior consultation with the treating health care provider;
- Treatment or removal of sebaceous cysts by expression;
- Administration of oral fluorescein to patients suspected as having diabetic retinopathy;
- Use of an auto-injector to counter anaphylaxis;
- Ordering of smears, cultures, sensitivities, complete blood count, mycobacterial culture, acid fast stain, urinalysis, tear fluid analysis, and X-rays necessary for the diagnosis of conditions or diseases of the eye or adnexa. An optometrist may order other types of images subject to prior consultation with an ophthalmologist or appropriate physician and surgeon;
- A clinical laboratory test or examination classified as waived under the Clinical Laboratory Improvement Amendments of 1988 (CLIA) (42 U.S.C. Sec. 263a; Public Law 100-578) necessary for the diagnosis of conditions and diseases of the eye or adnexa, to detect systemic disease with ocular effects;
- Skin test to diagnose ocular allergies. Skin tests shall be limited to the superficial layer of the skin;
- Punctal occlusion by plugs, excluding laser, diathermy, cryotherapy, or other means constituting surgery as specified;
- The prescription of therapeutic contact lenses, diagnostic contact lenses, or biological or technological corneal devices that diagnose or treat a condition, as specified;
- Removal of foreign bodies from the cornea, eyelid, and conjunctiva with any appropriate instrument other than a scalpel. Corneal foreign bodies shall be nonperforating, be no deeper than the midstroma, and require no surgical repair upon removal;
- For patients over 12 years of age, lacrimal irrigation and dilation, excluding probing of the nasal lacrimal tract;
- The Board shall certify any optometrist who graduated from an accredited school of optometry before May 1, 2000, to perform this procedure after submitting proof of satisfactory completion and confirmation of 10 procedures under the supervision of an ophthalmologist or optometrist who is certified in lacrimal irrigation and dilation. Any optometrist who graduated from an accredited school of optometry on or after May 1, 2000, shall be exempt from the certification requirement.
- Use of mechanical lipid extraction of meibomian glands and nonsurgical techniques.
- Specifies that In order to be certified to use therapeutic pharmaceutical agents and authorized to diagnose and treat the conditions listed above, an optometrist shall apply for a certificate from the Board and meet all requirements imposed by the Board.
- Authorizes the Board to grant a certificate to use therapeutic pharmaceutical agents to any applicant who graduated from a California accredited school of optometry prior to January 1, 1996, is licensed as an optometrist in California, and meets specified education and training requirements
- Authorizes the Board to grant a certificate to use therapeutic pharmaceutical agents to any applicant who graduated from a California accredited school of optometry on or after January 1, 1996, who is licensed as an optometrist in California, and who meets specified training and education requirements:
- Indicates that other than for prescription ophthalmic devices as specified, any dispensing of a therapeutic pharmaceutical agent by an optometrist shall be without charge.
- Specifies that the practice of optometry does not include performing surgery. “Surgery” means any procedure in which human tissue is cut, altered, or otherwise infiltrated by mechanical or laser means, as specified.
- Specifies an optometrist’s authority to utilize diagnostic laser and ultrasound technology within his or her scope of practice.
- States that in an emergency, an optometrist shall stabilize, if possible, and immediately refer any patient who has an acute attack of angle closure to an ophthalmologist.
- Defines “glaucoma” as:
- All primary open-angle glaucoma;
- Exfoliation and pigmentary glaucoma;
- Increase in intraocular pressure caused by steroid medication prescribed by the optometrist; and,
- Increase in intraocular pressure caused by steroid medication not prescribed by the optometrist, after consultation and treatment approval by the prescribing physician.
- Specifies requirements for optometrists certified for the treatment of glaucoma, in patients over 18 years of age.
- Defines “anterior segment laser” as any of the following:
- Therapeutic lasers appropriate for treatment of glaucoma;
- Peripheral iridotomy for the prophylactic treatment of angle closure glaucoma; and,
- Therapeutic lasers used for posterior capsulotomy secondary to cataract surgery.
- States that an optometrist certified to treat glaucoma shall be additionally certified for the use of anterior segment lasers after submitting proof of satisfactory completion of a course that is approved by the Board, provided by an accredited school of optometry, and developed in consultation with an ophthalmologist who has experience educating optometric students. The Board shall issue a certificate only to an optometrist that has graduated from an approved school of optometry.
- Indicates that the Board-approved course shall be at least 25 hours in length, and include a test for competency of the following:
- Laser physics, hazards, and safety;
- Biophysics of laser;
- Laser application in clinical optometry;
- Laser tissue interactions;
- Laser indications, contraindications, and potential complications;
- Gonioscopy;
- Laser therapy for open-angle glaucoma;
- Laser therapy for angle closure glaucoma;
- Posterior capsulotomy;
- Common complications of the lids, lashes, and lacrimal system;
- Medicolegal aspects of anterior segment procedures;
- Peripheral iridotomy; and,
- Laser trabeculoplasty.
- States that the school of optometry shall require each applicant for certification to perform a sufficient number of complete anterior segment laser procedures to verify that the applicant has demonstrated competency to practice independently. At a minimum, each applicant shall complete 24 anterior segment laser procedures on live humans as follows:
- Eight YAG capsulotomy procedures;
- Eight laser trabeculoplasty procedures; and,
- Eight peripheral iridotomy procedures.
- Requires the Board, by regulation, to set the fee for issuance and renewal of a certificate authorizing the use of anterior segment lasers at an amount no higher than the reasonable cost of regulating anterior segment laser certified optometrists, as specified. The fee shall not exceed one hundred fifty dollars ($150).
- Requires an optometrist certified to use anterior segment lasers to complete four hours of continuing education on anterior segment lasers as part of the required 50 hours of continuing education required to be completed every two years on the diagnosis, treatment, and management of glaucoma.
- Defines “minor procedure” as any of the following:
- Removal, destruction, or drainage of lesions of the eyelid and adnexa clinically evaluated by the optometrist to be noncancerous, not involving the eyelid margin, lacrimal supply or drainage systems, no deeper than the orbicularis muscle, and smaller than five millimeters in diameter;
- Closure of a wound resulting from a procedure, as specified; or,
- Administration of injections for the diagnoses or treatment of conditions of the eye and adnexa authorized by this chapter, excluding intraorbital injections and injections administered for cosmetic effect.
- Specifies that “minor procedures” do not include blepharoplasty or other cosmetic surgery procedures that reshape normal structures of the body in order to improve appearance and self-esteem.
- Indicates that an optometrist certified to treat glaucoma shall be additionally certified to perform minor procedures after submitting proof of satisfactory completion of a course that is approved by the Board, provided by an accredited school of optometry, and developed in consultation with an ophthalmologist who has experience teaching optometric students. The Board shall issue a certificate pursuant to this section only to an optometrist that has graduated from an approved school of optometry.
- Requires that the Board-approved course be at least 25 hours in length and include a test for competency of the following:
- Minor surgical procedures;
- Overview of surgical instruments, asepsis, and the state and federal Occupational Safety and Health Administrations;
- Surgical anatomy of the eyelids;
- Emergency surgical procedures;
- Chalazion management;
- Epiluminescence microscopy;
- Suture techniques;
- Local anesthesia techniques and complications;
- Anaphylaxsis and other office emergencies;
- Radiofrequency surgery;
- Postoperative wound care; and,
- Injection techniques.
- Requires the school of optometry to require each applicant for certification to perform a sufficient number of minor procedures to verify that the applicant has demonstrated competency to practice independently. At a minimum, each applicant shall perform 32 complete minor procedures on live humans.
- Authorizes the Board, by regulation, to set the fee for issuance and renewal of a certificate authorizing the use of minor procedures at an amount no greater than the reasonable cost of regulating minor procedure certified optometrists pursuant to this section. The fee shall not exceed one hundred fifty dollars ($150).
- Requires an optometrist certified to perform minor procedures to complete five hours of continuing education on the diagnosis, treatment, and management of lesions of the eyelid and adnexa as part of the 50 hours of continuing education required every two years.
- Authorizes the Board to grant to an optometrist a certificate for the use of immunizations, if the optometrist is certified and has met all of the following requirements:
- Completes an immunization training program endorsed by the federal Centers for Disease Control and Prevention (CDC) that, at a minimum, includes hands-on injection technique, clinical evaluation of indications and contraindications of vaccines, and the recognition and treatment of emergency reactions to vaccines, and maintains that training;
- Is certified in basic life support; and,
- Complies with all state and federal recordkeeping and reporting requirements, including providing documentation to the patient’s primary care provider and entering information in the appropriate immunization registry designated by the immunization branch of the State Department of Public Health.
- Defines “immunization” as the administration of immunizations for influenza, herpes zoster virus, and pneumococcus in compliance with individual Advisory Committee on Immunization Practices (ACIP) vaccine recommendations published by the CDC for persons 18 years of age or older.
- Authorizes the Board, by regulation, to set the fee for issuance and renewal of a certificate for the use of immunizations at the reasonable cost of regulating immunization certified optometrists. The fee shall not exceed one hundred dollars ($100).
- Subjects optometrists to laws regarding the purposes of practicing telehealth.
- Indicates that optometrists diagnosing or treating eye disease shall be held to the same standard of care to which physicians and surgeons and osteopathic physicians and surgeons are held. An optometrist shall consult with and, if necessary, refer to a physician and surgeon or other appropriate health care provider when a situation or condition occurs that is beyond the optometrist’s scope of practice.
- Declares that it is the intent of the Legislature that the Office of Statewide Health Planning and Development, under the Health Workforce Pilot Projects Program, designate a pilot project to test, demonstrate, and evaluate expanded roles for optometrists in the performance of management and treatment of diabetes mellitus, hypertension, and hypercholesterolemia.
FISCAL EFFECT: Unknown. This bill has been keyed fiscal by the Legislative Counsel.
COMMENTS:
Purpose. This bill is sponsored by the author. According to the author, “While merely 16 of California’s 58 counties meet the needed supply range for primary care physicians, we do have a robust network of providers that are well-trained, evenly distributed throughout the state, regulated by the [DCA] and well positioned to pay particular attention to currently underserved areas. Optometrists are one such provider group who receive a doctorate level training preparing them to be primary eye care providers, and independently diagnose and treat conditions of the eye. [This bill] will remove restrictions in current law to permit optometrists to examine, prevent, diagnose, and treat conditions and disorders of the visual system and the human eye to the full extent of their training. This includes the use of two types of therapeutic lasers by optometrists with postdoctoral advanced certification that have been developed for treatment of glaucoma and post-surgical cataract care, conditions that disproportionately affect patient groups that generally lack sufficient access to physicians. [This bill] is a limited expansion of scope for optometrists that is consistent with their education and training, and is a logical advancement of the profession that has been proven safe in other states. Moreover, the educational requirements contained in this bill are substantially greater than those required of optometrists in other states and exceed the minimum number of these procedures required for ophthalmologists by the Accreditation Council for Graduate Medical Education.”
Background. According to a report prepared by the Center for the Health Professions at the University of California San Francisco, the number of optometrist licenses in California has declined, but the number of licensees with a secondary practice location has increased. According to the Board, there are over 7,000 licensed optometrists in California, the largest population of optometrists in the United States. The majority of the licensed optometrists are generally concentrated in coastal counties, the Bay Area and counties in the Sacramento region. Several counties have no licensed optometrists with an address of record in those counties, and a number of other counties have ratios that indicate there is approximately one optometrist for every 10,000 people.
Optometrists’ and Ophthalmologists’ Education, Training, and Scope. This bill would expand the types of procedures an optometrist is authorized to perform. This would include some tasks that have been traditionally performed by ophthalmologists. As such, the current education, training and scope of each profession is outlined below.
- Optometrists. Optometrists are trained to diagnose mild to severe eye problems such as serious eye infections, inflammations of the eye, trauma, foreign bodies and glaucoma. They also examine the eye for vision prescription and corrective lenses.
After completion of an undergraduate degree, optometrists complete four years of and accredited optometry college after which they are awarded the Doctor of Optometry degree. Some optometrists also undertake an optional one year non-surgical residency program to enhance their experience in a particular area. Students graduate with 2500 to 3000 patient encounters; these include a mix of post-surgical, medical and routine visits.
Optometrists who graduated from an accredited school or college of optometry on or after May 1, 2008 receive certifications to use diagnostic pharmaceutical agents (DPA); to administer therapeutic pharmaceutical agents (TPA); to perform lacrimal irrigation and dilation (TPL); and to diagnose and treat primary open angle glaucoma (TLG). Optometrists who did not receive these certifications upon licensure may apply for these certifications after meeting the necessary requirements. In order to be certified, the optometrist must pass an exam, obtain a license to practice optometry, be certified by and accredited school of optometry that they are competent in the diagnosis, treatment and management of ocular systemic disease, and complete 10 hours of supervised practice with an ophthalmologist.
- Ophthalmologists. The central focus of ophthalmology is surgery and management of complex eye diseases. An ophthalmologist specializes in the refractive, medical and surgical care of the eyes and visual system and in the prevention of disease and injury.
After obtaining an undergraduate degree, ophthalmologists complete four years at an accredited medical school and earn a Medical Degree. This is followed by a one year internship and a three or four year surgical residency. Many ophthalmologists pursue additional fellowship training in specialized areas such as retina, glaucoma, or cornea. Ophthalmologists may become certified by the American Board of Ophthalmology, which requires, serving as the primary surgeon or first assistant to the primary surgeon for a minimum of 364 eye surgeries.
Other States. Since 1997, there have been over 45 attempts in over 20 states by optometry associations to expand the scope of practice for optometrists including legislating surgery privileges. However, with the exception of Oklahoma and West Virginia, most states continue to prohibit optometrists from performing surgery, and their statutes specify that the license to practice optometry does not include the right to practice medicine. States such as Colorado and North Carolina specifically exclude surgery from their definition of the practice of optometry. Other states have statutes that delineate between laser and non-laser surgery. Optometrists are authorized to prescribe oral medications in all 50 states, they may prescribe oral steroids in 34 states, injections in 15 states and use lasers in 1 state.
Prior Related Legislation. SB 492 (Hernandez) of 2013, would have permitted an optometrist to diagnose treat and manage additional conditions with ocular manifestations, directed the Board to establish educational and examination requirements and would have permitted optometrists to perform vaccinations and surgical and non-surgical primary care procedures. NOTE: This bill died on the Assembly inactive file.
SB 668 (Polanco) Chapter 13, Statutes of 1996, expanded the scope of practice of optometrists to provide for the diagnosis and treatment of specified conditions or diseases of the human eye or its appendages, and to use other therapeutic pharmaceutical agents.
SB 929 (Polanco) Chapter 676, Statutes of 2000, expanded the scope of lawful practice for optometrists by specifying additional diseases and conditions that optometrists may treat (in particular certain types of glaucoma) with specified medications, and by specifying the extent of physician involvement that is required under various circumstances.
SB 1406 (Correa) Chapter 352, Statutes of 2008, specified permissible procedures for certified optometrists, and created the Glaucoma Diagnosis and Treatment Advisory Committee to establish glaucoma certification requirements.
AMENDMENTS:
- The author outlines the need for additional health care practitioners to be permitted to administer vaccines to patients. As such, the author should strike all contents of the bill, with the exception of the provisions authorizing an optometrist to, after completing training as specified in the bill, be certified by the Board to provide the following vaccinations: 1) influenza, 2) herpes zoster virus, and 3) pneumococcus for persons 18 years of age or older.
- The current bill specifies the number of hours of training that an optometrist must complete in order to enjoy an expanded scope of practice. As there has been much debate about training, education, competence, and appropriateness of expanding the scope of practice for optometrists, the author should instead amend the bill to create a task force under the Board, including those most qualified to review the education and training of optometrists, and determine the hours of training and education needed to perform the following procedures: 1) YAG capsulotomy procedures, 2) laser trabeculoplasty procedures, and 3) peripheral iridotomy procedures.
The members of the task force should be appointed by the Director of the Department of Consumer Affairs by May 1, 2017. The task force should include: one professor of optometry, one practicing optometrist, one professor of ophthalmology, one practicing ophthalmologist, and one member of the public who has never been licensed by, or appointed to, the Board or the Medical Board of California.
The taskforce shall submit a report with recommendations on what the expanded scope for optometrists should include, as it pertains to the three specified procedures above, to the Governor, the President pro Tempore of the Senate, the Speaker of the Assembly, the Assembly Committee on Business and Professions, and the Senate Committee on Business, Professions and Economic Development, by May 1, 2018, on which date the task force shall cease to exist.
REGISTERED SUPPORT:
California Optometric Association
747 individuals
REGISTERED OPPOSITION:
American Academy of Dermatology Association
American Academy of Ophthalmology
American Association for Pediatric Ophthalmology and Strabismus
American College of Surgeons
American Glaucoma Society
American Medical Association
American Society of Cataract and Refractive Surgery
American Society of Ophthalmic Plastic and Reconstructive Surgery
American Society of Retina Specialists
Blind Children's Center
California Academy of Eye Physicians and Surgeons (unless amended)
California Academy of Family Physicians
California Black Chamber of Commerce
California Black Health Network
California Medical Association
California Society of Plastic Surgeons, Inc.
Capitol City Church
CB Communications
Faith in Action
Health & Human Resource Education Center
Inner Beauty
International Black Health Alliance
Let’s Face it Together
Lighthouse for Christ Mission
Medical Board of California (unless amended)
Sacramento Black Chamber of Commerce
Sacramento Cultural Hub
San Diego Black Health Associates
Stanford University School of Medicine
The Green Foundation
Over 400 individuals
Analysis Prepared by: Le Ondra Clark Harvey, Ph.D. / B. & P. / (916) 319-3301
SB 622
Page 12
Date of Hearing: July 14, 2015
ASSEMBLY COMMITTEE ON BUSINESS AND PROFESSIONS
Susan Bonilla, Chair
SB 622
(Hernandez) – As Amended May 4, 2015
SENATE VOTE: 33-4
SUBJECT: Optometry
SUMMARY: This bill expands the scope of practice for optometrists to include the expanded ability to order Clinical Laboratory Improvement Amendments (CLIA)-waived tests, use noninvasive, nonsurgical technology to treat a condition authorized by the Optometric Act (Act), perform laser and minor procedures, and administer certain vaccines.
EXISTING LAW:
Establishes the California Board of Optometry (Board), within the Department of Consumer Affairs (DCA), which licenses optometrists and regulates the practice of optometry. (BPC § 3010.5)
Authorizes the Board to establish educational and examination requirements for licensure. (BPC § 3041.2)
Defines the practice of optometry as follows: (BPC § 3041)
Prevention and diagnosis of disorders and dysfunctions of the visual system;
Treatment and management of certain disorders and dysfunctions of the visual systems;
Provision of rehabilitative optometric services;
Examination of the human eyes;
Determination of the powers or range of human vision;
Prescribing or directing the use of any optical device in connection with ocular exercises, visual training, vision training or orthoptics;
Prescribing of contact lenses and glasses; and,
Use of topical pharmaceutical agents for the purpose of the examination of the human eye or eyes for any disease or pathological condition.
Specifies that an optometrist who is certified to use therapeutic pharmaceutical agents may also diagnose and treat the human eye or eyes or any of its appendages for the following conditions: (BPC § 3041(b)(1))
Infections;
Ocular allergies;
Ocular inflammation, non-surgical in cause except when co-managed with the treating physician and surgeon;
Traumatic or recurrent conjunctival or corneal abrasions and erosions;
Corneal surface disease and dry eyes;
Ocular pain, non-surgical in cause except when co-managed with the treating physician and surgeon; and,
Glaucoma in patients over the age of 18.
Permits optometrists to use the following therapeutic pharmaceutical agents: (BPC § 3041(c))
Topical miotics;
Topical lubricants;
Anti-allergy agents;
Topical and oral anti-inflammatories;
Topical antibiotic agents;
Topical hyperosmotics;
Topical and oral anti-glaucoma agents;
Non-prescription medications;
Oral antihistamines;
Prescription oral non-steroidal anti-inflammatory agents;
Oral antibiotics for treatment of ocular disease;
Topical and oral antiviral medication for treatment of:
Herpes;
Viral Keratitis;
Herpes Simplex Viral conjunctivitis;
Periocular herpes simplex viral dermatitis;
Varicella zoster viral keratitis;
Varicella zoster viral conjunctivitis; and,
Periocular varicella zoster viral dermatitis;
Oral analgesics that are not controlled substances; and,
Codeine with compounds and hydrocodone with compounds with specific restrictions regarding usage timeframe.
Specifies that an optometrist who is certified to use therapeutic pharmaceutical agents may also perform the following: (BPC § 3401(e))
Corneal scraping with cultures;
Debridement of corneal epithelia;
Mechanical epilation;
Venipuncture for testing patients suspected of having diabetes;
Suture removal, with prior consultation with the treating physician and surgeon;
Treatment or removal of sebaceous cysts by expression;
Administration of oral fluorescein to patients suspected as having diabetic retinopathy;
Use of an auto-injector to counter anaphylaxis;
Ordering of smears, cultures, sensitivities, complete blood count, mycobacterial culture, acid fast stain, urinalysis, tear fluid analysis and X-rays necessary for the diagnosis of conditions or diseases of the eye or adnexa;
A clinical laboratory test or examination classified as waived under CLIA necessary for the diagnosis of conditions and diseases of the eye or adnexa;
Punctal occlusion by plugs, excluding laser, diathermy, cryotherapy or other means constituting surgery;
The prescription of therapeutic contact lenses, including lenses or devices that incorporate a medication or therapy the optometrist is certified to prescribe or provide;
Removal of foreign bodies from the cornea, eyelid and conjunctiva with any appropriate instrument other than a scalpel or needle; and,
Lacrimal irrigation and dilation, excluding probing of the nasal lacrimal tract for patients over 12 years of age.
THIS BILL:
Requires the Board to establish educational and examination requirements by regulation for licensure to ensure the competence of optometrists to practice pursuant to the Act, except as specified in the sections related to certification for minor procedures and lasers.
Adds “habilitative services” to the definition of the practice of optometry.
Authorizes the Board to promulgate regulations authorizing optometrists to use noninvasive, nonsurgical technology to treat a condition authorized by the Act. To qualify to use each new technology authorized, the Board shall require a licensee to take a minimum of four hours of education and perform an appropriate number of complete clinical procedures on live human patients.
Removes referral requirements related to the treatment of ocular inflammation, as specified.
Allows an optometrist to treat hypotrichosis and blepharitis.
Adds “conjunctival” to the types of surface diseases that an optometrist who is certified to use therapeutic pharmaceutical agents may diagnose and treat.
Removes exceptions to the types of infections of the anterior segment and adnexa that an optometrist may treat.
Removes referral protocols for the use of certain drugs.
Expands ability to order CLIA waived tests.
Extends from three to five days the time that codeine with compounds and hydrocodone with specified compounds may be used.
Allows an optometrist to collect a blood specimen by finger prick method.
Permits an optometrist to perform a skin test on the superficial layer of the skin to diagnose ocular allergies.
Allows an optometrist to prescribe biological or technological corneal devices.
Allows an optometrist to use a needle to remove objects from the cornea, eyelid, and conjunctiva.
Authorizes an optometrist to use mechanical lipid extraction on meibomian glands and nonsurgical techniques.
Authorizes an optometrist, as part of additional “minor procedures,” to administer injections for the diagnosis or treatment of conditions of the eye and adnexa authorized by the Act, excluding intraorbital injections and injections administered for cosmetic effect.
Expands the definition of glaucoma to include an “increase in intraocular pressure caused by steroid medication,” but specifies that an optometrist may only treat this type of glaucoma if the optometrist has prescribed the steroid, or has consulted with and received approval from the prescriber.
Expands the definition of glaucoma to include an “increase in intraocular pressure caused by steroid medication.”
Establishes a certification process for an optometrist to perform certain laser procedures, requiring 25 hours of education and 24 complete clinical procedures on live human patients.
Establishes continuing education hours for optometrists certified to perform laser procedures.
Establishes a certification course for an optometrist to perform minor procedures.
Defines minor procedures as removal, destruction, or drainage of lesions of the eyelid and adnexa clinically evaluated by the optometrist to be non-cancerous, not involving the eyelid margin, lacrimal supply or drainage systems, no deeper than the orbicularis muscle, and smaller than five millimeters in diameter, and closure of a wound, as specified. Specifies that minor procedures do not include blepharoplasty or other cosmetic surgery procedures that reshape normal structures of the body in order to improve appearance and self-esteem.
Requires 25 hours of education and 32 complete clinical procedures on live human patients.
Establishes continuing education requirements for optometrists certified to perform minor procedures.
Authorizes an optometrist to earn a certificate to administer immunizations for influenza, herpes zoster, and pneumococcus if the optometrist does all of the following:
Completes an immunization training program endorsed by the Centers for Disease Control and Prevention, or the Accreditation Council for Pharmacy Education that, at a minimum, includes hands-on injection technique, clinical evaluation of indications and contraindications of vaccines, and the recognition and treatment of emergency reactions to vaccines, and shall maintain that training;
Is certified in basic life support for health care professionals; and,
Complies with all state and federal recordkeeping and reporting requirements, including providing documentation to the patient’s primary care provider and entering information in the appropriate immunization registry designated by the immunization branch of the State Department of Public Health.
Defines unprofessional conduct to include failure for an optometrist to refer a patient to an appropriate physician if an examination of the eyes indicates a substantial likelihood of any pathology that requires the attention of that physician.
FISCAL EFFECT: According to the May 4, 2015 Senate Appropriations Committee analysis, this bill will result in costs of less than $150,000 to develop and update regulations by the Board. The bill will also result in minor costs to grant certifications to certain optometrists and enforce licensing regulations on those optometrists. The Board anticipates that a small number of optometrists will seek additional, post-graduate certification to perform additional procedures under the bill. Therefore, the additional licensing cost to issue those certifications and any additional enforcement activities relating to those new duties are expected to be minor. Minor costs are also anticipated for the Office of Statewide Health Planning and Development (OSHPD) to oversee a future Health Workforce Pilot Project relating to optometry. Under current practice, the costs of developing and managing a pilot project are borne by the sponsoring academic institution. The costs to the OSHPD to authorize and review any new pilot project are minor.
COMMENTS:
Purpose. This bill is sponsored by the author. According to the author, “While merely 16 of California’s 58 counties meet the needed supply range for primary care physicians, we do have a robust network of providers that are well-trained, evenly distributed throughout the state, regulated by the [DCA] and well positioned to pay particular attention to currently underserved areas. Optometrists are one such provider group who receive a doctorate level training preparing them to be primary eye care providers, and independently diagnose and treat conditions of the eye. [This bill] will remove restrictions in current law to permit optometrists to examine, prevent, diagnose, and treat conditions and disorders of the visual system and the human eye to the full extent of their training. This includes the use of two types of therapeutic lasers by optometrists with postdoctoral advanced certification that have been developed for treatment of glaucoma and post-surgical cataract care, conditions that disproportionately affect patient groups that generally lack sufficient access to physicians. [This bill] is a limited expansion of scope for optometrists that is consistent with their education and training, and is a logical advancement of the profession that has been proven safe in other states. Moreover, the educational requirements contained in this bill are substantially greater than those required of optometrists in other states and exceed the minimum number of these procedures required for ophthalmologists by the Accreditation Council for Graduate Medical Education.”
Background. According to a report prepared by the Center for the Health Professions at the University of California San Francisco, the number of optometrist licenses in California has declined, but the number of licensees with a secondary practice location has increased. According to the Board, there are approximately 7,565 licensed optometrists in California, the largest population of optometrists in the United States. Approximately 7,500 of these optometrists are certified to administer diagnostic pharmaceutical agents. The majority of the licensed optometrists are generally concentrated in coastal counties, the Bay Area and counties in the Sacramento region. Several counties have no licensed optometrists with an address of record in those counties, and a number of other counties have ratios that indicate there is approximately one optometrist for every 10,000 people.
Optometrists’ and Ophthalmologists’ Education, Training and Scope. This bill would expand the types of procedures an optometrist is authorized to perform. This would include some tasks that have been traditionally performed by ophthalmologists. As such, the current education, training and scope of each profession is outlined below.
Optometrists. Optometrists are trained to diagnose mild to severe eye problems such as serious eye infections, inflammations of the eye, trauma, foreign bodies and glaucoma. They also examine the eye for vision prescription and corrective lenses.
After completion of an undergraduate degree, optometrists complete four years of and accredited optometry college after which they are awarded the Doctor of Optometry degree. Some optometrists also undertake an optional one year non-surgical residency program to enhance their experience in a particular area. Students graduate with 2500 to 3000 patient encounters; these include a mix of post-surgical, medical and routine visits.
Optometrists who graduated from an accredited school or college of optometry on or after May 1, 2008 receive certifications to use diagnostic pharmaceutical agents (DPA); to administer therapeutic pharmaceutical agents (TPA); to perform lacrimal irrigation and dilation (TPL); and to diagnose and treat primary open angle glaucoma (TLG). Optometrists who did not receive these certifications upon licensure may apply for these certifications after meeting the necessary requirements. In order to be certified, the optometrist must pass an exam, obtain a license to practice optometry, be certified by and accredited school of optometry that they are competent in the diagnosis, treatment and management of ocular systemic disease and complete 10 hours of experience with an ophthalmologist.
Ophthalmologists. The central focus of ophthalmology is surgery and management of complex eye diseases. An ophthalmologist specializes in the refractive, medical and surgical care of the eyes and visual system and in the prevention of disease and injury.
After obtaining an undergraduate degree, ophthalmologists complete four years at an accredited medical school and earn a Medical Degree. This is followed by a one year internship and a three or four year surgical residency. Many ophthalmologists pursue additional fellowship training in specialized areas such as retina, glaucoma or cornea. Ophthalmologists may become certified by the American Board of Ophthalmology, which requires, serving as primary surgeon or first assistant to the primary surgeon on a minimum of 364 eye surgeries.
Changes to Current Scope of Practice. This bill would expand the scope of practice for optometrists. The following chart illustrates some of the salient changes that would be made to the current scope of practice for optometrists.
Current Scope |
Proposed Scope |
Defines the practice of optometry to include, among other things, the prevention and diagnosis of disorders and dysfunctions of the visual system, examination of the eyes, determination of the powers or range of human vision and prescribing of contact and spectacle lenses. |
Adds the provision of habilitative optometric services to the definition of the practice of optometry.
|
Limits the conditions of the eye and visual system that can be diagnosed and treated by a TPA certified optometrist. |
Allows TPA certified optometrists to treat conjunctival surface disease, hypotrichosis (via Latisse) and blepharitis.
Authorizes optometrists to perform all CLIA waived in office testing if the optometrist becomes registered as a lab director with the Department of Public Health. |
Specifies that an optometrist must consult with an ophthalmologist if an ocular inflammation, non-surgical in cause, and other diseases recur within one year of initial occurrence. |
Deletes these requirements. |
Limits treatment of ocular pain, non-surgical in cause, except when co-managed with the treating physician and surgeon, associated with conditions optometrists are authorized to treat. |
Allows for treatment of all ocular pain, non-surgical in cause, except when co-managed with the treating physician and surgeon. |
Allows removal of foreign bodies from cornea, eyelid, and conjunctiva with any appropriate instrument other than a scalpel or needle. |
Allows optometrists the use of a needle to remove foreign bodies from the eye. |
Limits prescriptions to Schedule III drugs, codeine with compounds and hydrocodone and limits the use of these to 3 days with a referral to an ophthalmologist if the pain persists. |
Changes the use to 5 days. |
Limits the definition of glaucoma. |
Adds to the definition of glaucoma : “increase in intraocular pressure caused by steroid medication prescribed by optometrist or prescribing physician”. |
Specifies that an optometrist cannot treat the lacrimal gland, the lacrimal drainage system and the sclera in patients younger than 12. |
Deletes this requirement. |
Allows optometrists to perform venipuncture for testing patients suspected of having diabetes. |
Amends the language to allow optometrists “to collect blood specimen by the finger prick method” to test for diabetes. |
No post-graduate certifications are required. |
Establishes three new post-graduate certifications: 1) anterior segment laser, 2) minor procedures and 3) immunization. |
Specifies what diagnoses specify the use of steroid medication and that an optometrist should consult with an ophthalmologist and/or appropriate physician and surgeon if a patient’s condition worsens 72 hours after being diagnosed. |
Deletes this requirement. |
Specifies that the optometrist shall refer the patient to an ophthalmologist if requested by the patient or if angle closure glaucoma develops. If the glaucoma patient also has diabetes, the optometrist shall consult with the physician treating the patient's diabetes in developing the glaucoma treatment plan and shall inform the physician in writing of any changes in the patient's glaucoma medication. |
Deletes these requirements. |
Specifies that if the patient has been diagnosed with a central corneal ulcer and the central corneal ulcer has not improved 48 hours after diagnosis, the optometrist shall refer the patient to an ophthalmologist.
Specifies that if the patient has been diagnosed with preseptal cellulitis or dacryocystitis and the condition has not improved 48 hours after diagnosis, the optometrist shall refer the patient to an ophthalmologist. |
Deletes these requirements. |
Specifies that if the patient has been diagnosed with herpes simplex keratitis or varicella zoster viral keratitis and the patient's condition has not improved seven days after diagnosis, or has not resolved three weeks after diagnosis the optometrist shall refer the patient to an ophthalmologist
Specifies that if the patient has been diagnosed with herpes simplex viral conjunctivitis, herpes simplex viral dermatitis, varicella zoster viral conjunctivitis, or varicella zoster viral dermatitis, and if the patient's condition worsens seven days after diagnosis, or has not resolved three weeks after diagnosis, the optometrist shall consult with and refer the patient to an ophthalmologist. |
Deletes these requirements. |
Requires that in any case where an optometrist is required to consult with an ophthalmologist, the optometrist shall maintain a written record in the patient's file of the information provided to the ophthalmologist, the ophthalmologist's response, and any other relevant information. Upon the consulting ophthalmologist's request and with the patient's consent, the optometrist shall furnish a copy of the record to the ophthalmologist. |
Deletes this requirement. |
|
Allows the Board to authorize the use of new non-invasive technology, after completion of a minimum of four hours of education courses on the new technology, and perform an appropriate number of complete clinical procedures on live human patients. |
|
Adds the ability for optometrists to perform skin tests to diagnose ocular allergies and limits these tests to the superficial lawyer of the skin. |
|
Adds the use of mechanical lipid extraction of meibomian glands and non-surgical techniques |
|
Defines minor procedures: “Minor procedures” does not include blepharoplasty or other cosmetic surgery procedures that reshape normal structures of the body in order to improve appearance and self-esteem. |
Other States. Since 1997, there have been over 45 attempts in over 20 states by optometry associations to expand the scope of practice for optometrists including legislating surgery privileges. However, with the exception of Oklahoma and West Virginia, most states continue to prohibit optometrists from performing surgery, and their statutes specify that the license to practice optometry does not include the right to practice medicine. States such as Colorado and North Carolina specifically exclude surgery from their definition of the practice of optometry. Other states have statutes that delineate between laser and non-laser surgery. Optometrists are authorized to prescribe oral medications in all 50 states, they may prescribe oral steroids in 34 states, injections in 15 states and use lasers in 1 state.
Prior Related Legislation. SB 492 (Hernandez) of 2013, would have permitted an optometrist to diagnose treat and manage additional conditions with ocular manifestations, directed the California Board of Optometry to establish educational and examination requirements and would have permitted optometrists to perform vaccinations and surgical and non-surgical primary care procedures. NOTE: This bill died on the Assembly inactive file.
SB 668 (Polanco) Chapter 13, Statutes of 1996, expanded the scope of practice of optometrists to provide for the diagnosis and treatment of specified conditions or diseases of the human eye or its appendages, and to use other therapeutic pharmaceutical agents.
SB 929 (Polanco) Chapter 676, Statutes of 2000, expanded the scope of lawful practice for optometrists by specifying additional diseases and conditions that optometrists may treat (in particular certain types of glaucoma) with specified medications, and by specifying the extent of physician involvement that is required under various circumstances.
SB 1406 (Correa) Chapter 352, Statutes of 2008, specified permissible procedures for certified optometrists, and created the Glaucoma Diagnosis and Treatment Advisory Committee to establish glaucoma certification requirements.
ARGUMENTS IN SUPPORT:
The Board of Optometry supports the bill and writes, “The Board is supportive of the intent and direction of the bill, specifically the utilization of the extensive training an education of optometrists to expand access to health care for millions of Californians.”
The California Association for Nurse Practitioners supports the bill and writes, “This bill would allow optometrists to practice more consistently with their education and training by authorizing them to treat and manage additional visual system conditions, administer flue, pneumonia and shingles vaccinations, and perform certain noninvasive procedures.”
The United Nurses Associations of California/Union of Health Care Professionals supports the bill and writes, “[This bill] is a very modest expansion of the types of services that an optometrist can provide and ensures that only qualified, trained and competent O.D.s are permitted to offer the expanded services. [This bill] specifically prohibits O.D.s from performing surgery, and instead authorizes O.D.s only to perform relatively minor procedures.”
ARGUMENTS IN OPPOSITION:
The California Academy of Eye Physicians and Surgeons opposes the bill and writes in their letter, “We are particularly concerned that the bill has moved away from the ‘comprehensive’ concept of a single certification in ‘advanced procedures.’ We believe someone training to be a surgeon needs to develop the surgical judgment common to performing all surgical procedures: understanding when (and when not to) do surgery, being able to anticipate, avoid, and recognize complications, and knowing how to address these complications when they do happen. It is unreasonable to expect these skills to be developed after the minimal experience called for in [this bill].”
The California Medical Association opposes the bill and writes, “The CMA opposes [this bill] because patient safety and quality of care demand that patients be assured that individuals who perform invasive procedures have appropriate medical education and education. The safe use of lasers and scalpels requires extensive medical education and training… In addition, the safe administration of immunizations requires extensive education, training, experience and the ability to monitor for side effects that far exceed an optometrist’s training in visual systems.”
The Medical Board of California also opposes this measure. They write in their opposition letter, “Although the services that optometrists are authorized to provide have been narrowed down compared to SB 492 from last year, the Board still has concerns with the length of additional training and the number of procedures required. The 25 hours of training and the specified number of procedures required by this bill are not enough to ensure that consumers are protected and that certified optometrists are properly trained.”
AMENDMENTS:
1. The following technical amendments should be made:
On page 7, line 34 strike: lawyer and insert: layer
On page 14, line 17, strike: “injections” and
after “intraorbital” insert: injections, intraocular
injections
On page 7, lines 9, strike: a, strike:
specimen, strike: finger prick
method and insert: skin puncture
In order to ensure that this bill will not expand the scope of laboratory tests that an optometrist can order, the following amendment should be made:
On page 7, line 30 after “CLIA” insert: and designated as waived in paragraph (9)
A complete minor procedure includes: 1) injections of medication, 2) removal or destruction of lesions and 3) any required wound closures. This bill defines minor procedures to be “either” of the 3 previously listed. The following amendment should be made in order to ensure that a complete procedure includes numbers 1 through 3 above:
On page 14, line 6, amend the bill as follows: For purposes of this chapter, “minor procedure” means completion of all of the following
In order to ensure that the courses outlined in this bill are taken post-graduation, the following amendment should be made:
On page 12, line 38, amend the bill as follows:
(b) An optometrist certified to treat glaucoma pursuant to Section 3041.2, after successful completion of a degree from an approved school of optometry, shall be additionally certified for the use of anterior segment lasers after submitting proof of satisfactory completion of a course that is approved by the board, provided by an accredited school of optometry, and developed in consultation with an ophthalmologist who has experience educating optometric students. The board shall issue a certificate pursuant to this section only to an optometrist that has graduated from an approved school of optometry.
In order to ensure that inspection authority for the Board of Optometry is consistent with other DCA healing arts boards’ inspection authority, the following should be added to the bill:
The board may at any time inspect any place of practice in which optometry is being practiced. The board’s inspection authority does not extend to premises that are not registered with the board. Nothing in this section shall be construed to affect the board’s ability to investigate alleged unlicensed activity or to inspect place of practice for which registration has lapsed or is delinquent.
REGISTERED SUPPORT:
Blue Shield of California
Board of Optometry
California Association for Nurse Practitioners
California Optometric Association
United Nurses Associations of California/Union of Health Care Professionals
REGISTERED OPPOSITION:
Academy of Eye Physicians and Surgeons
American Academy of Dermatology Association
American Academy of Ophthalmology
American Academy of Pediatrics
American Association of Orthopaedic Surgeons
American Association for Pediatric Ophthalmology and Strabismus
American College of Surgeons
American Glaucoma Society
American Medical Association
American Osteopathic Association
American Society of Cataract and Refractive Surgery
American Society of Ophthalmic Plastic and Reconstructive Surgery
American Society of Retina Specialists
Blind Children’s Center
California Academy of Eye Physicians and Surgeons
California Academy of Family Physicians
California Association for Medical Laboratory Technology
California Black Health Network
California Educators of Ophthalmology for Quality Care
California Medical Association
California Society of Dermatology and Dermatologic Surgery
California Society of Plastic Surgeons
Latino Physicians of California
Lighthouse for Christ Mission
Medical Board of California
Union of American Physicians and Dentists
Ventura County American Chinese Medical Dental Association
Over 600 physicians and individuals
Analysis Prepared by: Le Ondra Clark Harvey, Ph.D. / B. & P. / (916) 319-3301
SB 622
Page 12
Date of Hearing: July 7, 2015
ASSEMBLY COMMITTEE ON BUSINESS AND PROFESSIONS
Susan Bonilla, Chair
SB 622
(Hernandez) – As Amended May 4, 2015
SENATE VOTE: 33-4
SUBJECT: Optometry
SUMMARY: This bill expands the scope of practice for optometrists to include the expanded ability to order Clinical Laboratory Improvement Amendments (CLIA)-waived tests, use noninvasive, nonsurgical technology to treat a condition authorized by the Optometric Act (Act), perform laser and minor procedures, and administer certain vaccines.
EXISTING LAW:
Establishes the California Board of Optometry (Board), within the Department of Consumer Affairs (DCA), which licenses optometrists and regulates the practice of optometry. (BPC § 3010.5)
Authorizes the Board to establish educational and examination requirements for licensure. (BPC § 3041.2)
Defines the practice of optometry as follows: (BPC § 3041)
Prevention and diagnosis of disorders and dysfunctions of the visual system;
Treatment and management of certain disorders and dysfunctions of the visual systems;
Provision of rehabilitative optometric services;
Examination of the human eyes;
Determination of the powers or range of human vision;
Prescribing or directing the use of any optical device in connection with ocular exercises, visual training, vision training or orthoptics;
Prescribing of contact lenses and glasses; and,
Use of topical pharmaceutical agents for the purpose of the examination of the human eye or eyes for any disease or pathological condition.
Specifies that an optometrist who is certified to use therapeutic pharmaceutical agents may also diagnose and treat the human eye or eyes or any of its appendages for the following conditions: (BPC § 3041(b)(1))
Infections;
Ocular allergies;
Ocular inflammation, non-surgical in cause except when co-managed with the treating physician and surgeon;
Traumatic or recurrent conjunctival or corneal abrasions and erosions;
Corneal surface disease and dry eyes;
Ocular pain, non-surgical in cause except when co-managed with the treating physician and surgeon; and,
Glaucoma in patients over the age of 18.
Permits optometrists to use the following therapeutic pharmaceutical agents: (BPC § 3041(c))
Topical miotics;
Topical lubricants;
Anti-allergy agents;
Topical and oral anti-inflammatories;
Topical antibiotic agents;
Topical hyperosmotics;
Topical and oral anti-glaucoma agents;
Non-prescription medications;
Oral antihistamines;
Prescription oral non-steroidal anti-inflammatory agents;
Oral antibiotics for treatment of ocular disease;
Topical and oral antiviral medication for treatment of:
Herpes;
Viral Keratitis;
Herpes Simplex Viral conjunctivitis;
Periocular herpes simplex viral dermatitis;
Varicella zoster viral keratitis;
Varicella zoster viral conjunctivitis; and,
Periocular varicella zoster viral dermatitis;
Oral analgesics that are not controlled substances; and,
Codeine with compounds and hydrocodone with compounds with specific restrictions regarding usage timeframe.
Specifies that an optometrist who is certified to use therapeutic pharmaceutical agents may also perform the following: (BPC § 3401(e))
Corneal scraping with cultures;
Debridement of corneal epithelia;
Mechanical epilation;
Venipuncture for testing patients suspected of having diabetes;
Suture removal, with prior consultation with the treating physician and surgeon;
Treatment or removal of sebaceous cysts by expression;
Administration of oral fluorescein to patients suspected as having diabetic retinopathy;
Use of an auto-injector to counter anaphylaxis;
Ordering of smears, cultures, sensitivities, complete blood count, mycobacterial culture, acid fast stain, urinalysis, tear fluid analysis and X-rays necessary for the diagnosis of conditions or diseases of the eye or adnexa;
A clinical laboratory test or examination classified as waived under CLIA necessary for the diagnosis of conditions and diseases of the eye or adnexa;
Punctal occlusion by plugs, excluding laser, diathermy, cryotherapy or other means constituting surgery;
The prescription of therapeutic contact lenses, including lenses or devices that incorporate a medication or therapy the optometrist is certified to prescribe or provide;
Removal of foreign bodies from the cornea, eyelid and conjunctiva with any appropriate instrument other than a scalpel or needle; and,
Lacrimal irrigation and dilation, excluding probing of the nasal lacrimal tract for patients over 12 years of age.
THIS BILL:
Requires the Board to establish educational and examination requirements by regulation for licensure to ensure the competence of optometrists to practice pursuant to the Act, except as specified in the sections related to certification for minor procedures and lasers.
Adds “habilitative services” to the definition of the practice of optometry.
Authorizes the Board to promulgate regulations authorizing optometrists to use noninvasive, nonsurgical technology to treat a condition authorized by the Act. To qualify to use each new technology authorized, the Board shall require a licensee to take a minimum of four hours of education and perform an appropriate number of complete clinical procedures on live human patients.
Removes referral requirements related to the treatment of ocular inflammation, as specified.
Allows an optometrist to treat hypotrichosis and blepharitis.
Adds “conjunctival” to the types of surface diseases that an optometrist who is certified to use therapeutic pharmaceutical agents may diagnose and treat.
Removes exceptions to the types of infections of the anterior segment and adnexa that an optometrist may treat.
Removes referral protocols for the use of certain drugs.
Expands ability to order CLIA waived tests.
Extends from three to five days the time that codeine with compounds and hydrocodone with specified compounds may be used.
Allows an optometrist to collect a blood specimen by finger prick method.
Permits an optometrist to perform a skin test on the superficial layer of the skin to diagnose ocular allergies.
Allows an optometrist to prescribe biological or technological corneal devices.
Allows an optometrist to use a needle to remove objects from the cornea, eyelid, and conjunctiva.
Authorizes an optometrist to use mechanical lipid extraction on meibomian glands and nonsurgical techniques.
Authorizes an optometrist, as part of additional “minor procedures,” to administer injections for the diagnosis or treatment of conditions of the eye and adnexa authorized by the Act, excluding intraorbital injections and injections administered for cosmetic effect.
Expands the definition of glaucoma to include an “increase in intraocular pressure caused by steroid medication,” but specifies that an optometrist may only treat this type of glaucoma if the optometrist has prescribed the steroid, or has consulted with and received approval from the prescriber.
Expands the definition of glaucoma to include an “increase in intraocular pressure caused by steroid medication.”
Establishes a certification process for an optometrist to perform certain laser procedures, requiring 25 hours of education and 24 complete clinical procedures on live human patients.
Establishes continuing education hours for optometrists certified to perform laser procedures.
Establishes a certification course for an optometrist to perform minor procedures.
Defines minor procedures as removal, destruction, or drainage of lesions of the eyelid and adnexa clinically evaluated by the optometrist to be non-cancerous, not involving the eyelid margin, lacrimal supply or drainage systems, no deeper than the orbicularis muscle, and smaller than five millimeters in diameter, and closure of a wound, as specified. Specifies that minor procedures do not include blepharoplasty or other cosmetic surgery procedures that reshape normal structures of the body in order to improve appearance and self-esteem.
Requires 25 hours of education and 32 complete clinical procedures on live human patients.
Establishes continuing education requirements for optometrists certified to perform minor procedures.
Authorizes an optometrist to earn a certificate to administer immunizations for influenza, herpes zoster, and pneumococcus if the optometrist does all of the following:
Completes an immunization training program endorsed by the Centers for Disease Control and Prevention, or the Accreditation Council for Pharmacy Education that, at a minimum, includes hands-on injection technique, clinical evaluation of indications and contraindications of vaccines, and the recognition and treatment of emergency reactions to vaccines, and shall maintain that training;
Is certified in basic life support for health care professionals; and,
Complies with all state and federal recordkeeping and reporting requirements, including providing documentation to the patient’s primary care provider and entering information in the appropriate immunization registry designated by the immunization branch of the State Department of Public Health.
Defines unprofessional conduct to include failure for an optometrist to refer a patient to an appropriate physician if an examination of the eyes indicates a substantial likelihood of any pathology that requires the attention of that physician.
FISCAL EFFECT: According to the May 4, 2015 Senate Appropriations Committee analysis, this bill will result in costs of less than $150,000 to develop and update regulations by the Board. The bill will also result in minor costs to grant certifications to certain optometrists and enforce licensing regulations on those optometrists. The Board anticipates that a small number of optometrists will seek additional, post-graduate certification to perform additional procedures under the bill. Therefore, the additional licensing cost to issue those certifications and any additional enforcement activities relating to those new duties are expected to be minor. Minor costs are also anticipated for the Office of Statewide Health Planning and Development (OSHPD) to oversee a future Health Workforce Pilot Project relating to optometry. Under current practice, the costs of developing and managing a pilot project are borne by the sponsoring academic institution. The costs to the OSHPD to authorize and review any new pilot project are minor.
COMMENTS:
Purpose. This bill is sponsored by the author. According to the author, “While merely 16 of California’s 58 counties meet the needed supply range for primary care physicians, we do have a robust network of providers that are well-trained, evenly distributed throughout the state, regulated by the [DCA] and well positioned to pay particular attention to currently underserved areas. Optometrists are one such provider group who receive a doctorate level training preparing them to be primary eye care providers, and independently diagnose and treat conditions of the eye. [This bill] will remove restrictions in current law to permit optometrists to examine, prevent, diagnose, and treat conditions and disorders of the visual system and the human eye to the full extent of their training. This includes the use of two types of therapeutic lasers by optometrists with postdoctoral advanced certification that have been developed for treatment of glaucoma and post-surgical cataract care, conditions that disproportionately affect patient groups that generally lack sufficient access to physicians. [This bill] is a limited expansion of scope for optometrists that is consistent with their education and training, and is a logical advancement of the profession that has been proven safe in other states. Moreover, the educational requirements contained in this bill are substantially greater than those required of optometrists in other states and exceed the minimum number of these procedures required for ophthalmologists by the Accreditation Council for Graduate Medical Education.”
Background. According to a report prepared by the Center for the Health Professions at the University of California San Francisco, the number of optometrist licenses in California has declined, but the number of licensees with a secondary practice location has increased. According to the Board, there are approximately 7,565 licensed optometrists in California, the largest population of optometrists in the United States. Approximately 7,500 of these optometrists are certified to administer diagnostic pharmaceutical agents. The majority of the licensed optometrists are generally concentrated in coastal counties, the Bay Area and counties in the Sacramento region. Several counties have no licensed optometrists with an address of record in those counties, and a number of other counties have ratios that indicate there is approximately one optometrist for every 10,000 people.
Optometrists’ and Ophthalmologists’ Education, Training and Scope. This bill would expand the types of procedures an optometrist is authorized to perform. This would include some tasks that have been traditionally performed by ophthalmologists. As such, the current education, training and scope of each profession is outlined below.
Optometrists. Optometrists are trained to diagnose mild to severe eye problems such as serious eye infections, inflammations of the eye, trauma, foreign bodies and glaucoma. They also examine the eye for vision prescription and corrective lenses.
After completion of an undergraduate degree, optometrists complete four years of and accredited optometry college after which they are awarded the Doctor of Optometry degree. Some optometrists also undertake an optional one year non-surgical residency program to enhance their experience in a particular area. Students graduate with 2500 to 3000 patient encounters; these include a mix of post-surgical, medical and routine visits.
Optometrists who graduated from an accredited school or college of optometry on or after May 1, 2008 receive certifications to use diagnostic pharmaceutical agents (DPA); to administer therapeutic pharmaceutical agents (TPA); to perform lacrimal irrigation and dilation (TPL); and to diagnose and treat primary open angle glaucoma (TLG). Optometrists who did not receive these certifications upon licensure may apply for these certifications after meeting the necessary requirements. In order to be certified, the optometrist must pass an exam, obtain a license to practice optometry, be certified by and accredited school of optometry that they are competent in the diagnosis, treatment and management of ocular systemic disease and complete 10 hours of experience with an ophthalmologist.
Ophthalmologists. The central focus of ophthalmology is surgery and management of complex eye diseases. An ophthalmologist specializes in the refractive, medical and surgical care of the eyes and visual system and in the prevention of disease and injury.
After obtaining an undergraduate degree, ophthalmologists complete four years at an accredited medical school and earn a Medical Degree. This is followed by a one year internship and a three or four year surgical residency. Many ophthalmologists pursue additional fellowship training in specialized areas such as retina, glaucoma or cornea. Ophthalmologists may become certified by the American Board of Ophthalmology, which requires, serving as primary surgeon or first assistant to the primary surgeon on a minimum of 364 eye surgeries.
Changes to Current Scope of Practice. This bill would expand the scope of practice for optometrists. The following chart illustrates some of the salient changes that would be made to the current scope of practice for optometrists.
Current Scope |
Proposed Scope |
Defines the practice of optometry to include, among other things, the prevention and diagnosis of disorders and dysfunctions of the visual system, examination of the eyes, determination of the powers or range of human vision and prescribing of contact and spectacle lenses. |
Adds the provision of habilitative optometric services to the definition of the practice of optometry.
|
Limits the conditions of the eye and visual system that can be diagnosed and treated by a TPA certified optometrist. |
Allows TPA certified optometrists to treat conjunctival surface disease, hypotrichosis (via Latisse) and blepharitis.
Authorizes optometrists to perform all CLIA waived in office testing if the optometrist becomes registered as a lab director with the Department of Public Health. |
Specifies that an optometrist must consult with an ophthalmologist if an ocular inflammation, non-surgical in cause, and other diseases recur within one year of initial occurrence. |
Deletes these requirements. |
Limits treatment of ocular pain, non-surgical in cause, except when co-managed with the treating physician and surgeon, associated with conditions optometrists are authorized to treat. |
Allows for treatment of all ocular pain, non-surgical in cause, except when co-managed with the treating physician and surgeon. |
Allows removal of foreign bodies from cornea, eyelid, and conjunctiva with any appropriate instrument other than a scalpel or needle. |
Allows optometrists the use of a needle to remove foreign bodies from the eye. |
Limits prescriptions to Schedule III drugs, codeine with compounds and hydrocodone and limits the use of these to 3 days with a referral to an ophthalmologist if the pain persists. |
Changes the use to 5 days. |
Limits the definition of glaucoma. |
Adds to the definition of glaucoma : “increase in intraocular pressure caused by steroid medication prescribed by optometrist or prescribing physician”. |
Specifies that an optometrist cannot treat the lacrimal gland, the lacrimal drainage system and the sclera in patients younger than 12. |
Deletes this requirement. |
Allows optometrists to perform venipuncture for testing patients suspected of having diabetes. |
Amends the language to allow optometrists “to collect blood specimen by the finger prick method” to test for diabetes. |
No post-graduate certifications are required. |
Establishes three new post-graduate certifications: 1) anterior segment laser, 2) minor procedures and 3) immunization. |
Specifies what diagnoses specify the use of steroid medication and that an optometrist should consult with an ophthalmologist and/or appropriate physician and surgeon if a patient’s condition worsens 72 hours after being diagnosed. |
Deletes this requirement. |
Specifies that the optometrist shall refer the patient to an ophthalmologist if requested by the patient or if angle closure glaucoma develops. If the glaucoma patient also has diabetes, the optometrist shall consult with the physician treating the patient's diabetes in developing the glaucoma treatment plan and shall inform the physician in writing of any changes in the patient's glaucoma medication. |
Deletes these requirements. |
Specifies that if the patient has been diagnosed with a central corneal ulcer and the central corneal ulcer has not improved 48 hours after diagnosis, the optometrist shall refer the patient to an ophthalmologist.
Specifies that if the patient has been diagnosed with preseptal cellulitis or dacryocystitis and the condition has not improved 48 hours after diagnosis, the optometrist shall refer the patient to an ophthalmologist. |
Deletes these requirements. |
Specifies that if the patient has been diagnosed with herpes simplex keratitis or varicella zoster viral keratitis and the patient's condition has not improved seven days after diagnosis, or has not resolved three weeks after diagnosis the optometrist shall refer the patient to an ophthalmologist
Specifies that if the patient has been diagnosed with herpes simplex viral conjunctivitis, herpes simplex viral dermatitis, varicella zoster viral conjunctivitis, or varicella zoster viral dermatitis, and if the patient's condition worsens seven days after diagnosis, or has not resolved three weeks after diagnosis, the optometrist shall consult with and refer the patient to an ophthalmologist. |
Deletes these requirements. |
Requires that in any case where an optometrist is required to consult with an ophthalmologist, the optometrist shall maintain a written record in the patient's file of the information provided to the ophthalmologist, the ophthalmologist's response, and any other relevant information. Upon the consulting ophthalmologist's request and with the patient's consent, the optometrist shall furnish a copy of the record to the ophthalmologist. |
Deletes this requirement. |
|
Allows the Board to authorize the use of new non-invasive technology, after completion of a minimum of four hours of education courses on the new technology, and perform an appropriate number of complete clinical procedures on live human patients. |
|
Adds the ability for optometrists to perform skin tests to diagnose ocular allergies and limits these tests to the superficial lawyer of the skin. |
|
Adds the use of mechanical lipid extraction of meibomian glands and non-surgical techniques |
|
Defines minor procedures: “Minor procedures” does not include blepharoplasty or other cosmetic surgery procedures that reshape normal structures of the body in order to improve appearance and self-esteem. |
Other States. Since 1997, there have been over 45 attempts in over 20 states by optometry associations to expand the scope of practice for optometrists including legislating surgery privileges. However, with the exception of Oklahoma and West Virginia, most states continue to prohibit optometrists from performing surgery, and their statutes specify that the license to practice optometry does not include the right to practice medicine. States such as Colorado and North Carolina specifically exclude surgery from their definition of the practice of optometry. Other states have statutes that delineate between laser and non-laser surgery. Optometrists are authorized to prescribe oral medications in all 50 states, they may prescribe oral steroids in 34 states, injections in 15 states and use lasers in 1 state.
Prior Related Legislation. SB 492 (Hernandez) of 2013, would have permitted an optometrist to diagnose treat and manage additional conditions with ocular manifestations, directed the California Board of Optometry to establish educational and examination requirements and would have permitted optometrists to perform vaccinations and surgical and non-surgical primary care procedures. NOTE: This bill died on the Assembly inactive file.
SB 668 (Polanco) Chapter 13, Statutes of 1996, expanded the scope of practice of optometrists to provide for the diagnosis and treatment of specified conditions or diseases of the human eye or its appendages, and to use other therapeutic pharmaceutical agents.
SB 929 (Polanco) Chapter 676, Statutes of 2000, expanded the scope of lawful practice for optometrists by specifying additional diseases and conditions that optometrists may treat (in particular certain types of glaucoma) with specified medications, and by specifying the extent of physician involvement that is required under various circumstances.
SB 1406 (Correa) Chapter 352, Statutes of 2008, specified permissible procedures for certified optometrists, and created the Glaucoma Diagnosis and Treatment Advisory Committee to establish glaucoma certification requirements.
ARGUMENTS IN SUPPORT:
The Board of Optometry supports the bill and writes, “The Board is supportive of the intent and direction of the bill, specifically the utilization of the extensive training an education of optometrists to expand access to health care for millions of Californians.”
The California Association for Nurse Practitioners supports the bill and writes, “This bill would allow optometrists to practice more consistently with their education and training by authorizing them to treat and manage additional visual system conditions, administer flue, pneumonia and shingles vaccinations, and perform certain noninvasive procedures.”
The United Nurses Associations of California/Union of Health Care Professionals supports the bill and writes, “[This bill] is a very modest expansion of the types of services that an optometrist can provide and ensures that only qualified, trained and competent O.D.s are permitted to offer the expanded services. [This bill] specifically prohibits O.D.s from performing surgery, and instead authorizes O.D.s only to perform relatively minor procedures.”
ARGUMENTS IN OPPOSITION:
The California Academy of Eye Physicians and Surgeons opposes the bill and writes in their letter, “We are particularly concerned that the bill has moved away from the ‘comprehensive’ concept of a single certification in ‘advanced procedures.’ We believe someone training to be a surgeon needs to develop the surgical judgment common to performing all surgical procedures: understanding when (and when not to) do surgery, being able to anticipate, avoid, and recognize complications, and knowing how to address these complications when they do happen. It is unreasonable to expect these skills to be developed after the minimal experience called for in [this bill].”
The California Medical Association opposes the bill and writes, “The CMA opposes [this bill] because patient safety and quality of care demand that patients be assured that individuals who perform invasive procedures have appropriate medical education and education. The safe use of lasers and scalpels requires extensive medical education and training… In addition, the safe administration of immunizations requires extensive education, training, experience and the ability to monitor for side effects that far exceed an optometrist’s training in visual systems.”
The Medical Board of California also opposes this measure. They write in their opposition letter, “Although the services that optometrists are authorized to provide have been narrowed down compared to SB 492 from last year, the Board still has concerns with the length of additional training and the number of procedures required. The 25 hours of training and the specified number of procedures required by this bill are not enough to ensure that consumers are protected and that certified optometrists are properly trained.”
AMENDMENTS:
1. The following technical amendments should be made:
On page 7, line 34 strike: lawyer and insert: layer
On page 14, line 17, strike: “injections” and
after “intraorbital” insert: injections, intraocular
injections
On page 7, lines 9, strike: a, strike:
specimen, strike: finger prick
method and insert: skin puncture
In order to ensure that this bill will not expand the scope of laboratory tests that an optometrist can order, the following amendment should be made:
On page 7, line 30 after “CLIA” insert: and designated as waived in paragraph (9)
A complete minor procedure includes: 1) injections of medication, 2) removal or destruction of lesions and 3) any required wound closures. This bill defines minor procedures to be “either” of the 3 previously listed. The following amendment should be made in order to ensure that a complete procedure includes numbers 1 through 3 above:
On page 14, line 6, amend the bill as follows: For purposes of this chapter, “minor procedure” means completion of all of the following
In order to ensure that the courses outlined in this bill are taken post-graduation, the following amendment should be made:
On page 12, line 38, amend the bill as follows:
(b) An optometrist certified to treat glaucoma pursuant to Section 3041.2, after successful completion of a degree from an approved school of optometry, shall be additionally certified for the use of anterior segment lasers after submitting proof of satisfactory completion of a course that is approved by the board, provided by an accredited school of optometry, and developed in consultation with an ophthalmologist who has experience educating optometric students. The board shall issue a certificate pursuant to this section only to an optometrist that has graduated from an approved school of optometry.
In order to ensure that inspection authority for the Board of Optometry is consistent with other DCA healing arts boards’ inspection authority, the following should be added to the bill:
The board may at any time inspect any place of practice in which optometry is being practiced. The board’s inspection authority does not extend to premises that are not registered with the board. Nothing in this section shall be construed to affect the board’s ability to investigate alleged unlicensed activity or to inspect place of practice for which registration has lapsed or is delinquent.
REGISTERED SUPPORT:
Blue Shield of California
Board of Optometry
California Association for Nurse Practitioners
California Optometric Association
United Nurses Associations of California/Union of Health Care Professionals
REGISTERED OPPOSITION:
Academy of Eye Physicians and Surgeons
American Academy of Dermatology Association
American Academy of Ophthalmology
American Academy of Pediatrics
American Association of Orthopaedic Surgeons
American Association for Pediatric Ophthalmology and Strabismus
American College of Surgeons
American Glaucoma Society
American Medical Association
American Osteopathic Association
American Society of Cataract and Refractive Surgery
American Society of Ophthalmic Plastic and Reconstructive Surgery
American Society of Retina Specialists
Blind Children’s Center
California Academy of Eye Physicians and Surgeons
California Association for Medical Laboratory Technology
California Black Health Network
California Educators of Ophthalmology for Quality Care
California Medical Association
California Society of Plastic Surgeons
Latino Physicians of California
Lighthouse for Christ Mission
Medical Board of California
Union of American Physicians and Dentists
Ventura County American Chinese Medical Dental Association
Over 600 physicians and individuals
Analysis Prepared by: Le Ondra Clark Harvey, Ph.D. / B. & P. / (916) 319-3301
SB 622
Page 7
|
Office of Senate Floor Analyses (916) 651-1520 Fax: (916) 327-4478 |
THIRD READING
Bill No: SB 622
Amended: 5/4/15
SENATE BUS, PROF. & ECON. DEV. COMMITTEE: 9-0, 4/27/15
AYES: Hill, Bates, Berryhill, Block, Galgiani, Hernandez, Jackson, Mendoza, Wieckowski
SENATE APPROPRIATIONS COMMITTEE: 7-0, 5/18/15
AYES: Lara, Bates, Beall, Hill, Leyva, Mendoza, Nielsen
DIGEST: This bill expands the scope of practice for optometrists to include expanded ability to order the Clinical Laboratory Improvement Amendments (CLIA)-waived tests, use noninvasive, nonsurgical technology to treat a condition authorized by the Optometric Act (Act), perform laser and minor procedures, and administer certain vaccines.
Existing law:
Establishes the State Board of Optometry (Board) within the Department of Consumer Affairs, which licenses optometrists and regulates the practice of optometry. (Business and Professions Code (BPC) § 3010.5)
Defines the practice of optometry as follows:
The prevention and diagnosis of disorders and dysfunctions of the visual system;
Treatment and management of certain disorders and dysfunctions of the visual systems;
Provision of rehabilitative optometric services;
Examination of the human eyes;
Determination of the powers or range of human vision;
The prescribing or directing the use of any optical device in connection with ocular exercises, visual training, vision training or orthoptics;
Prescribing of contact lenses and glasses; and
The use of topical pharmaceutical agents for the purpose of the examination of the human eye or eyes for any disease or pathological condition.
(BPC § 3041)
This bill:
Authorizes the Board to establish educational and examination requirements by regulation for licensure to ensure the competence of optometrists to practice pursuant to the Act, except as specified in the sections related to certification for minor procedures and lasers.
Adds “habilitative services” to the definition of the practice of optometry.
Authorizes the Board to promulgate regulations authorizing optometrists to use noninvasive, nonsurgical technology to treat a condition authorized by the Act. To qualify to use each new technology authorized, the Board shall require a licensee to take a minimum of four hours’ education and perform an appropriate number of complete clinical procedures on live human patients.
Removes referral requirements related to the treatment of ocular inflammation, as specified.
Allows an optometrist to treat hypotrichosis and blepharitis.
Adds “conjunctival” to the types of surface diseases that an optometrist who is certified to use therapeutic pharmaceutical agents may diagnose and treat.
Removes exceptions to the types of infections of the anterior segment and adnexa that an optometrist may treat.
Removes referral protocols for the use of certain drugs.
Expands ability to order CLIA waived tests.
Extends from three to five days the time that codeine with compounds and hydrocodone with specified compounds may be used.
Allows an optometrist to collect a blood specimen by finger prick method.
Permits an optometrist to perform a skin test on the superficial layer of the skin to diagnose ocular allergies.
Allows an optometrist to prescribe biological or technological corneal devices.
Allows an optometrist to use a needle to remove objects from the cornea, eyelid, and conjunctiva.
Authorizes an optometrist to use mechanical lipid extraction on meibomian glands and nonsurgical techniques.
Authorizes an optometrist, as part of additional “minor procedures,” to administer injections for the diagnosis or treatment of conditions of the eye and adnexa authorized by the Act, excluding intraorbital injections and injections administered for cosmetic effect.
Expands the definition of glaucoma by including that caused by an “increase in intraocular pressure caused by steroid medication,” but specifies that an optometrist may only treat this type of glaucoma if the optometrist has prescribed the steroid, or has consulted with and received approval from, the prescriber.
Establishes a certification process for an optometrist to perform certain laser procedures, requiring 25 hours of education and 24 complete clinical procedures on live human patients.
Expands the definition of glaucoma by including an “increase in intraocular pressure caused by steroid medication.”
Establishes continuing education hours for optometrists certified to perform laser procedures.
Establishes a certification course for an optometrist to perform minor procedures. Minor procedures are defined as removal, destruction, or drainage of lesions of the eyelid and adnexa clinically evaluated by the optometrist to be noncancerous, not involving the eyelid margin, lacrimal supply or drainage systems, no deeper than the orbicularis muscle, and smaller than five millimeters in diameter, and closure of a wound, as specified. Specifies that minor procedures do not include blepharoplasty or other cosmetic surgery procedures that reshape normal structures of the body in order to improve appearance and self-esteem. Requires 25 hours of education and 32 complete clinical procedures on live human patients.
Establishes continuing education requirements for optometrists certified to perform minor procedures.
Authorizes an optometrist to earn a certificate to administer immunizations for influenza, herpes zoster, and pneumococcus if the optometrist does all of the following:
Completes an immunization training program endorsed by the Centers for Disease Control and Prevention, or the Accreditation Council for Pharmacy Education that, at a minimum, includes hands-on injection technique, clinical evaluation of indications and contraindications of vaccines, and the recognition and treatment of emergency reactions to vaccines, and shall maintain that training.
Is certified in basic life support for health care professionals.
Complies with all state and federal recordkeeping and reporting requirements, including providing documentation to the patient’s primary care provider and entering information in the appropriate immunization registry designated by the immunization branch of the State Department of Public Health.
Declares as unprofessional conduct the failure for an optometrist to refer a patient to an appropriate physician if an examination of the eyes indicates a substantial likelihood of any pathology that requires the attention of that physician.
Background
The practice of optometry. An optometrist (Doctor of Optometry or O.D.) is an independent primary health care professional for the eye. Optometrists examine, diagnose, treat, and manage diseases, injuries, and disorders of the visual system, the eye, and associated structures, as well as identify related systemic conditions affecting the eye. O.D.s prescribe medications, low vision rehabilitation, vision therapy, spectacle lenses, contact lenses, and perform certain surgical procedures. Optometrists have a narrower scope of practice than do ophthalmologists, but are held to the identical standard of care for the same treatments they provide.
An O.D. degree requires both an undergraduate education and four years of professional education at a college of optometry. Some optometrists also undertake an optional one year non-surgical residency program to enhance their experience in a particular area. Students graduate with 2,500-3,000 patient encounters, which include a mix of post-surgical, medical and routine visits.
In order to be licensed to practice by the Board, an individual must obtain an O.D. degree, pass the three part National Board of Examiners in Optometry examination, and the California Optometric State Law Examination. There are currently 9,100 optometrists practicing in California.
The practice of
ophthalmology. An ophthalmologist is a physician and surgeon who
has specialty training in the
anatomy, function and diseases of the eye. The central focus
of ophthalmology is surgery and management of complex eye diseases.
An ophthalmologist specializes in the refractive, medical and
surgical care of the eyes and visual system, and in the prevention of
disease and injury.
To become an ophthalmologist, an
individual must obtain an undergraduate degree, complete four years
of graduate education at an accredited medical school and earn a
Medical Degree, complete a one year internship, and a three or four
year residency. There are currently 1,800-2,100 ophthalmologists in
California, not all of whom are in active practice.
FISCAL EFFECT: Appropriation: Yes Fiscal Com.: Yes Local: Yes
According to the Senate Appropriations Committee:
Costs of less than $150,000 to develop and update regulations by the Board (State Optometry Fund).
Minor costs to grant certifications to certain optometrists and enforce licensing regulations on those optometrists (State Optometry Fund). The Board anticipates that a small number of optometrists will seek additional, post-graduate certification to perform additional procedures under this bill. Therefore, the additional licensing cost to issue those certifications and any additional enforcement activities relating to those new duties are expected to be minor.
Minor costs for the Office of Statewide Health Planning and Development to oversee a future Health Workforce Pilot Project relating to optometry. Under current practice, the costs of developing and managing a pilot project are borne by the sponsoring academic institution. The costs to the Office to authorize and review any new pilot project are minor.
California Association of Health System Pharmacists
California Optometric Association
VSP Vision Care
Western University of Health Sciences
Numerous individuals
OPPOSITION: (Verified 5/19/15)
American Federation of State, County and Municipal Employees
Blind Childrens Center
California Academy of Eye Physicians & Surgeons
California Academy of Family Physicians
California Medical Association
California Society of Plastic Surgeons
Latino Physicians of California
Medical Board of California
Ventura County American Chinese Medical Dental Association
Numerous Individuals
ARGUMENTS IN SUPPORT: The California Optometric Association writes, “Doctors of optometry have a critical role to play in providing primary care and making the promise of the Affordable Care Act a reality. They already provide the vast majority of eye care in the Medi-Cal program and they are located in all but one California county (Alpine). In order to improve access to health care in California, we must provide timely care where and when it’s needed by utilizing the full complement of our clinical abilities.”
ARGUMENTS IN OPPOSITION: The California Academy of Family Physicians write, “Physicians see many benefits from working collaboratively with other health care professionals to meet patient care demand, but the framework of care delivery should be within the scope of practice that each health care professional is qualified to perform. Arbitrarily allowing allied health care professionals to render services that are beyond a provider’s scope can lead to increased costs through over-utilization of tests, over prescribing of medications, and excess referrals to specialists; and in this case, the potential for incredible harm to patients.”
Prepared by: Sarah Huchel / B., P. & E.D. / (916) 651-4104
5/20/15 11:44:31
SB 622 (Hernandez) Page 2 of 2
SENATE COMMITTEE ON APPROPRIATIONS
Senator Ricardo Lara, Chair
2015 - 2016 Regular Session
SB 622 (Hernandez) - Optometry
|
|
Version: May 4, 2015 |
Policy Vote: B., P. & E.D. 9 - 0 |
Urgency: No |
Mandate: Yes |
Hearing Date: May 18, 2015 |
Consultant: Brendan McCarthy |
This bill does not meet the criteria for referral to the Suspense File.
Bill Summary:
SB 622 would expand the scope of practice for optometrists by authorizing specially certified optometrists to perform certain tests, provide certain immunizations, and to use lasers for certain procedures.
Fiscal Impact:
Costs of less than $150,000 to develop and update regulations by the Board of Optometry (State Optometry Fund).
Minor costs to grant certifications to certain optometrists and enforce licensing regulations on those optometrists (State Optometry Fund). The Board of Optometry anticipates that a small number of optometrists will seek additional, post-graduate certification to perform additional procedures under the bill. Therefore, the additional licensing cost to issue those certifications and any additional enforcement activities relating to those new duties are expected to be minor.
Minor costs for the Office of Statewide Health Planning and Development to oversee a future Health Workforce Pilot Project relating to optometry. Under current practice, the costs of developing and managing a pilot project are borne by the sponsoring academic institution. The costs to the Office to authorize and review any new pilot project are minor.
Background:
Under current law, optometrists are licensed and regulated by the California Optometry Board. Current law establishes the scope of practice for optometrists and indicates what services an optometrist is authorized to provide to patients. In general, optometrists are trained and authorized to diagnose mild to severe eye problems, to prescribe corrective lenses, and provide other, specified services. An optometrist may apply for certification to provide certain additional services, such as the treatment of primary open angle glaucoma.
Proposed Law:
SB 622 would expand the scope of practice for optometrists by authorizing specially certified optometrists to perform certain tests, provide certain immunizations, and to use lasers for certain procedures.
Specific provisions of the bill would:
Add the provision of habilitative services to the practice of optometry;
Authorize the Board of Optometry to allow optometrists to use nonsurgical technology to treat any authorized condition under the Optometry Practice Act;
Authorize an optometrist certified to use therapeutic pharmaceutical agents to collect a blood specimen, perform skin tests, and to use mechanical lipid extraction of certain glands;
Require the Board to grant an optometrist certified to treat glaucoma a certificate for the use of specified immunizations;
Authorize an optometrist to be certified to use anterior segment lasers and to be certified to perform minor procedures;
Require the Board to charge specified fees to cover its costs;
State legislative intent that the Office of Statewide Health Planning and Development authorize a health workforce pilot project relating to expanded roles for optometrists with respect to diabetes, hypertension, and hypercholesterolemia.
Related Legislation:
SB 492 (Hernandez, 2014) would have created an advance practice certificate for optometrists, allowing certificated optometrists to perform additional procedures. That bill died on the Assembly Floor.
Staff Comments:
By expanding the scope of practice for optometrists, this bill will allow optometrists to provide more care to patients. Additional care provided by optometrists may increase overall utilization of health care, to the extent that patients are currently unable to get care from other practitioners, such as ophthalmologists or primary care physicians. On the other hand, patients may substitute care from an optometrist for care from another practitioner. In addition, to the extent that patients are currently unable to access primary care services, those patients may ultimately end up receiving care in another setting, such as an emergency room, urgent care facility, or community clinic. Care provided in those settings is likely to be more costly than primary care (for those patients who require such care). The overall impact on health care spending (including for state-funded programs) from this bill is not likely to result in significant costs or savings.
-- END --
SB 622 (Hernandez) Page 9 of 9
SENATE COMMITTEE ON
BUSINESS, PROFESSIONS AND ECONOMIC DEVELOPMENT
Senator Jerry Hill, Chair
2015 - 2016 Regular
Bill No: SB 622 Hearing Date: April 27, 2015
Author: |
Hernandez |
||
Version: |
April 9, 2015 |
||
Urgency: |
No |
Fiscal: |
Yes |
Consultant: |
Sarah Huchel |
||
Subject: Optometry.
SUMMARY:
Expands the scope of practice for optometrists to include expanding ability to order tests, use pharmaceuticals -- including for off-label use, and perform laser and minor procedures, and administer vaccines.
Existing law:
Establishes the State Board of Optometry (Board) within the Department of Consumer Affairs, which licenses optometrists and regulates the practice of optometry. (Business and Professions Code (BPC) § 3010.5)
Authorizes the Board to establish educational and examination requirements for licensure. (BPC § 3041.2)
Defines the practice of optometry as follows:
The prevention and diagnosis of disorders and dysfunctions of the visual system;
Treatment and management of certain disorders and dysfunctions of the visual systems;
Provision of rehabilitative optometric services;
Examination of the human eyes;
Determination of the powers or range of human vision;
The prescribing or directing the use of any optical device in connection with ocular exercises, visual training, vision training or orthoptics;
Prescribing of contact lenses and glasses; and
The use of topical pharmaceutical agents for the purpose of the examination of the human eye or eyes for any disease or pathological condition. (BPC 3041)
Specifies that an optometrist who is certified to use therapeutic pharmaceutical agents may also diagnose and treat the human eye or eyes or any of its appendages for the following conditions: infections; ocular allergies; ocular inflammation, non-surgical in cause except when co-managed with the treating physician and surgeon; traumatic or recurrent conjunctival or corneal abrasions and erosions; corneal surface disease and dry eyes; ocular pain, non-surgical in cause except when co-managed with the treating physician and surgeon; and glaucoma in patients over the age of 18. (BPC § 3041(b)(1))
Permits optometrists to use specified therapeutic pharmaceutical agents, including codeine with compounds and hydrocodone with compounds provided that use does not exceed three days. (BPC § 3041(c))
Specifies that an optometrist who is certified to use therapeutic pharmaceutical agents may also perform the following:
Corneal scraping with cultures;
Debridement of corneal epithelia;
Mechanical epilation;
Venipuncture for testing patients suspected of having diabetes;
Suture removal, with prior consultation with the treating physician and surgeon;
Treatment or removal of sebaceous cysts by expression;
Administration of oral fluorescein to patients suspected as having diabetic retinopathy;
Use of an auto-injector to counter anaphylaxis;
Ordering of smears, cultures, sensitivities, complete blood count, mycobacterial culture, acid fast stain, urinalysis, tear fluid analysis and X-rays necessary for the diagnosis of conditions or diseases of the eye or adnexa;
A clinical laboratory test or examination classified as waived under CLIA [Clinical Laboratory Improvement Amendments] necessary for the diagnosis of conditions and diseases of the eye or adnexa;
Punctal occlusion by plugs, excluding laser, diathermy, cryotherapy or other means constituting surgery;
The prescription of therapeutic contact lenses, including lenses or devices that incorporate a medication or therapy the optometrist is certified to prescribe or provide;
Removal of foreign bodies from the cornea, eyelid and conjunctiva with any appropriate instrument other than a scalpel or needle; and
Lacrimal irrigation and dilation, excluding probing of the nasal lacrimal tract for patients over 12 years of age. (BPC § 3041(e))
This
bill:
Adds “habilitative services” to the definition of the practice of optometry.
Authorizes the Board to establish educational and examination requirements for practices authorized in the Optometry Practice Act, including determining education and examination requirements for the certifications established in the bill.
Authorizes the Board to allow optometrists to use nonsurgical technology to treat a condition authorized by the Act.
Adds “conjunctival” to the types of surface diseases that an optometrist who is certified to use therapeutic pharmaceutical agents may diagnose and treat.
Removes exceptions to the types of infections of the anterior segment and adnexa that an optometrist may treat.
Removes exceptions to the types of ocular inflammation, nonsurgical in cause, that an optometrist may treat.
Allows an optometrist to treat eyelid disorders, including, but not limited to, hypotrichosis and blepharitis.
Expands the number and type of drugs an optometrist certified to use therapeutic pharmaceutical agents may use to include:
All oral and topical diagnostic and therapeutic pharmaceutical agents that are not controlled substances. The use of pharmaceutical agents shall be limited to the use for which the drug has been approved for marketing by the federal Food and Drug Administration (FDA).
Permits off-label drug use if all of the following requirements are met:
The drug is approved by the FDA.
The drug has been recognized for treatment of the condition by either of the following:
The American Hospital Formulary Service’s Drug Information.
Two articles from major peer reviewed medical journals that present data supporting the proposed off-label use or uses as generally safe and effective, unless there is clear and convincing contradictory evidence presented in a major peer reviewed medical journal.
Extends from three to five days the time that codeine with compounds and hydrocodone with specified compounds may be used.
Allows an optometrist to collect a blood specimen by finger prick method.
Authorizes an optometrist to order any clinical laboratory and imaging tests, including those waived by CLIA, related to the practice of optometry, rather than just specified types.
Permits an optometrist to perform a skin test on the superficial lawyer of the skin to diagnose ocular allergies.
Allows an optometrist to prescribe biological or technological corneal devices.
Allows an optometrist to use a needle to remove objects from the cornea, eyelid, and conjunctiva.
Authorizes an optometrist to use mechanical lipid extraction on meibomian glands and nonsurgical techniques.
Authorizes an optometrist to administer injections for the diagnoses or treatment of conditions of the eye and adnexa, excluding intraorbital injections and injections administered for cosmetic effect, provided that the optometrist has satisfactorily received four hours of continuing education.
Expands the definition of glaucoma by including an “increase in intraocular pressure caused by steroid medication.”
Establishes a certification process for an optometrist to perform certain laser procedures.
Establishes a certification course for an optometrist to perform minor procedures. Minor procedures are defined as removal, destruction, or drainage of lesions of the eyelid and adnexa clinically evaluated by the optometrist to be noncancerous, not involving the eyelid margin, lacrimal supply or drainage systems, no deeper than the orbicularis muscle, and smaller than five millimeters in diameter, and closure of a wound, as specified.
Authorizes an optometrist to independently initiate and administer vaccines listed on the routine immunization schedules recommended by the federal Advisory Committee on Immunization Practices (ACIP), in compliance with individual ACIP vaccine recommendations, and published by the federal Centers for Disease Control and Prevention (CDC) for persons three years of age and older, if the optometrist does all of the following:
Complete an immunization training program endorsed by the CDC or the Accreditation Council for Pharmacy Education that, at a minimum, includes hands-on injection technique, clinical evaluation of indications and contraindications of vaccines, and the recognition and treatment of emergency reactions to vaccines, and shall maintain that training.
Be certified in basic life support for health care professionals.
Comply with all state and federal recordkeeping and reporting requirements, including providing documentation to the patient’s primary care provider and entering information in the appropriate immunization registry designated by the immunization branch of the State Department of Public Health.
FISCAL EFFECT:
Unknown. This bill is keyed “fiscal” by Legislative Counsel.
COMMENTS:
Purpose. This bill is sponsored by the Author. According to the Author’s office, “As a result of implementation of the ACA, about 3 million additional Californians are eligible for health insurance and the recently insured are increasing demand for health care on an already strained system. Californians deserve timely access to high quality care offered by a range of safe, efficient, and regulated providers. In California we have a robust network of providers that are well-trained, evenly distributed throughout the state, regulated by the Department of Consumer Affairs and well positioned to pay particular attention to currently underserved areas. Optometrists are one such provider group who receive a doctorate level training preparing them to be primary eye care providers, and independently diagnose and treat conditions of the eye. SB 622 will remove restrictions in current law to permit optometrists to examine, prevent, diagnose, and treat conditions and disorders of the visual system and the human eye to the full extent of their training. This includes the use of two types of therapeutic lasers by optometrists with postdoctoral advanced certification that have been developed for treatment of glaucoma and post- surgical cataract care, conditions that disproportionately affect patient groups that generally lack sufficient access to physicians. SB 622 is a limited expansion of scope for optometrists that is consistent with their education and training, and is a logical advancement of the profession that has been proven safe in other states.”
The Practice of Optometry. An optometrist (Doctor of Optometry or O.D.) is an independent primary health care professional for the eye. Optometrists examine, diagnose, treat, and manage diseases, injuries, and disorders of the visual system, the eye, and associated structures, as well as identify related systemic conditions affecting the eye. ODs prescribe medications, low vision rehabilitation, vision therapy, spectacle lenses, contact lenses, and perform certain surgical procedures. Optometrists have a narrower scope of practice than do ophthalmologists, but are held to the identical standard of care for the same treatments they provide.
An O.D. degree requires both an undergraduate education in a college or university and four years of professional education at a college of optometry. Some optometrists also undertake an optional one year non-surgical residency program to enhance their experience in a particular area. Students graduate with 2,500-3,000 patient encounters; these include a mix of post-surgical, medical and routine visits.
In order to be licensed to practice by the California Board of
Optometry, an individual must obtain an O.D. degree, pass the three
part National Board of Examiners in Optometry examination, and the
California Optometric State Law Examination. There are currently
9,100 optometrists in practice in California.
Optometrists are trained to diagnose mild to severe eye problems such as serious eye infections, inflammations of the eye, trauma, foreign bodies and glaucoma (pressure inside the eyeball). They also examine the eye for vision prescription and corrective lenses. Optometrists may also pursue any of five additional state certifications to perform certain advanced procedures: use of diagnostic pharmaceutical agents (DPA); use of therapeutic pharmaceutical agents (TPA); lacrimal irrigation and dilation for individuals over the age of 12 + TPA (TPL); diagnosis and treatment of open angle glaucoma for adults + TPA (TPG); and a combination of TPA, TPL and TPG.
The Practice of Ophthalmology. An ophthalmologist is a physician and surgeon who has specialty training in the anatomy, function and diseases of the eye. The central focus of ophthalmology is surgery and management of complex eye diseases. An ophthalmologist specializes in the refractive, medical and surgical care of the eyes and visual system, and in the prevention of disease and injury.
To become an ophthalmologist, an individual must obtain an undergraduate degree, complete four years of graduate education at an accredited medical school and earn a Medical Degree, complete a one year internship, and a three or four year residency. Many ophthalmologists pursue additional fellowship training in specialized areas such as the retina, glaucoma treatment or the cornea. Ophthalmologists may become certified by the American Board of Ophthalmology, which requires serving as primary surgeon or first assistant to the primary surgeon on a minimum of 364 eye surgeries.
There are currently 1,800-2,100 ophthalmologists in California, not all of whom are in active practice.
Prior Legislation. SB 492 (Hernandez) would have created an advanced practice certificate, enabling optometrists to perform a limited range of therapeutic laser procedures for the eye and surgical procedures related to the eyelid, as well as certain injections and immunizations, and generally revised the Optometry Practice Act to clarify and expand the range of an optometrist's scope of practice.
(Status: Held on the Assembly Floor.)
SB 1406 (Correa) (Chapter 352, Statutes of 2008) specified permissible procedures for certified optometrists, and created the Glaucoma Diagnosis and Treatment Advisory Committee to establish glaucoma certification requirements.
SB 929 (Polanco) (Chapter 676, Statutes of 2000)
expanded the scope of lawful practice for optometrists by specifying
additional diseases and conditions that optometrists may treat (in
particular certain types of glaucoma) with specified medications, and
by specifying the extent of physician involvement that is required
under various circumstances.
SB 668 (Polanco) (Chapter 13, Statutes of 1996) expanded
the scope of practice of optometrists to provide for the diagnosis
and treatment of specified conditions or diseases of the human eye or
its appendages, and to use other therapeutic pharmaceutical agents.
Arguments in Support. The California Optometric Association writes, “Doctors of optometry have a critical role to play in providing primary care and making the promise of the Affordable Care Act a reality. They already provide the vast majority of eye care in the Medi-Cal program and they are located in all but one California county (Alpine). In order to improve access to health care in California, we must provide timely care where and when it’s needed by utilizing the full complement of our clinical abilities.”
Western University of Health Sciences writes, “[SB 622] makes sense. It requires the same, or higher, standards set by residency education in ophthalmology. It ensures that doctors of optometry will have the appropriate knowledge and skills required to implement the new elements of care that are included in this bill. The legislation has checks and balances in place to ensure that doctors of optometry can safely provide these services to their patients.
Arguments in Opposition. The California Academy of Family Physicians write, “Physicians see many benefits from working collaboratively with other health care professionals to meet patient care demand, but the framework of care delivery should be within the scope of practice that each health care professional is qualified to perform. Arbitrarily allowing allied health care professionals to render services that are beyond a provider’s scope can lead to increased costs through over-utilization of tests, over prescribing of medications, and excess referrals to specialists; and in this case, the potential for incredible harm to patients.”
The California Medical Association writes, “Optometrists serve an important function in the health care community. Specifically, optometrists are health practitioners involved exclusively with vision problems, including examining the eyes to determine the presence of vision problems, determining visual acuity, and prescribing spectacles, contact lenses, and eye exercises. SB 622 proposes expanding the optometrist scope of practice to include a wide range of services that optometrists simply do not have the education, training, and experience to provide.”
Author’s Proposed Amendments: Following lengthy negotiations with stakeholders, the Author is proposing the following amendments:
Authorizes the Board to establish educational and examination requirements by regulation for licensure to ensure the competence of optometrists to practice pursuant to the Act, except as specified in the sections related to certification for minor procedures and lasers.
Authorizes the Board to promulgate regulations authorizing optometrists to use noninvasive, nonsurgical technology to treat a condition authorized by the Act. To qualify to use each new technology authorized, the Board shall require a licensee to take a minimum of four hours’ education and perform an appropriate number of complete clinical procedures on live human patients.
Removes referral requirements related to the treatment of ocular inflammation, as specified.
Allows an optometrist to treat hypotrichosis and blepharitis.
Restores current law related to the use of drugs.
Removes referral protocols for the use of certain drugs.
Restores ordering of additional tests to existing law, but expands ability to order CLIA waived tests.
Authorizes an optometrist, as part of additional “minor procedures,” to administer injections for the diagnosis or treatment of conditions of the eye and adnexa authorized by the Act, excluding intraorbital injections and injections administered for cosmetic effect.
Expands the definition of glaucoma by including that caused by an “increase in intraocular pressure caused by steroid medication,” but specifies that an optometrist may only treat this type of glaucoma if the optometrist has prescribed the steroid, or has consulted with and received approval from, the prescriber.
Establishes a certification process for an optometrist to perform certain laser procedures, requiring 25 hours of education and 24 complete clinical procedures on live human patients.
Establishes continuing education hours for optometrists certified to perform laser procedures.
Establishes a certification course for an optometrist to perform minor procedures. Minor procedures are defined as removal, destruction, or drainage of lesions of the eyelid and adnexa clinically evaluated by the optometrist to be noncancerous, not involving the eyelid margin, lacrimal supply or drainage systems, no deeper than the orbicularis muscle, and smaller than five millimeters in diameter, and closure of a wound, as specified. Specifies that minor procedures do not include blepharoplasty or other cosmetic surgery procedures that reshape normal structures of the body in order to improve appearance and self-esteem. Requires 25 hours of education and 32 complete clinical procedures on live human patients.
Establishes continuing education requirements for optometrists certified to perform minor procedures.
Authorizes an optometrist to earn a certificate to administer immunizations for influenza, herpes zoster, and pneumococcus if the optometrist does all of the following:
Completes an immunization training program endorsed by the CDC, or the Accreditation Council for Pharmacy Education that, at a minimum, includes hands-on injection technique, clinical evaluation of indications and contraindications of vaccines, and the recognition and treatment of emergency reactions to vaccines, and shall maintain that training.
Is certified in basic life support for health care professionals.
Complies with all state and federal recordkeeping and reporting requirements, including providing documentation to the patient’s primary care provider and entering information in the appropriate immunization registry designated by the immunization branch of the State Department of Public Health.
Declares as unprofessional conduct the failure for an optometrist to refer a patient to an appropriate physician if an examination of the eyes indicates a substantial likelihood of any pathology that requires the attention of that physician.
SUPPORT AND OPPOSITION:
Support:
California Optometric Association
Western University of Health Sciences
Opposition:
American Federation of State, County and Municipal Employees (AFSCME)
Blind Childrens Center
California Academy of Eye Physicians & Surgeons (CAEPS)
California Academy of Family Physicians (CAFP)
California Medical Association (CMA)
California Society of Plastic Surgeons (CSPS)
Latino Physicians of California (LPOC)
Ventura County American Chinese Medical Dental Association (VC AC M/D)
Numerous Individuals
-- END --
Discussed in Hearing
View Older HearingsBill Author
Bill Co-Author(s):